LABEL>1
GE, an GE mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in GE organization, cell growth, and fluid-phase endocytosis of GE, a PROTEIN1 mutant defective in PROTEIN2 binding.
LABEL>1
GE, an PROTEIN1 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN2 organization, cell growth, and fluid-phase endocytosis of GE, a GE mutant defective in GE binding.
LABEL>1
The PROTEIN1 monomer-binding protein, PROTEIN2, influences the dynamics of GE filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on GE, and promoting barbed-end assembly.
LABEL>1
The GE monomer-binding protein, GE, influences the dynamics of PROTEIN1 filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN2, and promoting barbed-end assembly.
LABEL>1
The GE monomer-binding protein, PROTEIN1, influences the dynamics of GE filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN2, and promoting barbed-end assembly.
LABEL>1
The GE monomer-binding protein, PROTEIN1, influences the dynamics of PROTEIN2 filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on GE, and promoting barbed-end assembly.
LABEL>1
To study GE function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN1 gene (GE) and examined the consequences of specific point mutations on growth and PROTEIN2 organization.
LABEL>1
To study GE function, we extensively mutagenized the Saccharomyces cerevisiae GE gene (PROTEIN1) and examined the consequences of specific point mutations on growth and PROTEIN2 organization.
LABEL>1
Involvement of PROTEIN1 in the PROTEIN2-based motility of L. monocytogenes in cells and in cell-free extracts.
LABEL>1
Isolation of PROTEIN1 from embryonic chicken skeletal muscle and evaluation of its interaction with different PROTEIN2 isoforms.
LABEL>1
These results indicate that the assembly of GE and PROTEIN1 is regulated differently by PROTEIN2 in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.
LABEL>1
These results indicate that the assembly of PROTEIN1 and GE is regulated differently by PROTEIN2 in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.
LABEL>1
Isolation of human PROTEIN1 and its binding specificity with PROTEIN2.
LABEL>1
It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G PROTEIN1 from PROTEIN2 or promoting the cross-linking of GE or its anchorage to the plasma membrane.
LABEL>1
It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of GE, 120 molecules of PROTEIN1 PROTEIN2, and 60 molecules each of GE and GE.
LABEL>1
Native PROTEIN1, purified from extracts of lung epithelial cells by affinity binding to a poly-L-proline matrix, stimulated the PROTEIN2-saturated RSV transcription by 2.5- to 3-fold.
LABEL>1
It therefore appears that PROTEIN1 and PROTEIN2 multigene families are both expressed in a species specific fashion but are independently regulated within a species.
LABEL>1
Kinetic measurements indicate that PROTEIN1 binding to GE weakens the affinity of PROTEIN2 for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
LABEL>1
Kinetic measurements indicate that GE binding to PROTEIN1 weakens the affinity of PROTEIN2 for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
LABEL>1
Kinetic measurements indicate that PROTEIN1 binding to PROTEIN2 weakens the affinity of GE for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
LABEL>1
The data suggest that GE binding to PROTEIN1 weakens nucleotide binding to GE by disrupting Mg(2+) coordination in the PROTEIN2 central cleft.
LABEL>1
The data suggest that GE binding to GE weakens nucleotide binding to PROTEIN1 by disrupting Mg(2+) coordination in the PROTEIN2 central cleft.
LABEL>1
The data suggest that PROTEIN1 binding to GE weakens nucleotide binding to GE by disrupting Mg(2+) coordination in the PROTEIN2 central cleft.
LABEL>1
The data suggest that GE binding to PROTEIN1 weakens nucleotide binding to PROTEIN2 by disrupting Mg(2+) coordination in the GE central cleft.
LABEL>1
The data suggest that PROTEIN1 binding to PROTEIN2 weakens nucleotide binding to GE by disrupting Mg(2+) coordination in the GE central cleft.
LABEL>1
The data suggest that PROTEIN1 binding to GE weakens nucleotide binding to PROTEIN2 by disrupting Mg(2+) coordination in the GE central cleft.
LABEL>1
Kinetic studies on the effect of yeast PROTEIN1 on yeast PROTEIN2 polymerization.
LABEL>1
The results suggest some cooperativity with respect to PROTEIN1 binding to filamentous PROTEIN2 which may be pH dependent.
LABEL>1
Like GE, the GE-associated proteins GE, PROTEIN1 and the PROTEIN2 were also found to accumulate around entering bacteria.
LABEL>1
Like GE, the GE-associated proteins PROTEIN1, GE and the PROTEIN2 were also found to accumulate around entering bacteria.
LABEL>1
Like GE, the PROTEIN1-associated proteins GE, GE and the PROTEIN2 were also found to accumulate around entering bacteria.
LABEL>1
Like PROTEIN1, the GE-associated proteins GE, GE and the PROTEIN2 were also found to accumulate around entering bacteria.
LABEL>1
Like GE, the GE-associated proteins PROTEIN1, PROTEIN2 and the GE were also found to accumulate around entering bacteria.
LABEL>1
Like GE, the PROTEIN1-associated proteins GE, PROTEIN2 and the GE were also found to accumulate around entering bacteria.
LABEL>1
Like PROTEIN1, the GE-associated proteins GE, PROTEIN2 and the GE were also found to accumulate around entering bacteria.
LABEL>1
Like GE, the PROTEIN1-associated proteins PROTEIN2, GE and the GE were also found to accumulate around entering bacteria.
LABEL>1
Like PROTEIN1, the GE-associated proteins PROTEIN2, GE and the GE were also found to accumulate around entering bacteria.
LABEL>1
Like GE, PROTEIN1 phosphorylated GE specifically at Ser-3 and induced formation of PROTEIN2 stress fibers and focal adhesions.
LABEL>1
Like PROTEIN1, GE phosphorylated GE specifically at Ser-3 and induced formation of PROTEIN2 stress fibers and focal adhesions.
LABEL>1
Like GE, PROTEIN1 phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of GE stress fibers and focal adhesions.
LABEL>1
Like PROTEIN1, GE phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of GE stress fibers and focal adhesions.
LABEL>1
GE (PROTEIN1) phosphorylates GE, an GE, and regulates PROTEIN2 cytoskeletal reorganization.
LABEL>1
PROTEIN1 (GE) phosphorylates GE, an GE, and regulates PROTEIN2 cytoskeletal reorganization.
LABEL>1
GE (GE) phosphorylates PROTEIN1, an PROTEIN2, and regulates GE cytoskeletal reorganization.
LABEL>1
GE (PROTEIN1) phosphorylates PROTEIN2, an GE, and regulates GE cytoskeletal reorganization.
LABEL>1
PROTEIN1 (GE) phosphorylates PROTEIN2, an GE, and regulates GE cytoskeletal reorganization.
LABEL>1
Live dynamics of Dictyostelium PROTEIN1 suggests a role in remodeling PROTEIN2 latticework into bundles.
LABEL>1
These results demonstrate that PROTEIN1 plays a crucial role in vivo in rapid remodeling of the cortical PROTEIN2 meshwork into bundles.
LABEL>1
Localization of GE to the leading edge of a migrating cell can lead to local accumulation of PROTEIN1, which in turn can supply PROTEIN2 monomers to growing filament ends.
LABEL>1
Localization of PROTEIN1 to the leading edge of a migrating cell can lead to local accumulation of PROTEIN2, which in turn can supply GE monomers to growing filament ends.
LABEL>1
Mammalian GE (PROTEIN1) phosphorylate GE and induce PROTEIN2 cytoskeletal reorganization.
LABEL>1
Mammalian PROTEIN1 (GE) phosphorylate GE and induce PROTEIN2 cytoskeletal reorganization.
LABEL>1
Mammalian GE (PROTEIN1) phosphorylate PROTEIN2 and induce GE cytoskeletal reorganization.
LABEL>1
Mammalian PROTEIN1 (GE) phosphorylate PROTEIN2 and induce GE cytoskeletal reorganization.
LABEL>1
MATERIALS AND METHODS: A mutation in the GE (GE) predicted to interfere strongly with PROTEIN1's binding to PROTEIN2 was designed and used to create an animal model for HCM.
LABEL>1
MATERIALS AND METHODS: A mutation in the PROTEIN1 (GE) predicted to interfere strongly with PROTEIN2's binding to GE was designed and used to create an animal model for HCM.
LABEL>1
MATERIALS AND METHODS: A mutation in the GE (PROTEIN1) predicted to interfere strongly with PROTEIN2's binding to GE was designed and used to create an animal model for HCM.
LABEL>1
MATERIALS AND METHODS: A mutation in the PROTEIN1 (GE) predicted to interfere strongly with GE's binding to PROTEIN2 was designed and used to create an animal model for HCM.
LABEL>1
MATERIALS AND METHODS: A mutation in the GE (PROTEIN1) predicted to interfere strongly with GE's binding to PROTEIN2 was designed and used to create an animal model for HCM.
LABEL>1
GE is the previously identified GE, which encodes PROTEIN1, required for proper organization of the PROTEIN2 cytoskeleton.
LABEL>1
GE is the previously identified PROTEIN1, which encodes PROTEIN2, required for proper organization of the GE cytoskeleton.
LABEL>1
Mechanism of inhibition of GE-dependent DNA synthesis by the PROTEIN1 PROTEIN2.
LABEL>1
Mechanism of regulation of PROTEIN1 polymerization by Physarum PROTEIN2.
LABEL>1
The apparent critical concentration for polymerization of PROTEIN1 is increased by the addition of PROTEIN2.
LABEL>1
Membranous staining and concomitant cytoplasmic localization of GE, PROTEIN1 and PROTEIN2 were seen in one case with abnormal GE immunoreactivity.
LABEL>1
Membranous staining and concomitant cytoplasmic localization of PROTEIN1, GE and PROTEIN2 were seen in one case with abnormal GE immunoreactivity.
LABEL>1
Membranous staining and concomitant cytoplasmic localization of PROTEIN1, PROTEIN2 and GE were seen in one case with abnormal GE immunoreactivity.
LABEL>1
METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of GE, GE, GE, GE, and GE; the cell-cell adhesion molecules of GE, GE, and GE; and the PROTEIN1 of PROTEIN2 and GE.
LABEL>1
METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of GE, GE, GE, GE, and GE; the cell-cell adhesion molecules of GE, GE, and GE; and the PROTEIN1 of GE and PROTEIN2.
LABEL>1
Microinjection or stable expression of PROTEIN1 into keratinocytes promotes the loss of GE and GE and relocalization of PROTEIN2 to the cytoplasm and nucleus.
LABEL>1
Microinjection or stable expression of PROTEIN1 into keratinocytes promotes the loss of PROTEIN2 and GE and relocalization of GE to the cytoplasm and nucleus.
LABEL>1
Microinjection or stable expression of PROTEIN1 into keratinocytes promotes the loss of GE and PROTEIN2 and relocalization of GE to the cytoplasm and nucleus.
LABEL>1
GE is fused in-frame to a different exon of GE in two patients producing chimeric proteins containing the AT-hooks, GE homology domain, and transcriptional repression domain of GE fused to the PROTEIN1 binding domain or to the bromodomain of PROTEIN2.
LABEL>1
GE is fused in-frame to a different exon of GE in two patients producing chimeric proteins containing the AT-hooks, PROTEIN1 homology domain, and transcriptional repression domain of PROTEIN2 fused to the GE binding domain or to the bromodomain of GE.
LABEL>1
Modifying preselected sites on proteins: the stretch of residues 633-642 of the PROTEIN1 is part of the PROTEIN2-binding site.
LABEL>1
Molecular analysis of the PROTEIN1-GE complex elucidated the central role of PROTEIN2 in this adhesion complex, as it binds to the cytoplasmic domain of GE and to GE.
LABEL>1
Molecular analysis of the GE-PROTEIN1 complex elucidated the central role of PROTEIN2 in this adhesion complex, as it binds to the cytoplasmic domain of GE and to GE.
LABEL>1
Molecular analysis of the GE-GE complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of GE and to PROTEIN2.
LABEL>1
Molecular analysis of the GE-GE complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN2 and to GE.
LABEL>1
Molecular analysis of the PROTEIN1-PROTEIN2 complex elucidated the central role of GE in this adhesion complex, as it binds to the cytoplasmic domain of GE and to GE.
LABEL>1
PROTEIN1 may also function in signalling pathways, given its homology to the gene product of the Drosophila segment polarity gene PROTEIN2, which is known to be involved in the wingless signalling cascade.
LABEL>1
Molecular cloning and primary structure analysis demonstrated that GE is homologous to GE and the PROTEIN1 is homologous to human PROTEIN2 and the Drosophila gene product GE.
LABEL>1
Molecular cloning and primary structure analysis demonstrated that GE is homologous to GE and the PROTEIN1 is homologous to human GE and the Drosophila gene product PROTEIN2.
LABEL>1
Molecular cloning and primary structure analysis demonstrated that PROTEIN1 is homologous to PROTEIN2 and the GE is homologous to human GE and the Drosophila gene product GE.
LABEL>1
One complex is composed of GE, GE and GE, the other of PROTEIN1, GE and PROTEIN2.
LABEL>1
One complex is composed of GE, GE and GE, the other of PROTEIN1, PROTEIN2 and GE.
LABEL>1
One complex is composed of GE, GE and GE, the other of GE, PROTEIN1 and PROTEIN2.
LABEL>1
One complex is composed of PROTEIN1, PROTEIN2 and GE, the other of GE, GE and GE.
LABEL>1
One complex is composed of GE, PROTEIN1 and PROTEIN2, the other of GE, GE and GE.
LABEL>1
One complex is composed of PROTEIN1, GE and PROTEIN2, the other of GE, GE and GE.
LABEL>1
[Molecular functions of PROTEIN1 which regulates reorganization of PROTEIN2 cytoskeleton].
LABEL>1
Molecules known to link PROTEIN1 filaments to membrane were also examined, including GE, PROTEIN2, GE, and GE, but none was identified at the host-parasite junction.
LABEL>1
Molecules known to link PROTEIN1 filaments to membrane were also examined, including GE, GE, PROTEIN2, and GE, but none was identified at the host-parasite junction.
LABEL>1
Molecules known to link PROTEIN1 filaments to membrane were also examined, including GE, GE, GE, and PROTEIN2, but none was identified at the host-parasite junction.
LABEL>1
Molecules known to link PROTEIN1 filaments to membrane were also examined, including PROTEIN2, GE, GE, and GE, but none was identified at the host-parasite junction.
LABEL>1
Other PROTEIN1-associated proteins, including PROTEIN2, GE, and GE, are not present.
LABEL>1
Other PROTEIN1-associated proteins, including GE, GE, and PROTEIN2, are not present.
LABEL>1
Other PROTEIN1-associated proteins, including GE, PROTEIN2, and GE, are not present.
LABEL>1
Monoclonal antibodies recognizing the N- and C-terminal regions of PROTEIN1 disrupt PROTEIN2 stress fibers when microinjected into human fibroblasts.
LABEL>1
These results show that the C-terminal GE-binding site is distinct from the region recognized by the anti-functional antibody PROTEIN1, raising the possibility that it binds to a novel functionally important ligand-binding site in the PROTEIN2 molecule.
LABEL>1
These results show that the C-terminal PROTEIN1-binding site is distinct from the region recognized by the anti-functional antibody GE, raising the possibility that it binds to a novel functionally important ligand-binding site in the PROTEIN2 molecule.
LABEL>1
To investigate the possibility that PROTEIN1 disrupts GE stress fibers by binding directly to the C-terminal GE binding site, additional PROTEIN2 fusion proteins were generated and analyzed for GE and GE binding.
LABEL>1
To investigate the possibility that GE disrupts GE stress fibers by binding directly to the C-terminal PROTEIN1 binding site, additional PROTEIN2 fusion proteins were generated and analyzed for GE and GE binding.
LABEL>1
To investigate the possibility that GE disrupts GE stress fibers by binding directly to the C-terminal GE binding site, additional PROTEIN1 fusion proteins were generated and analyzed for GE and PROTEIN2 binding.
LABEL>1
To investigate the possibility that GE disrupts GE stress fibers by binding directly to the C-terminal GE binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN2 and GE binding.
LABEL>1
To investigate the possibility that GE disrupts PROTEIN1 stress fibers by binding directly to the C-terminal GE binding site, additional PROTEIN2 fusion proteins were generated and analyzed for GE and GE binding.
LABEL>1
To investigate the possibility that PROTEIN1 disrupts PROTEIN2 stress fibers by binding directly to the C-terminal GE binding site, additional GE fusion proteins were generated and analyzed for GE and GE binding.
LABEL>1
Moreover, GE, but not PROTEIN1 or GE, appears to co-localize with PROTEIN2 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following GE cross-linking.
LABEL>1
Moreover, GE, but not GE or PROTEIN1, appears to co-localize with PROTEIN2 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following GE cross-linking.
LABEL>1
Moreover, PROTEIN1, but not GE or GE, appears to co-localize with PROTEIN2 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following GE cross-linking.
LABEL>1
Moreover, ectopic expression of GE and GE can stimulate the PROTEIN1 promoter in an PROTEIN2-dependent manner, and this is inhibited by coexpression of the GE(GE) GE.
LABEL>1
Moreover, ectopic expression of GE and GE can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the PROTEIN1(GE) PROTEIN2.
LABEL>1
Moreover, ectopic expression of GE and GE can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(PROTEIN1) PROTEIN2.
LABEL>1
Moreover, ectopic expression of GE and PROTEIN1 can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the PROTEIN2(GE) GE.
LABEL>1
Moreover, ectopic expression of GE and GE can stimulate the PROTEIN1 promoter in an GE-dependent manner, and this is inhibited by coexpression of the PROTEIN2(GE) GE.
LABEL>1
Moreover, ectopic expression of PROTEIN1 and GE can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the PROTEIN2(GE) GE.
LABEL>1
Moreover, ectopic expression of GE and PROTEIN1 can stimulate the PROTEIN2 promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(GE) GE.
LABEL>1
Moreover, ectopic expression of GE and PROTEIN1 can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(PROTEIN2) GE.
LABEL>1
Moreover, ectopic expression of GE and GE can stimulate the PROTEIN1 promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(PROTEIN2) GE.
LABEL>1
Moreover, ectopic expression of PROTEIN1 and GE can stimulate the PROTEIN2 promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(GE) GE.
LABEL>1
Moreover, ectopic expression of PROTEIN1 and GE can stimulate the GE promoter in an GE-dependent manner, and this is inhibited by coexpression of the GE(PROTEIN2) GE.
LABEL>1
pH control of PROTEIN1 polymerization by PROTEIN2.
LABEL>1
Most of these PROTEIN1, with their intracellular domains, interact with the GE-containing cytoskeleton, via linking proteins such as GE and PROTEIN2, while one of them interacts with the GE filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most of these PROTEIN1, with their intracellular domains, interact with the GE-containing cytoskeleton, via linking proteins such as PROTEIN2 and GE, while one of them interacts with the GE filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most of these PROTEIN1, with their intracellular domains, interact with the PROTEIN2-containing cytoskeleton, via linking proteins such as GE and GE, while one of them interacts with the GE filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most of these PROTEIN1, with their intracellular domains, interact with the GE-containing cytoskeleton, via linking proteins such as GE and GE, while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most of these GE, with their intracellular domains, interact with the PROTEIN1-containing cytoskeleton, via linking proteins such as GE and PROTEIN2, while one of them interacts with the GE filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most of these GE, with their intracellular domains, interact with the PROTEIN1-containing cytoskeleton, via linking proteins such as PROTEIN2 and GE, while one of them interacts with the GE filaments, via an as yet unknown linking molecule(s).
LABEL>1
Most previous studies have focused on PROTEIN1 itself rather than its complex with PROTEIN2.
LABEL>1
Motile areas of leech neurites are rich in microfilaments and two PROTEIN1: PROTEIN2 and GE.
LABEL>1
Motile areas of leech neurites are rich in microfilaments and two PROTEIN1: GE and PROTEIN2.
LABEL>1
The colocalization of GE and PROTEIN1 in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the PROTEIN2 dynamics that underlie neurite growth.
LABEL>1
The colocalization of PROTEIN1 and PROTEIN2 in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the GE dynamics that underlie neurite growth.
LABEL>1
The colocalization of PROTEIN1 and GE in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the PROTEIN2 dynamics that underlie neurite growth.
LABEL>1
Mutants of GE and PROTEIN1, which encode GE and PROTEIN2 respectively, display disorganized GE patches in all cells.
LABEL>1
Mutants of PROTEIN1 and GE, which encode PROTEIN2 and GE respectively, display disorganized GE patches in all cells.
LABEL>1
Mutations in GE and PROTEIN1, the two yeast PROTEIN2 homologs, cause very similar growth phenotypes, a depolarized GE cytoskeleton, and a defect in the internalization step of endocytosis.
LABEL>1
Mutations in GE and PROTEIN1, the two yeast GE homologs, cause very similar growth phenotypes, a depolarized PROTEIN2 cytoskeleton, and a defect in the internalization step of endocytosis.
LABEL>1
Mutations in PROTEIN1 and GE, the two yeast PROTEIN2 homologs, cause very similar growth phenotypes, a depolarized GE cytoskeleton, and a defect in the internalization step of endocytosis.
LABEL>1
Mutations in PROTEIN1 and GE, the two yeast GE homologs, cause very similar growth phenotypes, a depolarized PROTEIN2 cytoskeleton, and a defect in the internalization step of endocytosis.
LABEL>1
Mutations that alter putative RNA-binding residues of either GE RRM are lethal in vivo, but do not prevent binding to GE in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN1 are not required for interaction with PROTEIN2.
LABEL>1
Mutations that alter putative RNA-binding residues of either PROTEIN1 RRM are lethal in vivo, but do not prevent binding to PROTEIN2 in vitro, suggesting that the predicted RNA-binding surfaces of GE are not required for interaction with GE.
LABEL>1
Recombinant PROTEIN1 protein has a general RNA-binding activity that does not require PROTEIN2.
LABEL>1
PROTEIN1 shows homology to the head domains and the coiledcoil tail of the conventional GE and carries putative binding sites for ATP and PROTEIN2.
LABEL>1
PROTEIN1 shows homology to the head domains and the coiledcoil tail of the conventional PROTEIN2 and carries putative binding sites for ATP and GE.
LABEL>1
Neither can PROTEIN1, in the presence of the peptide, promote PROTEIN2 polymerization during its early phase consistent with a lower affinity.
LABEL>1
The resulting GE-peptide complex overcomes the combined capacity of GE and PROTEIN1 to inhibit PROTEIN2 nucleation and restores the extent of filament formation.
LABEL>1
The resulting GE-peptide complex overcomes the combined capacity of PROTEIN1 and GE to inhibit PROTEIN2 nucleation and restores the extent of filament formation.
LABEL>1
The resulting PROTEIN1-peptide complex overcomes the combined capacity of GE and GE to inhibit PROTEIN2 nucleation and restores the extent of filament formation.
LABEL>1
Newly disclosed interactions between GE, exchange factors for PROTEIN1 proteinGE of the PROTEIN2 and GE families, the translational regulator GE, and GE like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between GE, exchange factors for PROTEIN1 proteinGE of the GE and GE families, the translational regulator PROTEIN2, and GE like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between GE, exchange factors for PROTEIN1 proteinGE of the GE and GE families, the translational regulator GE, and PROTEIN2 like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between PROTEIN1, exchange factors for PROTEIN2 proteinGE of the GE and GE families, the translational regulator GE, and GE like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between GE, exchange factors for PROTEIN1 proteinGE of the GE and PROTEIN2 families, the translational regulator GE, and GE like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between GE, exchange factors for GE proteinGE of the GE and GE families, the translational regulator PROTEIN1, and PROTEIN2 like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between PROTEIN1, exchange factors for GE proteinGE of the GE and GE families, the translational regulator PROTEIN2, and GE like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between GE, exchange factors for GE proteinGE of the GE and GE families, the translational regulator GE, and PROTEIN1 like PROTEIN2 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
Newly disclosed interactions between PROTEIN1, exchange factors for GE proteinGE of the GE and GE families, the translational regulator GE, and PROTEIN2 like GE might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
LABEL>1
N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of GE assembly through its association with the PROTEIN1, PROTEIN2, and GE.
LABEL>1
N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of GE assembly through its association with the PROTEIN1, GE, and PROTEIN2.
LABEL>1
N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN1 assembly through its association with the GE, PROTEIN2, and GE.
LABEL>1
N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN1 assembly through its association with the GE, GE, and PROTEIN2.
LABEL>1
Notably, the two pro-apoptotic adapter proteins GE and PROTEIN1 are also involved in the activation of PROTEIN2.
LABEL>1
Notably, the two pro-apoptotic adapter proteins PROTEIN1 and GE are also involved in the activation of PROTEIN2.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of PROTEIN1 (GE) in acting synergistically with GE (GE) to induce cartilage GE breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of PROTEIN1 (GE) in acting synergistically with PROTEIN2 (GE) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of PROTEIN1 (GE) in acting synergistically with GE (PROTEIN2) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of PROTEIN1 (GE) in acting synergistically with GE (GE) to induce cartilage PROTEIN2 breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding PROTEIN1 can mimic the effects of GE (GE) in acting synergistically with GE (GE) to induce cartilage GE breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (GE) in acting synergistically with PROTEIN1 (GE) to induce cartilage GE breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (GE) in acting synergistically with GE (PROTEIN1) to induce cartilage GE breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (PROTEIN1) in acting synergistically with GE (GE) to induce cartilage GE breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding PROTEIN1 can mimic the effects of GE (GE) in acting synergistically with PROTEIN2 (GE) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding PROTEIN1 can mimic the effects of GE (GE) in acting synergistically with GE (PROTEIN2) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding PROTEIN1 can mimic the effects of GE (GE) in acting synergistically with GE (GE) to induce cartilage PROTEIN2 breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other PROTEIN1 (GE) binding PROTEIN2 can mimic the effects of GE (GE) in acting synergistically with GE (GE) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (PROTEIN1) binding PROTEIN2 can mimic the effects of GE (GE) in acting synergistically with GE (GE) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (GE) in acting synergistically with PROTEIN1 (GE) to induce cartilage PROTEIN2 breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (PROTEIN1) in acting synergistically with PROTEIN2 (GE) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (GE) in acting synergistically with GE (PROTEIN1) to induce cartilage PROTEIN2 breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (PROTEIN1) in acting synergistically with GE (PROTEIN2) to induce cartilage GE breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
OBJECTIVE: To determine whether other GE (GE) binding GE can mimic the effects of GE (PROTEIN1) in acting synergistically with GE (GE) to induce cartilage PROTEIN2 breakdown and GE expression, and to determine which receptors mediate these effects.
LABEL>1
GE and GE were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1 PROTEIN2, and GE was released.
LABEL>1
PROTEIN1 and GE were phosphorylated before the infected myotubes entered S phase, despite the high expression of the GE PROTEIN2, and GE was released.
LABEL>1
GE and PROTEIN1 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the GE PROTEIN2, and GE was released.
LABEL>1
Once the GE monomer is bound to the filament, the PROTEIN1 is released, and is available to bind to additional PROTEIN2 monomers.
LABEL>1
One involves PROTEIN1, which has recently been shown to bind PROTEIN2 directly.
LABEL>1
One, GE (also called GE), binds to GE/GE but not to GE; another, PROTEIN1, binds to the GE GE but not to GE/PROTEIN2; and the third, GE, binds weakly to both receptors.
LABEL>1
One, PROTEIN1 (also called GE), binds to GE/GE but not to PROTEIN2; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, PROTEIN1 (also called GE), binds to GE/PROTEIN2 but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, PROTEIN1 (also called GE), binds to PROTEIN2/GE but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to GE/GE but not to GE; another, PROTEIN1, binds to the GE GE but not to PROTEIN2/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to GE/GE but not to GE; another, PROTEIN1, binds to the PROTEIN2 GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called PROTEIN1), binds to GE/GE but not to PROTEIN2; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to GE/GE but not to PROTEIN1; another, GE, binds to the GE GE but not to GE/GE; and the third, PROTEIN2, binds weakly to both receptors.
LABEL>1
One, GE (also called PROTEIN1), binds to GE/PROTEIN2 but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called PROTEIN1), binds to PROTEIN2/GE but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to GE/PROTEIN1 but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, PROTEIN2, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to PROTEIN1/GE but not to GE; another, GE, binds to the GE GE but not to GE/GE; and the third, PROTEIN2, binds weakly to both receptors.
LABEL>1
One, GE (also called GE), binds to GE/GE but not to GE; another, GE, binds to the PROTEIN1 PROTEIN2 but not to GE/GE; and the third, GE, binds weakly to both receptors.
LABEL>1
One mutation, GE, is in the gene encoding PROTEIN1, another PROTEIN2, which was expected because null mutations in GE and GE are known to be synthetic-lethal.
LABEL>1
One such protein is the yeast PROTEIN1 PROTEIN2, which is homologous to vertebrate GE (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).
LABEL>1
One such protein is the yeast GE PROTEIN1, which is homologous to vertebrate PROTEIN2 (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).
LABEL>1
Only the unphosphorylated form of PROTEIN1 is an active form that binds PROTEIN2, whereas the regulatory mechanisms of GE have not been elucidated.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and PROTEIN1), the GE (PROTEIN2), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and PROTEIN1), the GE (GE), and the viral GE (PROTEIN2) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components (GE, GE, and PROTEIN2), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and PROTEIN1), the GE (GE), and the viral PROTEIN2 (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, GE, and PROTEIN2), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, PROTEIN1, and PROTEIN2), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and PROTEIN1), the PROTEIN2 (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and GE), the GE (PROTEIN1), and the viral GE (PROTEIN2) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and GE), the GE (PROTEIN1), and the viral PROTEIN2 (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, GE, and GE), the GE (PROTEIN2), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, PROTEIN1, and GE), the GE (PROTEIN2), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, GE, and GE), the GE (GE), and the viral GE (PROTEIN2) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, PROTEIN1, and GE), the GE (GE), and the viral GE (PROTEIN2) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and GE), the PROTEIN1 (GE), and the viral GE (PROTEIN2) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components (PROTEIN2, GE, and GE), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components (GE, PROTEIN2, and GE), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, GE, and GE), the GE (GE), and the viral PROTEIN2 (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, PROTEIN1, and GE), the GE (GE), and the viral PROTEIN2 (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, GE, and GE), the PROTEIN1 (GE), and the viral PROTEIN2 (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, PROTEIN2, and GE), the GE (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (PROTEIN1, GE, and GE), the PROTEIN2 (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
On the basis of these results, we present a model for prereplicative site formation in infected cells in which the GE components (GE, PROTEIN1, and GE), the PROTEIN2 (GE), and the viral GE (GE) assemble together to initiate the process.
LABEL>1
We observed that four replication proteins, GE, GE GE, and PROTEIN1, are necessary for the localization of PROTEIN2 (GE) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, GE, GE PROTEIN1, and GE, are necessary for the localization of PROTEIN2 (GE) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, GE, PROTEIN1 GE, and GE, are necessary for the localization of PROTEIN2 (GE) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, PROTEIN1, GE GE, and GE, are necessary for the localization of PROTEIN2 (GE) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, GE, GE GE, and PROTEIN1, are necessary for the localization of GE (PROTEIN2) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, GE, GE PROTEIN1, and GE, are necessary for the localization of GE (PROTEIN2) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, GE, PROTEIN1 GE, and GE, are necessary for the localization of GE (PROTEIN2) to prereplicative sites natural infection conditions.
LABEL>1
We observed that four replication proteins, PROTEIN1, GE GE, and GE, are necessary for the localization of GE (PROTEIN2) to prereplicative sites natural infection conditions.
LABEL>1
On the other hand, we have recently proposed the importance of PROTEIN1, an PROTEIN2-binding phosphoprotein, in phagocyte functions through dephosphorylation and translocation to the plasma membrane regions.
LABEL>1
Other mammalian GE such as GE and PROTEIN1 but also GE from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN2(GE) phosphorylation.
LABEL>1
Other mammalian GE such as GE and PROTEIN1 but also GE from Physarum polycephalum are similar targets for PIP2-stimulated GE(PROTEIN2) phosphorylation.
LABEL>1
Other mammalian PROTEIN1 such as GE and PROTEIN2 but also GE from Physarum polycephalum are similar targets for PIP2-stimulated GE(GE) phosphorylation.
LABEL>1
Other mammalian GE such as GE and GE but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN2(GE) phosphorylation.
LABEL>1
Other mammalian GE such as GE and GE but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated GE(PROTEIN2) phosphorylation.
LABEL>1
Other mammalian PROTEIN1 such as GE and GE but also PROTEIN2 from Physarum polycephalum are similar targets for PIP2-stimulated GE(GE) phosphorylation.
LABEL>1
Other mammalian GE such as PROTEIN1 and GE but also GE from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN2(GE) phosphorylation.
LABEL>1
Other mammalian GE such as PROTEIN1 and GE but also GE from Physarum polycephalum are similar targets for PIP2-stimulated GE(PROTEIN2) phosphorylation.
LABEL>1
Other mammalian PROTEIN1 such as PROTEIN2 and GE but also GE from Physarum polycephalum are similar targets for PIP2-stimulated GE(GE) phosphorylation.
LABEL>1
Other than monomeric PROTEIN1, no major PROTEIN2 ligands are detected in crude extracts.
LABEL>1
Our results show that the major pool of polymerizable PROTEIN1 monomers is complexed with PROTEIN2 and spread throughout the cytoplasm.
LABEL>1
Selective monoclonal antibodies confirm that most of the PROTEIN1 is bound to PROTEIN2: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.
LABEL>1
We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN1 is bound to its known ligands: GE, membrane PIP(2), PROTEIN2rGE/3 complex and polyproline sequences.
LABEL>1
We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much GE is bound to its known ligands: GE, membrane PIP(2), PROTEIN1rGE/3 complex and polyproline sequences.
LABEL>1
We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN1 is bound to its known ligands: PROTEIN2, membrane PIP(2), GErGE/3 complex and polyproline sequences.
LABEL>1
We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN1 is bound to its known ligands: GE, membrane PIP(2), PROTEIN2rGE/3 complex and polyproline sequences.
LABEL>1
Our data indicate that even GE of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN1 are engaged in regulating either the stability or the kinetic properties of PROTEIN2 filaments.
LABEL>1
Our data, which suggest that pollen PROTEIN1 can regulate GE-based cytoskeletal protein assembly and PROTEIN2roteiGE or phosphatase activity, indicate a possible role for the involvement of GE in signaling pathways that may regulate pollen tube growth.
LABEL>1
Our data, which suggest that pollen PROTEIN1 can regulate GE-based cytoskeletal protein assembly and PROTEIN2roteiGE or phosphatase activity, indicate a possible role for the involvement of GE in signaling pathways that may regulate pollen tube growth.
LABEL>1
Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with GE and PROTEIN2 but not with GE.
LABEL>1
Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with PROTEIN2 and GE but not with GE.
LABEL>1
Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with GE and GE but not with PROTEIN2.
LABEL>1
Our results showed that cell morphology, cell adhesion pattern, GE organization, and distribution of PROTEIN1 subunits, GE, GE, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2.
LABEL>1
Our results showed that cell morphology, cell adhesion pattern, GE organization, and distribution of GE subunits, GE, PROTEIN1, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2.
LABEL>1
Our results showed that cell morphology, cell adhesion pattern, GE organization, and distribution of GE subunits, PROTEIN1, GE, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2.
LABEL>1
Our results showed that cell morphology, cell adhesion pattern, PROTEIN1 organization, and distribution of GE subunits, GE, GE, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2.
LABEL>1
Overexpression of a gene fragment encoding the GE binding domain of PROTEIN1 stimulates transcription from the PROTEIN2 gene promoter.
LABEL>1
Overexpression of a gene fragment encoding the PROTEIN1 binding domain of PROTEIN2 stimulates transcription from the GE gene promoter.
LABEL>1
Overexpression of PROTEIN1 stimulates bundling of PROTEIN2 filaments, membrane ruffling, and cell movement in Dictyostelium.
LABEL>1
Overexpression of GE and PROTEIN1 (PROTEIN2): effect on cell cycle regulation in HeLa cells.
LABEL>1
PROTEIN1 (GE/GE), a GE, induces G1 arrest and can inhibit the activity of the GE (PROTEIN2).
LABEL>1
PROTEIN1 (GE/GE), a GE, induces G1 arrest and can inhibit the activity of the PROTEIN2 (GE).
LABEL>1
PROTEIN1 (GE/GE), a PROTEIN2, induces G1 arrest and can inhibit the activity of the GE (GE).
LABEL>1
GE (GE/PROTEIN1), a GE, induces G1 arrest and can inhibit the activity of the GE (PROTEIN2).
LABEL>1
GE (PROTEIN1/GE), a GE, induces G1 arrest and can inhibit the activity of the GE (PROTEIN2).
LABEL>1
GE (GE/PROTEIN1), a GE, induces G1 arrest and can inhibit the activity of the PROTEIN2 (GE).
LABEL>1
GE (GE/PROTEIN1), a PROTEIN2, induces G1 arrest and can inhibit the activity of the GE (GE).
LABEL>1
GE (PROTEIN1/GE), a GE, induces G1 arrest and can inhibit the activity of the PROTEIN2 (GE).
LABEL>1
GE (PROTEIN1/GE), a PROTEIN2, induces G1 arrest and can inhibit the activity of the GE (GE).
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the PROTEIN1, GE(PROTEIN2/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the PROTEIN1, GE(GE/PROTEIN2), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the PROTEIN1, PROTEIN2(GE/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-PROTEIN1 activity was associated with increased binding of the GE, GE(PROTEIN2/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, GE(PROTEIN1/GE), to the PROTEIN2-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, GE(PROTEIN1/GE), to the GE-PROTEIN2 complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-GE activity was associated with increased binding of the GE, GE(PROTEIN2/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-PROTEIN1 activity was associated with increased binding of the GE, GE(GE/GE), to the PROTEIN2-GE complex.
LABEL>1
GE-dependent downregulation of GE-PROTEIN1 activity was associated with increased binding of the GE, GE(GE/PROTEIN2), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-PROTEIN1 activity was associated with increased binding of the GE, GE(GE/GE), to the GE-PROTEIN2 complex.
LABEL>1
PROTEIN1-dependent downregulation of GE-PROTEIN2 activity was associated with increased binding of the GE, GE(GE/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-PROTEIN2 activity was associated with increased binding of the GE, GE(GE/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-PROTEIN1 activity was associated with increased binding of the GE, PROTEIN2(GE/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, GE(GE/PROTEIN1), to the PROTEIN2-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, GE(GE/GE), to the PROTEIN1-PROTEIN2 complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-GE activity was associated with increased binding of the GE, GE(GE/GE), to the PROTEIN2-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, PROTEIN1(GE/GE), to the PROTEIN2-GE complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, GE(GE/PROTEIN1), to the GE-PROTEIN2 complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-GE activity was associated with increased binding of the GE, GE(GE/PROTEIN2), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-GE activity was associated with increased binding of the GE, GE(GE/GE), to the GE-PROTEIN2 complex.
LABEL>1
GE-dependent downregulation of GE-GE activity was associated with increased binding of the GE, PROTEIN1(GE/GE), to the GE-PROTEIN2 complex.
LABEL>1
PROTEIN1-dependent downregulation of PROTEIN2-GE activity was associated with increased binding of the GE, GE(GE/GE), to the GE-GE complex.
LABEL>1
GE-dependent downregulation of PROTEIN1-GE activity was associated with increased binding of the GE, PROTEIN2(GE/GE), to the GE-GE complex.
LABEL>1
Phosphorylation of PROTEIN1 by GE was not affected by the presence of various concentrations of PROTEIN2.
LABEL>1
Phosphorylation of GE by PROTEIN1 was not affected by the presence of various concentrations of PROTEIN2.
LABEL>1
Phosphorylation of PROTEIN1 by PROTEIN2 was not affected by the presence of various concentrations of GE.
LABEL>1
Phosphorylation of the headpiece domain could regulate the PROTEIN1 binding and bundling properties of PROTEIN2, or it could regulate the interaction of GE with other proteins.
LABEL>1
Phosphorylation of the headpiece domain could regulate the GE binding and bundling properties of PROTEIN1, or it could regulate the interaction of PROTEIN2 with other proteins.
LABEL>1
Photochemical cleavage of PROTEIN1 and the effect on the interaction with PROTEIN2.
LABEL>1
Previous studies have yielded conflicting results concerning the physiological role of PROTEIN1, a 12-15-kD PROTEIN2- and phosphoinositide-binding protein, as a regulator of GE polymerization.
LABEL>1
Previous studies have yielded conflicting results concerning the physiological role of PROTEIN1, a 12-15-kD GE- and phosphoinositide-binding protein, as a regulator of PROTEIN2 polymerization.
LABEL>1
Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of PROTEIN1 and GE with PROTEIN2.
LABEL>1
Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of GE and PROTEIN1 with PROTEIN2.
LABEL>1
GE and PROTEIN1 have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric PROTEIN2 to the same extent.
LABEL>1
PROTEIN1 and GE have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric PROTEIN2 to the same extent.
LABEL>1
PROTEIN1 and PROTEIN2 have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric GE to the same extent.
LABEL>1
GE binds PROTEIN1 with a similar affinity to that of PROTEIN2, although it inhibits GE polymerization more strongly than GE under non-equilibrium conditions.
LABEL>1
PROTEIN1 binds PROTEIN2 with a similar affinity to that of GE, although it inhibits GE polymerization more strongly than GE under non-equilibrium conditions.
LABEL>1
PROTEIN1 binds GE with a similar affinity to that of GE, although it inhibits PROTEIN2 polymerization more strongly than GE under non-equilibrium conditions.
LABEL>1
GE binds GE with a similar affinity to that of GE, although it inhibits PROTEIN1 polymerization more strongly than PROTEIN2 under non-equilibrium conditions.
LABEL>1
Since functional characteristics for PROTEIN1 are lacking, we assayed the PROTEIN2, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.
LABEL>1
GE is generally thought to regulate GE polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN1 and PROTEIN2 raised the possibility that GE might also regulate lipid metabolism.
LABEL>1
PROTEIN1 is generally thought to regulate PROTEIN2 polymerization, but the observation that acidic phospholipids dissociate the complex of GE and GE raised the possibility that GE might also regulate lipid metabolism.
LABEL>1
The PROTEIN1 PROTEIN2 binds to PIP2 and inhibits its hydrolysis by GE.
LABEL>1
The cellular concentrations and binding characteristics of these molecules are consistent with PROTEIN1 being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of PROTEIN2 polymerization.
LABEL>1
GE also bind polyphosphoinositides, which can disrupt the PROTEIN1-PROTEIN2 complex, and proline-rich ligands which localize GE to sites requiring extensive GE filament accumulation.
LABEL>1
PROTEIN1 also bind polyphosphoinositides, which can disrupt the GE-PROTEIN2 complex, and proline-rich ligands which localize GE to sites requiring extensive GE filament accumulation.
LABEL>1
PROTEIN1 also bind polyphosphoinositides, which can disrupt the PROTEIN2-GE complex, and proline-rich ligands which localize GE to sites requiring extensive GE filament accumulation.
LABEL>1
Protein phosphorylation of PROTEIN1, an PROTEIN2 that depolymerizes GE filaments, suppresses its function.
LABEL>1
Protein phosphorylation of PROTEIN1, an GE that depolymerizes PROTEIN2 filaments, suppresses its function.
LABEL>1
PROTEIN1 fragments form complexes with GE, PROTEIN2, and GE, all components of adherens junctions.
LABEL>1
PROTEIN1 fragments form complexes with PROTEIN2, GE, and GE, all components of adherens junctions.
LABEL>1
PROTEIN1 fragments form complexes with GE, GE, and PROTEIN2, all components of adherens junctions.
LABEL>1
GE fragments form complexes with PROTEIN1, PROTEIN2, and GE, all components of adherens junctions.
LABEL>1
GE fragments form complexes with GE, PROTEIN1, and PROTEIN2, all components of adherens junctions.
LABEL>1
GE fragments form complexes with PROTEIN1, GE, and PROTEIN2, all components of adherens junctions.
LABEL>1
The presence of GE in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a PROTEIN1 mediated mechanism for the attachment of PROTEIN2 filaments to the cell surfaces in the cleavage furrow.
LABEL>1
Pyrenyliodoacetamide labeling of cysteine 374 of PROTEIN1 reduces the affinity for PROTEIN2 10-fold.
LABEL>1
Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of PROTEIN1 for PROTEIN2.
LABEL>1
Three methods, fluorescence anisotropy of rhodamine-labeled GE, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba PROTEIN1 binding amoeba PROTEIN2 monomers with bound Mg-ATP.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1, GE, GE, PROTEIN2, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, PROTEIN1, GE, PROTEIN2, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, GE, GE, PROTEIN1, and PROTEIN2.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, GE, PROTEIN1, PROTEIN2, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1, PROTEIN2, GE, GE, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1, GE, GE, GE, and PROTEIN2.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1, GE, PROTEIN2, GE, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, PROTEIN1, GE, GE, and PROTEIN2.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, PROTEIN1, PROTEIN2, GE, and GE.
LABEL>1
Quantitation of the appearance of GE banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: GE, GE, PROTEIN1, GE, and PROTEIN2.
LABEL>1
Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana GE (GE) is a member of the PROTEIN1 family of PROTEIN2 filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
LABEL>1
Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN1 (GE) is a member of the PROTEIN2 family of GE filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
LABEL>1
Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana GE (PROTEIN1) is a member of the PROTEIN2 family of GE filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
LABEL>1
Recently we reported that the isolated 23 kDa N-terminal fragment of PROTEIN1, which contains the 'consensus' ATP binding site, binds to PROTEIN2 in an ATP-sensitive manner (Muhlrad, A. (1989) Biochemistry 28, 4002).
LABEL>1
Recombinant human PROTEIN1 can simultaneously bind to the GE/GE complex but does not bind PROTEIN2 directly.
LABEL>1
Recombinant human PROTEIN1 can simultaneously bind to the GE/PROTEIN2 complex but does not bind GE directly.
LABEL>1
Recombinant human PROTEIN1 can simultaneously bind to the PROTEIN2/GE complex but does not bind GE directly.
LABEL>1
Recombinant human GE can simultaneously bind to the PROTEIN1/PROTEIN2 complex but does not bind GE directly.
LABEL>1
Recruitment of a PROTEIN1 to PROTEIN2-rich protrusions in Dictyostelium.
LABEL>1
Reinvestigation of the inhibition of PROTEIN1 polymerization by PROTEIN2.
LABEL>1
The very much lower affinity of PROTEIN1 for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled GE in the presence of GE and the apparently weak inhibition by GE of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled GE.
LABEL>1
Removal of the amino-terminal tails of either GE GE or PROTEIN1 PROTEIN2 allowed these polyamides to bind.
LABEL>1
Removal of the amino-terminal tails of either PROTEIN1 PROTEIN2 or GE GE allowed these polyamides to bind.
LABEL>1
Requirement of the yeast GE and PROTEIN1 genes for PROTEIN2-dependent genomic stability.
LABEL>1
Requirement of the yeast PROTEIN1 and GE genes for PROTEIN2-dependent genomic stability.
LABEL>1
Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with GE or PROTEIN2 and that GE and GE constitute alternate pathways of GE-dependent mismatch repair.
LABEL>1
Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with PROTEIN2 or GE and that GE and GE constitute alternate pathways of GE-dependent mismatch repair.
LABEL>1
Results from epistasis analyses indicate that GE functions in mismatch repair in conjunction with GE or GE and that GE and PROTEIN1 constitute alternate pathways of PROTEIN2-dependent mismatch repair.
LABEL>1
Results from epistasis analyses indicate that GE functions in mismatch repair in conjunction with GE or GE and that PROTEIN1 and GE constitute alternate pathways of PROTEIN2-dependent mismatch repair.
LABEL>1
Requirement of yeast PROTEIN1 for PROTEIN2 organization and morphogenesis in vivo.
LABEL>1
Reversible binding of PROTEIN1 to GE and PROTEIN2 in human platelet extracts.
LABEL>1
Reversible binding of PROTEIN1 to PROTEIN2 and GE in human platelet extracts.
LABEL>1
Sepharose beads coupled to either monoclonal anti-GE antibodies or to polyproline were used to extract GE and PROTEIN1, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN2 with sufficient affinity to withstand dilution (high-affinity complexes).
LABEL>1
Sepharose beads coupled to either monoclonal anti-GE antibodies or to polyproline were used to extract PROTEIN1 and GE, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN2 with sufficient affinity to withstand dilution (high-affinity complexes).
LABEL>1
PROTEIN1, within seconds, caused quantitative conversion of GElateleGE and gelsolin to high-affinity complexes with PROTEIN2, but these complexes were not present 5 min after stimulation.
LABEL>1
PROTEIN1, within seconds, caused quantitative conversion of PROTEIN2lateleGE and gelsolin to high-affinity complexes with GE, but these complexes were not present 5 min after stimulation.
LABEL>1
PROTEIN1, within seconds, caused quantitative conversion of PROTEIN2lateleGE and gelsolin to high-affinity complexes with GE, but these complexes were not present 5 min after stimulation.
LABEL>1
GE, within seconds, caused quantitative conversion of PROTEIN1lateleGE and gelsolin to high-affinity complexes with PROTEIN2, but these complexes were not present 5 min after stimulation.
LABEL>1
GE, within seconds, caused quantitative conversion of PROTEIN1lateleGE and gelsolin to high-affinity complexes with PROTEIN2, but these complexes were not present 5 min after stimulation.
LABEL>1
PROTEIN1, one of the cleavage products, enhanced interaction between GE and GE/GE and increased cells' sensitivity to PROTEIN2.
LABEL>1
PROTEIN1, one of the cleavage products, enhanced interaction between GE and PROTEIN2/GE and increased cells' sensitivity to GE.
LABEL>1
GE, one of the cleavage products, enhanced interaction between PROTEIN1 and PROTEIN2/GE and increased cells' sensitivity to GE.
LABEL>1
PROTEIN1, one of the cleavage products, enhanced interaction between GE and GE/PROTEIN2 and increased cells' sensitivity to GE.
LABEL>1
PROTEIN1, one of the cleavage products, enhanced interaction between PROTEIN2 and GE/GE and increased cells' sensitivity to GE.
LABEL>1
GE, one of the cleavage products, enhanced interaction between PROTEIN1 and GE/PROTEIN2 and increased cells' sensitivity to GE.
LABEL>1
Rod formation was prevented by coexpression of GE, PROTEIN1, and GE, which bind to the GE repeats of PROTEIN2, but not by coexpression of GE, although GE expression did prevent accumulation of GE in the nucleus.
LABEL>1
Rod formation was prevented by coexpression of GE, GE, and GE, which bind to the GE repeats of GE, but not by coexpression of GE, although PROTEIN1 expression did prevent accumulation of PROTEIN2 in the nucleus.
LABEL>1
Rod formation was prevented by coexpression of GE, GE, and GE, which bind to the PROTEIN1 repeats of PROTEIN2, but not by coexpression of GE, although GE expression did prevent accumulation of GE in the nucleus.
LABEL>1
Rod formation was prevented by coexpression of GE, GE, and PROTEIN1, which bind to the GE repeats of PROTEIN2, but not by coexpression of GE, although GE expression did prevent accumulation of GE in the nucleus.
LABEL>1
Rod formation was prevented by coexpression of PROTEIN1, GE, and GE, which bind to the GE repeats of PROTEIN2, but not by coexpression of GE, although GE expression did prevent accumulation of GE in the nucleus.
LABEL>1
Role of GE in PROTEIN1-stimulated PROTEIN2 polymerization and lamellipod protrusion.
LABEL>1
Role of PROTEIN1 in GE-stimulated PROTEIN2 polymerization and lamellipod protrusion.
LABEL>1
These results support a model in which PROTEIN1 stimulation recruits PROTEIN2 to the leading edge where its severing activity is activated, leading to the generation of short GE filaments with free barbed ends that participate in the nucleation of GE polymerization.
LABEL>1
These results support a model in which GE stimulation recruits PROTEIN1 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN2 filaments with free barbed ends that participate in the nucleation of GE polymerization.
LABEL>1
These results support a model in which GE stimulation recruits GE to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN1 filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.
LABEL>1
To investigate the role of PROTEIN1 in GE-stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of GE relative to free barbed ends and characterized the GE dynamics by measuring the changes in the number of GE filaments.
LABEL>1
To investigate the role of GE in PROTEIN1-stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of GE relative to free barbed ends and characterized the GE dynamics by measuring the changes in the number of GE filaments.
LABEL>1
Saccharomyces cerevisiae PROTEIN1 functions with PROTEIN2PROTEIN3GE, 2 and 4 in a pathway leading to normal microtubule stability.
LABEL>1
Saccharomyces cerevisiae PROTEIN1 functions with PROTEIN2PROTEIN3GE, 2 and 4 in a pathway leading to normal microtubule stability.
LABEL>1
Saccharomyces cerevisiae PROTEIN1 functions with PROTEIN2PROTEIN3GE, 2 and 4 in a pathway leading to normal microtubule stability.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and GE, GE, GE, GE, GE, and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and GE, GE, PROTEIN2, GE, GE, and GE subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and GE, GE, GE, PROTEIN2, GE, and GE subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and PROTEIN2, GE, GE, GE, GE, and GE subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and GE, PROTEIN2, GE, GE, GE, and GE subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Saccharomyces cerevisiae GE was identified in a two-hybrid screen using GE as "bait," and pairwise interactions between PROTEIN1 and GE, GE, GE, GE, PROTEIN2, and GE subsequently were demonstrated by two-hybrid analysis.
LABEL>1
Semiserial sections were subjected to immunohistochemical staining with antibodies to GE (GE), GE and PROTEIN1 isoforms: GE, PROTEIN2 and GE.
LABEL>1
Semiserial sections were subjected to immunohistochemical staining with antibodies to GE (GE), GE and PROTEIN1 isoforms: PROTEIN2, GE and GE.
LABEL>1
Semiserial sections were subjected to immunohistochemical staining with antibodies to GE (GE), GE and PROTEIN1 isoforms: GE, GE and PROTEIN2.
LABEL>1
Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of GE, an upstream activating sequence required for damage regulation of the GE transcript, and also contain two sites for restriction enzyme PROTEIN2; the presence of GE restriction sites has been associated with cell cycle regulation.
LABEL>1
Sequences upstream of the coding region for GE protein share homology with the damage response sequence element of PROTEIN1, an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme GE; the presence of GE restriction sites has been associated with cell cycle regulation.
LABEL>1
Sequences upstream of the coding region for PROTEIN1 protein share homology with the damage response sequence element of PROTEIN2, an upstream activating sequence required for damage regulation of the GE transcript, and also contain two sites for restriction enzyme GE; the presence of GE restriction sites has been associated with cell cycle regulation.
LABEL>1
Ser-133 phosphorylation enhances PROTEIN1 activity by promoting interaction with a 265-kDa GE referred to as PROTEIN2 (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).
LABEL>1
Ser-133 phosphorylation enhances PROTEIN1 activity by promoting interaction with a 265-kDa PROTEIN2 referred to as GE (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).
LABEL>1
Seventeen embryonic genes were identified as GE, GE, GE, GE (GE), GE, GE, PROTEIN1 PROTEIN2, GE and nine novel sequences designated as A1-9.
LABEL>1
Several intracellular proteins termed PROTEIN1, including GE, GE, and GE, are tightly associated with these PROTEIN2 and serve to link them to the cytoskeleton.
LABEL>1
Several intracellular proteins termed PROTEIN1, including GE, GE, and PROTEIN2, are tightly associated with these GE and serve to link them to the cytoskeleton.
LABEL>1
Several intracellular proteins termed PROTEIN1, including PROTEIN2, GE, and GE, are tightly associated with these GE and serve to link them to the cytoskeleton.
LABEL>1
Several intracellular proteins termed PROTEIN1, including GE, PROTEIN2, and GE, are tightly associated with these GE and serve to link them to the cytoskeleton.
LABEL>1
Several lines of evidence show that the GE fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human GE rebind quantitatively to poly-L-proline and bind to GE in the same way as native, conventionally purified GE without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN2; 3) dialyzed Acanthamoeba GE has an NMR spectrum identical with that of native GE; and 4) dialyzed human and Acanthamoeba GE inhibit GE polymerization.
LABEL>1
Several lines of evidence show that the GE fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human GE rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN2 without urea treatment; 2) dialyzed GE form 3-D crystals under the same conditions as native GE; 3) dialyzed Acanthamoeba GE has an NMR spectrum identical with that of native GE; and 4) dialyzed human and Acanthamoeba GE inhibit GE polymerization.
LABEL>1
Several lines of evidence show that the GE fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN1 rebind quantitatively to poly-L-proline and bind to PROTEIN2 in the same way as native, conventionally purified GE without urea treatment; 2) dialyzed GE form 3-D crystals under the same conditions as native GE; 3) dialyzed Acanthamoeba GE has an NMR spectrum identical with that of native GE; and 4) dialyzed human and Acanthamoeba GE inhibit GE polymerization.
LABEL>1
Several lines of evidence show that the GE fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human GE rebind quantitatively to poly-L-proline and bind to GE in the same way as native, conventionally purified GE without urea treatment; 2) dialyzed GE form 3-D crystals under the same conditions as native GE; 3) dialyzed Acanthamoeba PROTEIN1 has an NMR spectrum identical with that of native PROTEIN2; and 4) dialyzed human and Acanthamoeba GE inhibit GE polymerization.
LABEL>1
Several lines of evidence show that the GE fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human GE rebind quantitatively to poly-L-proline and bind to GE in the same way as native, conventionally purified GE without urea treatment; 2) dialyzed GE form 3-D crystals under the same conditions as native GE; 3) dialyzed Acanthamoeba GE has an NMR spectrum identical with that of native GE; and 4) dialyzed human and Acanthamoeba PROTEIN1 inhibit PROTEIN2 polymerization.
LABEL>1
Signaling pathways involved in dephosphorylation and localization of the PROTEIN1 PROTEIN2 in stimulated human neutrophils.
LABEL>1
These findings suggest a role of PROTEIN1 in stimulus-dependent PROTEIN2 remodeling in motile neutrophils.
LABEL>1
Significantly, those GE mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN1 crystal structure previously defined as the PROTEIN2 (GE)-binding site.
LABEL>1
Significantly, those GE mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN1 crystal structure previously defined as the GE (PROTEIN2)-binding site.
LABEL>1
Silencing mediated by PROTEIN1-PROTEIN2 requires the trans-acting factors that normally participate in repression, namely, GE, GE, GE, and GE GE.
LABEL>1
Silencing mediated by GE-GE requires the trans-acting factors that normally participate in repression, namely, GE, GE, GE, and PROTEIN1 PROTEIN2.
LABEL>1
Since both PROTEIN1 and PROTEIN2 have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of GE filaments in living cells.
LABEL>1
Since PROTEIN1 is a recombinational protein associated with PROTEIN2, this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.
LABEL>1
PROTEIN1, which consists of a full length GE and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and PROTEIN2.
LABEL>1
PROTEIN1, which consists of a full length PROTEIN2 and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and GE.
LABEL>1
PROTEIN1 prepared from chicken gizzard binds to PROTEIN2 in vitro.
LABEL>1
Specific antibodies to PROTEIN1 isoforms (PROTEIN2, GE, GE), GE, and GE and cDNAs for GE were used.
LABEL>1
Specific antibodies to PROTEIN1 isoforms (GE, PROTEIN2, GE), GE, and GE and cDNAs for GE were used.
LABEL>1
Specific antibodies to PROTEIN1 isoforms (GE, GE, PROTEIN2), GE, and GE and cDNAs for GE were used.
LABEL>1
Specific interaction between the PROTEIN1 (GE) and the GE (PROTEIN2) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
LABEL>1
Specific interaction between the GE (PROTEIN1) and the GE (PROTEIN2) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
LABEL>1
Specific interaction between the PROTEIN1 (GE) and the PROTEIN2 (GE) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
LABEL>1
Specific interaction between the GE (PROTEIN1) and the PROTEIN2 (GE) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
LABEL>1
Specific interactions between the GE (PROTEIN1) and the PROTEIN2 (GE) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
LABEL>1
Specific interactions between the PROTEIN1 (GE) and the PROTEIN2 (GE) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
LABEL>1
Specific interactions between the GE (PROTEIN1) and the GE (PROTEIN2) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
LABEL>1
Specific interactions between the PROTEIN1 (GE) and the GE (PROTEIN2) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
LABEL>1
Stable transfection of mutant PROTEIN1 molecules showed that deletion of the PROTEIN2 binding domain, but not the GE binding domain, abolished GE downregulation.
LABEL>1
Stable transfection of mutant PROTEIN1 molecules showed that deletion of the GE binding domain, but not the PROTEIN2 binding domain, abolished GE downregulation.
LABEL>1
Stable transfection of mutant PROTEIN1 molecules showed that deletion of the GE binding domain, but not the GE binding domain, abolished PROTEIN2 downregulation.
LABEL>1
Studies on cultured cells have suggested that both PROTEIN1 and GE are important for the adhesive function of PROTEIN2.
LABEL>1
Studies on cultured cells have suggested that both GE and PROTEIN1 are important for the adhesive function of PROTEIN2.
LABEL>1
Studies on the interaction between PROTEIN1 and PROTEIN2 purified by a new method.
LABEL>1
Study of mutated yeast GE and GE from Acanthamoeba suggests that the ability of PROTEIN1 to suppress GE cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN2.
LABEL>1
Such motifs are known to bind to GE (PROTEIN1), small proteins engaged in the control of PROTEIN2 dynamics.
LABEL>1
Such motifs are known to bind to PROTEIN1 (GE), small proteins engaged in the control of PROTEIN2 dynamics.
LABEL>1
Suppression of cell transformation by the GE PROTEIN1 requires binding to PROTEIN2.
LABEL>1
Suppression of cell transformation by the PROTEIN1 PROTEIN2 requires binding to GE.
LABEL>1
GE (PROTEIN1) is a GE highly expressed in testicular germ cells and has the potential to phosphorylate GE and induce PROTEIN2 cytoskeletal reorganization.
LABEL>1
PROTEIN1 (GE) is a GE highly expressed in testicular germ cells and has the potential to phosphorylate GE and induce PROTEIN2 cytoskeletal reorganization.
LABEL>1
GE (PROTEIN1) is a PROTEIN2 highly expressed in testicular germ cells and has the potential to phosphorylate GE and induce GE cytoskeletal reorganization.
LABEL>1
GE (PROTEIN1) is a GE highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce GE cytoskeletal reorganization.
LABEL>1
PROTEIN1 (GE) is a PROTEIN2 highly expressed in testicular germ cells and has the potential to phosphorylate GE and induce GE cytoskeletal reorganization.
LABEL>1
PROTEIN1 (GE) is a GE highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce GE cytoskeletal reorganization.
LABEL>1
The PROTEIN1 PROTEIN2 was isolated from Tetrahymena thermophila by affinity chromatography, and the peptide sequence was determined for part of the protein.
LABEL>1
The PROTEIN1 bundle formation induced by overexpression of PROTEIN2 is accompanied with an increase in cell motility of Dictyostelium cells. 4.
LABEL>1
The PROTEIN1 cytoskeleton-associated protein PROTEIN2 binds to GE, GE, and GE.
LABEL>1
The GE cytoskeleton-associated protein PROTEIN1 binds to PROTEIN2, GE, and GE.
LABEL>1
The GE cytoskeleton-associated protein PROTEIN1 binds to GE, PROTEIN2, and GE.
LABEL>1
The GE cytoskeleton-associated protein PROTEIN1 binds to GE, GE, and PROTEIN2.
LABEL>1
The GE molecule links GE/ GE or PROTEIN1/PROTEIN2 complexes to the GE cytoskeleton.
LABEL>1
The PROTEIN1 molecule links GE/ GE or PROTEIN2/GE complexes to the GE cytoskeleton.
LABEL>1
The GE molecule links GE/ GE or PROTEIN1/GE complexes to the PROTEIN2 cytoskeleton.
LABEL>1
The GE molecule links PROTEIN1/ PROTEIN2 or GE/GE complexes to the GE cytoskeleton.
LABEL>1
The PROTEIN1 molecule links GE/ PROTEIN2 or GE/GE complexes to the GE cytoskeleton.
LABEL>1
The GE molecule links GE/ PROTEIN1 or GE/GE complexes to the PROTEIN2 cytoskeleton.
LABEL>1
The PROTEIN1 molecule links PROTEIN2/ GE or GE/GE complexes to the GE cytoskeleton.
LABEL>1
The GE molecule links PROTEIN1/ GE or GE/GE complexes to the PROTEIN2 cytoskeleton.
LABEL>1
The PROTEIN1 molecule links GE/ GE or GE/PROTEIN2 complexes to the GE cytoskeleton.
LABEL>1
The GE molecule links GE/ GE or GE/PROTEIN1 complexes to the PROTEIN2 cytoskeleton.
LABEL>1
The PROTEIN1 molecule links GE/ GE or GE/GE complexes to the PROTEIN2 cytoskeleton.
LABEL>1
The ability of these three mutant GE proteins to form specific interactions with other members of the GE complex, PROTEIN1 and PROTEIN2, indicates that the functional domains required for replication activity of GE are separable from domains responsible for protein-protein interactions.
LABEL>1
The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the GE complex, GE and PROTEIN2, indicates that the functional domains required for replication activity of GE are separable from domains responsible for protein-protein interactions.
LABEL>1
The ability of these three mutant GE proteins to form specific interactions with other members of the PROTEIN1 complex, GE and PROTEIN2, indicates that the functional domains required for replication activity of GE are separable from domains responsible for protein-protein interactions.
LABEL>1
The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the GE complex, PROTEIN2 and GE, indicates that the functional domains required for replication activity of GE are separable from domains responsible for protein-protein interactions.
LABEL>1
The ability of these three mutant GE proteins to form specific interactions with other members of the PROTEIN1 complex, PROTEIN2 and GE, indicates that the functional domains required for replication activity of GE are separable from domains responsible for protein-protein interactions.
LABEL>1
The ability of PROTEIN1 to replace GE is dependent on its WH2 GE binding domain and a putative PROTEIN2 binding domain.
LABEL>1
The ability of PROTEIN1 to replace GE is dependent on its WH2 PROTEIN2 binding domain and a putative GE binding domain.
LABEL>1
The ability of PROTEIN1 to replace PROTEIN2 is dependent on its WH2 GE binding domain and a putative GE binding domain.
LABEL>1
Thus, like PROTEIN1, GE functions in yeast to link the polarity development pathway and the PROTEIN2 cytoskeleton to generate cytoskeletal asymmetry.
LABEL>1
Thus, like GE, PROTEIN1 functions in yeast to link the polarity development pathway and the PROTEIN2 cytoskeleton to generate cytoskeletal asymmetry.
LABEL>1
The PROTEIN1 binding domain of PROTEIN2 is sufficient to contact to GE in vitro.
LABEL>1
The GE binding domain of PROTEIN1 is sufficient to contact to PROTEIN2 in vitro.
LABEL>1
The activation of the PROTEIN1-PROTEIN2 protein leads to an accumulation of high levels of GE protein and a repression of the GE GE under all culture conditions tested.
LABEL>1
The activation of the PROTEIN1-GE protein leads to an accumulation of high levels of PROTEIN2 protein and a repression of the GE GE under all culture conditions tested.
LABEL>1
The activation of the PROTEIN1-GE protein leads to an accumulation of high levels of GE protein and a repression of the PROTEIN2 GE under all culture conditions tested.
LABEL>1
The activation of the GE-PROTEIN1 protein leads to an accumulation of high levels of PROTEIN2 protein and a repression of the GE GE under all culture conditions tested.
LABEL>1
The activation of the GE-PROTEIN1 protein leads to an accumulation of high levels of GE protein and a repression of the PROTEIN2 GE under all culture conditions tested.
LABEL>1
The activation of the GE-GE protein leads to an accumulation of high levels of GE protein and a repression of the PROTEIN1 PROTEIN2 under all culture conditions tested.
LABEL>1
The affinity of yeast PROTEIN1 for rabbit PROTEIN2 (2.9 microM) is approximately 30-fold weaker than the affinity of human GE for rabbit GE (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two GE.
LABEL>1
The affinity of yeast GE for rabbit GE (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two GE.
LABEL>1
The interactions of yeast and human GErofilinGE with rabbit PROTEIN1 were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.
LABEL>1
The interactions of yeast and human PROTEIN1rofilinGE with rabbit PROTEIN2 were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.
LABEL>1
The in vivo and in vitro properties of yeast PROTEIN1 mutants with altered poly-L-proline and PROTEIN2 binding sites are discussed in the context of the crystal structure.
LABEL>1
The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN2 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast GE and pyrene-labeled yeast GE.
LABEL>1
The titration of pyrene-labeled rabbit GE with human GE yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN1 and pyrene-labeled yeast PROTEIN2.
LABEL>1
The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two PROTEIN1-associated proteins of the adherens junctions, such as PROTEIN2 and GE, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.
LABEL>1
The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two PROTEIN1-associated proteins of the adherens junctions, such as GE and PROTEIN2, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.
LABEL>1
The amount of unassembled PROTEIN1 (12 microM) is accounted for by the sequestering functions of GE (20 microM) and PROTEIN2 (5 microM), the barbed ends being capped.
LABEL>1
The amount of unassembled PROTEIN1 (12 microM) is accounted for by the sequestering functions of PROTEIN2 (20 microM) and GE (5 microM), the barbed ends being capped.
LABEL>1
The PROTEIN1 binding site on PROTEIN2 may be discontinuous since neither the carboxyl- nor amino-terminal halves of GE will independently associate with GE, although the amino-terminal half independently binds GE.
LABEL>1
The GE binding site on GE may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN1 will independently associate with GE, although the amino-terminal half independently binds PROTEIN2.
LABEL>1
The GE binding site on GE may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN1 will independently associate with PROTEIN2, although the amino-terminal half independently binds GE.
LABEL>1
The PROTEIN1 protein and PROTEIN2 form similar but independent complexes with GE, GE, and GE.
LABEL>1
The GE protein and PROTEIN1 form similar but independent complexes with GE, GE, and PROTEIN2.
LABEL>1
The GE protein and PROTEIN1 form similar but independent complexes with PROTEIN2, GE, and GE.
LABEL>1
The GE protein and PROTEIN1 form similar but independent complexes with GE, PROTEIN2, and GE.
LABEL>1
The PROTEIN1 protein and GE form similar but independent complexes with GE, GE, and PROTEIN2.
LABEL>1
The PROTEIN1 protein and GE form similar but independent complexes with PROTEIN2, GE, and GE.
LABEL>1
The PROTEIN1 protein and GE form similar but independent complexes with GE, PROTEIN2, and GE.
LABEL>1
The GE protein and GE form similar but independent complexes with PROTEIN1, GE, and PROTEIN2.
LABEL>1
The GE protein and GE form similar but independent complexes with GE, PROTEIN1, and PROTEIN2.
LABEL>1
The GE protein and GE form similar but independent complexes with PROTEIN1, PROTEIN2, and GE.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of PROTEIN1, PROTEIN2, and GE which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, PROTEIN1, and PROTEIN2 which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, PROTEIN1, and GE which are independent from the PROTEIN2-GE complexes.
LABEL>1
Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of GE, PROTEIN2, and GE which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, PROTEIN1, and GE which are independent from the GE-PROTEIN2 complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of PROTEIN1, GE, and PROTEIN2 which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of PROTEIN1, GE, and GE which are independent from the PROTEIN2-GE complexes.
LABEL>1
Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of PROTEIN2, GE, and GE which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of PROTEIN1, GE, and GE which are independent from the GE-PROTEIN2 complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, GE, and PROTEIN1 which are independent from the PROTEIN2-GE complexes.
LABEL>1
Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of GE, GE, and PROTEIN2 which are independent from the GE-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, GE, and PROTEIN1 which are independent from the GE-PROTEIN2 complexes.
LABEL>1
Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of GE, GE, and GE which are independent from the PROTEIN2-GE complexes.
LABEL>1
Thus, GE forms distinct heteromeric complexes containing combinations of GE, GE, and GE which are independent from the PROTEIN1-PROTEIN2 complexes.
LABEL>1
Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of GE, GE, and GE which are independent from the GE-PROTEIN2 complexes.
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, PROTEIN1, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, PROTEIN1, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN1; and five apparently novel proteins, GE, GE, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN1, GE, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, PROTEIN1, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and GE; and five apparently novel proteins, GE, GE, GE, PROTEIN2, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, PROTEIN1, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN1; and five apparently novel proteins, GE, GE, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN1, GE, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, PROTEIN1, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and GE; and five apparently novel proteins, GE, GE, GE, GE, and PROTEIN2 (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, PROTEIN2, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN2; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN2, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN2 and GE; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, PROTEIN2, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN2; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN2, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, GE, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The PROTEIN1rGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN2 and GE; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN1; and five apparently novel proteins, GE, PROTEIN2, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN1, PROTEIN2, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, GE, PROTEIN1, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and GE; and five apparently novel proteins, GE, PROTEIN2, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN1; and five apparently novel proteins, PROTEIN2, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two PROTEIN1-related proteins, GE and PROTEIN2; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and PROTEIN1; and five apparently novel proteins, GE, GE, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and PROTEIN2; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, GE and GE; and five apparently novel proteins, PROTEIN1, GE, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and GE; and five apparently novel proteins, PROTEIN2, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two PROTEIN1-related proteins, PROTEIN2 and GE; and five apparently novel proteins, GE, GE, GE, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on GE, consists of seven polypeptides; two GE-related proteins, PROTEIN1 and GE; and five apparently novel proteins, GE, GE, PROTEIN2, GE, and GE (Machesky et al., 1994).
LABEL>1
The GErGE/3 complex with full-length GE, GE containing P, W, and A domains, or GE containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN2, giving active nucleation over a low background of spontaneous nucleation.
LABEL>1
The PROTEIN1rGE/3 complex with full-length GE, GE containing P, W, and A domains, or GE containing W and A domains overcomes inhibition of nucleation by the GE monomer-binding protein PROTEIN2, giving active nucleation over a low background of spontaneous nucleation.
LABEL>1
The PROTEIN1rGE/3 complex with full-length GE, GE containing P, W, and A domains, or GE containing W and A domains overcomes inhibition of nucleation by the GE monomer-binding protein PROTEIN2, giving active nucleation over a low background of spontaneous nucleation.
LABEL>1
The PROTEIN1rGE/3 complex with full-length GE, GE containing P, W, and A domains, or GE containing W and A domains overcomes inhibition of nucleation by the GE monomer-binding protein GE, giving active nucleation over a low background of spontaneous nucleation.
LABEL>1
The assay detects the high-affinity binding of PROTEIN1 to GE (PROTEIN2), GE or GE.
LABEL>1
The assay detects the high-affinity binding of PROTEIN1 to GE (GE), PROTEIN2 or GE.
LABEL>1
The assay detects the high-affinity binding of PROTEIN1 to PROTEIN2 (GE), GE or GE.
LABEL>1
The assay detects the high-affinity binding of PROTEIN1 to GE (GE), GE or PROTEIN2.
LABEL>1
The PROTEIN1 component of the herpes simplex virus GE complex stimulates primer synthesis by a subassembly of the GE and PROTEIN2 components.
LABEL>1
The GE component of the herpes simplex virus GE complex stimulates primer synthesis by a subassembly of the PROTEIN1 and PROTEIN2 components.
LABEL>1
The PROTEIN1 component of the herpes simplex virus PROTEIN2 complex stimulates primer synthesis by a subassembly of the GE and GE components.
LABEL>1
The PROTEIN1 component of the herpes simplex virus GE complex stimulates primer synthesis by a subassembly of the PROTEIN2 and GE components.
LABEL>1
The herpes simplex virus type 1 (HSV) GE, PROTEIN1, and PROTEIN2 proteins form a helicase-primase complex in infected cells.
LABEL>1
The herpes simplex virus type 1 (HSV) PROTEIN1, GE, and PROTEIN2 proteins form a helicase-primase complex in infected cells.
LABEL>1
The herpes simplex virus type 1 (HSV) PROTEIN1, PROTEIN2, and GE proteins form a helicase-primase complex in infected cells.
LABEL>1
The GE-binding region is distinct from major anti-PROTEIN1 mAb epitopes on the human GE(PROTEIN2) molecule.
LABEL>1
The GE-binding region is distinct from major anti-PROTEIN1 mAb epitopes on the human PROTEIN2(GE) molecule.
LABEL>1
The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN2 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the GE tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added GE concentration.
LABEL>1
These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of PROTEIN1 on the assembly of PROTEIN2 that had been fluorescently labeled or otherwise modified at Cys 374.
LABEL>1
The binding surfaces for segment 1 and PROTEIN1 are different, although they peripherally overlap on PROTEIN2.
LABEL>1
This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with PROTEIN2, GE segment 1, and GE.
LABEL>1
This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with GE, GE segment 1, and PROTEIN2.
LABEL>1
This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with GE, PROTEIN2 segment 1, and GE.
LABEL>1
The PROTEIN1 (GE) contains the PROTEIN2- and ATP-binding sites and represents the molecular motor of muscle contraction.
LABEL>1
The GE (PROTEIN1) contains the PROTEIN2- and ATP-binding sites and represents the molecular motor of muscle contraction.
LABEL>1
The GE (PROTEIN1) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [PROTEIN2] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE GE in vivo.
LABEL>1
The PROTEIN1 (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [PROTEIN2] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE GE in vivo.
LABEL>1
The GE (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [PROTEIN1] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE PROTEIN2 in vivo.
LABEL>1
The GE (PROTEIN1) of vesicular stomatitis virus (VSV) serotypes New Jersey [PROTEIN2] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE GE in vivo.
LABEL>1
The PROTEIN1 (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [PROTEIN2] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE GE in vivo.
LABEL>1
The GE (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [PROTEIN1] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE PROTEIN2 in vivo.
LABEL>1
The GE (PROTEIN1) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE PROTEIN2 in vivo.
LABEL>1
The PROTEIN1 (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the GE PROTEIN2 in vivo.
LABEL>1
The GE (GE) of vesicular stomatitis virus (VSV) serotypes New Jersey [GE] and Indiana [GE] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN1 PROTEIN2 in vivo.
LABEL>1
The GE-like central (vc) region of GE induces PROTEIN1rGE/3 complex-dependent PROTEIN2 nucleation.
LABEL>1
The GE-like central (vc) region of GE induces PROTEIN1rGE/3 complex-dependent PROTEIN2 nucleation.
LABEL>1
The GE-like central (vc) region of PROTEIN1 induces GErGE/3 complex-dependent PROTEIN2 nucleation.
LABEL>1
The PROTEIN1-like central (vc) region of PROTEIN2 induces GErGE/3 complex-dependent GE nucleation.
LABEL>1
The GE-like central (vc) region of GE induces PROTEIN1rGE/3 complex-dependent GE nucleation.
LABEL>1
The C374S mutation had the most pronounced effect; it reduced the polymerizability of the PROTEIN1, abolished its binding to PROTEIN2, and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.
LABEL>1
The PROTEIN1-associated proteins, PROTEIN2 and GE, were present in both mesotheliomas and adenocarcinomas.
LABEL>1
The PROTEIN1-associated proteins, GE and PROTEIN2, were present in both mesotheliomas and adenocarcinomas.
LABEL>1
The GE Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the PROTEIN1- or ATP-binding capacities of two size-limited recombinant PROTEIN2 fragments.
LABEL>1
The PROTEIN1 Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the PROTEIN2- or ATP-binding capacities of two size-limited recombinant GE fragments.
LABEL>1
The PROTEIN1 Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the GE- or ATP-binding capacities of two size-limited recombinant PROTEIN2 fragments.
LABEL>1
The cellular transcription co-activators GE and the PROTEIN1 PROTEIN2 are cellular targets for transformation by the GE proteins of non-oncogenic adenovirus 5 (Ad5).
LABEL>1
The cellular transcription co-activators GE and the GE PROTEIN1 are cellular targets for transformation by the PROTEIN2 proteins of non-oncogenic adenovirus 5 (Ad5).
LABEL>1
The cellular transcription co-activators PROTEIN1 and the GE GE are cellular targets for transformation by the PROTEIN2 proteins of non-oncogenic adenovirus 5 (Ad5).
LABEL>1
The characteristics of the PROTEIN1 and GE interactions with PROTEIN2 are similar.
LABEL>1
The characteristics of the GE and PROTEIN1 interactions with PROTEIN2 are similar.
LABEL>1
The characteristics of the PROTEIN1 and PROTEIN2 interactions with GE are similar.
LABEL>1
The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal GE (PROTEIN1), PROTEIN2 and GE.
LABEL>1
The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal GE (PROTEIN1), GE and PROTEIN2.
LABEL>1
The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN1 (GE), PROTEIN2 and GE.
LABEL>1
The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN1 (GE), GE and PROTEIN2.
LABEL>1
The common denominator is impaired PROTEIN1 association with either PROTEIN2 (PaTuII) or GE (BxPc3 and T3M4).
LABEL>1
The common denominator is impaired PROTEIN1 association with either GE (PaTuII) or PROTEIN2 (BxPc3 and T3M4).
LABEL>1
The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with GE, GE, and PROTEIN2.
LABEL>1
The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with GE, PROTEIN2, and GE.
LABEL>1
The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN2, GE, and GE.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; PROTEIN1 GE and PROTEIN2 show less heterogeneity.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; PROTEIN1 PROTEIN2 and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1 PROTEIN2 (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core PROTEIN1 from Physarum, GE GE, GE, GE, and PROTEIN2, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core PROTEIN1 from Physarum, GE PROTEIN2, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core PROTEIN1 from Physarum, GE GE, GE, PROTEIN2, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core PROTEIN1 from Physarum, GE GE, PROTEIN2, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1 PROTEIN2; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; PROTEIN1 PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, GE GE, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); PROTEIN1 PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, PROTEIN1 GE, GE, GE, and PROTEIN2, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, PROTEIN1 PROTEIN2, GE, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, PROTEIN1 GE, GE, PROTEIN2, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The core GE from Physarum, PROTEIN1 GE, PROTEIN2, GE, and GE, are rapidly acetylated; GE GE shows five subfractions, analogous to the five subfractions of mammalian GE GE (containing zero to four acetyllysine residues per molecule); GE GE has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of GE GE; GE GE and GE show less heterogeneity.
LABEL>1
The C-terminal of GE comprises the "death domain" that is responsible for association of PROTEIN1 and other death domain-containing proteins such as PROTEIN2 and GE.
LABEL>1
The C-terminal of GE comprises the "death domain" that is responsible for association of PROTEIN1 and other death domain-containing proteins such as GE and PROTEIN2.
LABEL>1
The C-terminal region of GE was, however, necessary to bring PROTEIN1 and PROTEIN2 into the core complex.
LABEL>1
The C-terminal region of PROTEIN1 was, however, necessary to bring PROTEIN2 and GE into the core complex.
LABEL>1
The C-terminal region of PROTEIN1 was, however, necessary to bring GE and PROTEIN2 into the core complex.
LABEL>1
The cytoplasmic domain of PROTEIN1 cannot directly associate with PROTEIN2 but interacts with high affinity with GE, whereas the binding of GE (GE) to GE is less efficient.
LABEL>1
The cytoplasmic domain of GE cannot directly associate with GE but interacts with high affinity with GE, whereas the binding of GE (PROTEIN1) to PROTEIN2 is less efficient.
LABEL>1
The cytoplasmic domain of PROTEIN1 cannot directly associate with GE but interacts with high affinity with PROTEIN2, whereas the binding of GE (GE) to GE is less efficient.
LABEL>1
The cytoplasmic domain of GE cannot directly associate with GE but interacts with high affinity with GE, whereas the binding of PROTEIN1 (GE) to PROTEIN2 is less efficient.
LABEL>1
PROTEIN1 and PROTEIN2 assemble into a 1:1 heterodimeric complex.
LABEL>1
The deduced peptide sequence contained a nuclear localization signal and a putative PROTEIN1-binding sequence as reported in PROTEIN2.
LABEL>1
The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the PROTEIN1/poly-proline binding protein, PROTEIN2, and the GE family of regulatory modules.
LABEL>1
The domains in GE that are involved in GE binding and transcriptional activation are highly related to the adenoviral PROTEIN1-associated cellular protein PROTEIN2 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, GE and GE (refs 4 and 5, respectively), whose functions are unknown.
LABEL>1
The domains in PROTEIN1 that are involved in GE binding and transcriptional activation are highly related to the adenoviral GE-associated cellular protein GE (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, GE and PROTEIN2 (refs 4 and 5, respectively), whose functions are unknown.
LABEL>1
The domains in PROTEIN1 that are involved in GE binding and transcriptional activation are highly related to the adenoviral GE-associated cellular protein PROTEIN2 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, GE and GE (refs 4 and 5, respectively), whose functions are unknown.
LABEL>1
The domains in PROTEIN1 that are involved in GE binding and transcriptional activation are highly related to the adenoviral GE-associated cellular protein GE (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN2 and GE (refs 4 and 5, respectively), whose functions are unknown.
LABEL>1
The domains in PROTEIN1 that are involved in PROTEIN2 binding and transcriptional activation are highly related to the adenoviral GE-associated cellular protein GE (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, GE and GE (refs 4 and 5, respectively), whose functions are unknown.
LABEL>1
The drastic effects of the exogenous PROTEIN1 on PROTEIN2 assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).
LABEL>1
The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that PROTEIN1 is deeply involved in the regulation of PROTEIN2 assembly in developing skeletal muscle.
LABEL>1
The PROTEIN1-associated proteins PROTEIN2 and GE were not significantly affected by treatment with GE.
LABEL>1
The PROTEIN1-associated proteins GE and PROTEIN2 were not significantly affected by treatment with GE.
LABEL>1
The effects of two adhesion substrates (serum and PROTEIN1) and time in culture on the expression of genes encoding PROTEIN2 (GE) isoforms and GE were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
LABEL>1
The effects of two adhesion substrates (serum and PROTEIN1) and time in culture on the expression of genes encoding GE (PROTEIN2) isoforms and GE were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
LABEL>1
The effects of two adhesion substrates (serum and PROTEIN1) and time in culture on the expression of genes encoding GE (GE) isoforms and PROTEIN2 were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
LABEL>1
The existence of this pathway helps to explain some of the effects of PROTEIN1 and GE in the control of PROTEIN2 dynamics.
LABEL>1
The existence of this pathway helps to explain some of the effects of GE and PROTEIN1 in the control of PROTEIN2 dynamics.
LABEL>1
The findings suggest that PROTEIN1 GE are involved in GE-mediated enhancement of PROTEIN2 production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of GE production.
LABEL>1
The findings suggest that GE GE are involved in PROTEIN1-mediated enhancement of PROTEIN2 production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of GE production.
LABEL>1
The findings suggest that PROTEIN1 PROTEIN2 are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of GE production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and PROTEIN1, but not via GE GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via GE GE, may be involved in the PROTEIN1-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/PROTEIN1 and GE, but not via GE GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (PROTEIN1)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor PROTEIN1 and pathways via GE (GE)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via PROTEIN1 GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via PROTEIN1 (GE)/GE and GE, but not via GE GE, may be involved in the GE-mediated enhancement of PROTEIN2 production.
LABEL>1
The findings suggest that GE GE are involved in GE-mediated enhancement of GE production in Jurkat cells and that the transcription factor GE and pathways via GE (GE)/GE and GE, but not via PROTEIN1 PROTEIN2, may be involved in the GE-mediated enhancement of GE production.
LABEL>1
The head domain of PROTEIN1 thus binds to PROTEIN2 to form a link to the GE cytoskeleton and can thus regulate GE function.
LABEL>1
The head domain of GE thus binds to PROTEIN1 to form a link to the PROTEIN2 cytoskeleton and can thus regulate GE function.
LABEL>1
The head domain of PROTEIN1 thus binds to GE to form a link to the GE cytoskeleton and can thus regulate PROTEIN2 function.
LABEL>1
The head domain of PROTEIN1 thus binds to GE to form a link to the PROTEIN2 cytoskeleton and can thus regulate GE function.
LABEL>1
The herpes simplex virus PROTEIN1 complex, a heterotrimer of the PROTEIN2, GE, and GE proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus GE complex, a heterotrimer of the PROTEIN1, PROTEIN2, and GE proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus GE complex, a heterotrimer of the PROTEIN1, GE, and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus PROTEIN1 complex, a heterotrimer of the GE, PROTEIN2, and GE proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus PROTEIN1 complex, a heterotrimer of the GE, GE, and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus GE complex, a heterotrimer of the GE, PROTEIN1, and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
LABEL>1
The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the GE but not the PROTEIN2 or GE replication proteins in virus-infected cells.
LABEL>1
The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the PROTEIN2 but not the GE or GE replication proteins in virus-infected cells.
LABEL>1
The herpes simplex virus type 1 PROTEIN1 protein influences the intracellular localization of the GE but not the GE or PROTEIN2 replication proteins in virus-infected cells.
LABEL>1
The herpes simplex virus type-1 PROTEIN1 is a heterotrimer encoded by the GE, PROTEIN2, and GE genes.
LABEL>1
The herpes simplex virus type-1 PROTEIN1 is a heterotrimer encoded by the GE, GE, and PROTEIN2 genes.
LABEL>1
The herpes simplex virus type-1 PROTEIN1 is a heterotrimer encoded by the PROTEIN2, GE, and GE genes.
LABEL>1
The Herpes simplex virus type 1 PROTEIN1 consists of three subunits that are the products of the PROTEIN2, GE, and GE genes.
LABEL>1
The Herpes simplex virus type 1 GE consists of three subunits that are the products of the PROTEIN1, PROTEIN2, and GE genes.
LABEL>1
The Herpes simplex virus type 1 GE consists of three subunits that are the products of the PROTEIN1, GE, and PROTEIN2 genes.
LABEL>1
The Herpes simplex virus type 1 PROTEIN1 consists of three subunits that are the products of the GE, PROTEIN2, and GE genes.
LABEL>1
The Herpes simplex virus type 1 PROTEIN1 consists of three subunits that are the products of the GE, GE, and PROTEIN2 genes.
LABEL>1
The Herpes simplex virus type 1 GE consists of three subunits that are the products of the GE, PROTEIN1, and PROTEIN2 genes.
LABEL>1
The herpes simplex virus type-1 GE, PROTEIN1, and GE genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
LABEL>1
The herpes simplex virus type-1 PROTEIN1, GE, and GE genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
LABEL>1
The herpes simplex virus type-1 GE, GE, and PROTEIN1 genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
LABEL>1
The higher affinity of vaccinia PROTEIN1 for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN2 or poly(L-proline) and the concentration of vaccinia GE expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia GE binds preferentially to PIP and PIP2 in vivo.
LABEL>1
We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate GE, purified the recombinant viral PROTEIN1, and characterized its interactions with PROTEIN2 and polyphosphoinositides.
LABEL>1
The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of GE, the GE GE and of GE and decreased expression of the PROTEIN1 PROTEIN2.
LABEL>1
The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of GE, the PROTEIN1 PROTEIN2 and of GE and decreased expression of the GE GE.
LABEL>1
The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1-binding motif in the metazoan focal adhesion protein PROTEIN2 and the yeast protein GE.
LABEL>1
The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1-binding motif in the metazoan focal adhesion protein GE and the yeast protein PROTEIN2.
LABEL>1
The influence of these PROTEIN1 on cell morphology and the distribution pattern of GE, PROTEIN2, GE, and GE was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
LABEL>1
The influence of these PROTEIN1 on cell morphology and the distribution pattern of PROTEIN2, GE, GE, and GE was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
LABEL>1
The influence of these PROTEIN1 on cell morphology and the distribution pattern of GE, GE, GE, and PROTEIN2 was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
LABEL>1
The influence of these PROTEIN1 on cell morphology and the distribution pattern of GE, GE, PROTEIN2, and GE was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
LABEL>1
The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN1 GE(PROTEIN2) but a striking inhibition of the expression of GE.
LABEL>1
The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN1 PROTEIN2(GE) but a striking inhibition of the expression of GE.
LABEL>1
The interaction between the human respiratory syncytial virus GE (PROTEIN1) and PROTEIN2 (GE) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
LABEL>1
The interaction between the human respiratory syncytial virus PROTEIN1 (GE) and PROTEIN2 (GE) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
LABEL>1
The interaction between the human respiratory syncytial virus GE (PROTEIN1) and GE (PROTEIN2) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
LABEL>1
The interaction between the human respiratory syncytial virus PROTEIN1 (GE) and GE (PROTEIN2) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
LABEL>1
The interaction of a mouse monoclonal antibody (PROTEIN1) and birch PROTEIN2, a structurally well conserved GE- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.
LABEL>1
The interaction of a mouse monoclonal antibody (GE) and birch PROTEIN1, a structurally well conserved PROTEIN2- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 (GE) with GE (GE) and PROTEIN2 (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) GE (PROTEIN1) with GE (GE) and PROTEIN2 (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 (GE) with GE (PROTEIN2) and GE (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) GE (PROTEIN1) with GE (PROTEIN2) and GE (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 (GE) with PROTEIN2 (GE) and GE (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) GE (PROTEIN1) with PROTEIN2 (GE) and GE (GE) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 (GE) with GE (GE) and GE (PROTEIN2) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interaction of bovine respiratory syncytial virus (BRSV) GE (PROTEIN1) with GE (GE) and GE (PROTEIN2) proteins was investigated using an intracellular BRSV-GE minigenome replication system.
LABEL>1
The interactions of PROTEIN1 with GE, PROTEIN2 and GE are compared.
LABEL>1
The interactions of PROTEIN1 with PROTEIN2, GE and GE are compared.
LABEL>1
The interactions of PROTEIN1 with GE, GE and PROTEIN2 are compared.
LABEL>1
The intracellular molecules GE and PROTEIN1 actively regulate PROTEIN2-based motility and participate in the signaling pathways used to steer growth cones.
LABEL>1
The intracellular molecules PROTEIN1 and GE actively regulate PROTEIN2-based motility and participate in the signaling pathways used to steer growth cones.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and PROTEIN1 and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and PROTEIN1 and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and PROTEIN1 and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and PROTEIN1 and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
The involvement of the death adaptor proteins PROTEIN1/GE, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins PROTEIN1/GE, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins PROTEIN1/GE, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins PROTEIN1/GE, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, PROTEIN1, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, PROTEIN1, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, PROTEIN1, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, PROTEIN1, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/PROTEIN1, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/PROTEIN1, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/PROTEIN1, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/PROTEIN1, GE, and GE and the apoptosis-initiating GEaspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (PROTEIN2 and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing PROTEIN2RAIL receptorGE and 2 (GE and GE) are controversial.
LABEL>1
The involvement of the death adaptor proteins GE/GE, GE, and GE and the apoptosis-initiating PROTEIN1aspaseGE and -10 in death signaling by the two death-inducing GERAIL receptorGE and 2 (GE and PROTEIN2) are controversial.
LABEL>1
Their abilities to store lipids and express PROTEIN1 intermediate filaments, GE, and PROTEIN2 in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
LABEL>1
Their abilities to store lipids and express GE intermediate filaments, PROTEIN1, and PROTEIN2 in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
LABEL>1
Their abilities to store lipids and express PROTEIN1 intermediate filaments, PROTEIN2, and GE in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1, GE, GE and PROTEIN2.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1, PROTEIN2, GE and GE.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1, GE, PROTEIN2 and GE.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: GE, PROTEIN1, GE and PROTEIN2.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: GE, GE, PROTEIN1 and PROTEIN2.
LABEL>1
The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: GE, PROTEIN1, PROTEIN2 and GE.
LABEL>1
The junctional multidomain protein PROTEIN1 is a binding partner of the PROTEIN2 GE and associates with the GE cytoskeletal regulator GE.
LABEL>1
The junctional multidomain protein PROTEIN1 is a binding partner of the GE GE and associates with the GE cytoskeletal regulator PROTEIN2.
LABEL>1
The junctional multidomain protein GE is a binding partner of the PROTEIN1 PROTEIN2 and associates with the GE cytoskeletal regulator GE.
LABEL>1
The junctional multidomain protein GE is a binding partner of the GE GE and associates with the PROTEIN1 cytoskeletal regulator PROTEIN2.
LABEL>1
To our knowledge, PROTEIN1 is the only integral component in cell-cell junctions discovered thus far that interacts with PROTEIN2 and thus could modulate GE modeling proximal to adhesion complexes.
LABEL>1
To our knowledge, PROTEIN1 is the only integral component in cell-cell junctions discovered thus far that interacts with GE and thus could modulate PROTEIN2 modeling proximal to adhesion complexes.
LABEL>1
The tandem repeat domain in the Listeria monocytogenes PROTEIN1 protein controls the rate of GE-based motility, the percentage of moving bacteria, and the localization of GE and PROTEIN2.
LABEL>1
The tandem repeat domain in the Listeria monocytogenes PROTEIN1 protein controls the rate of PROTEIN2-based motility, the percentage of moving bacteria, and the localization of GE and GE.
LABEL>1
The tandem repeat domain in the Listeria monocytogenes PROTEIN1 protein controls the rate of GE-based motility, the percentage of moving bacteria, and the localization of PROTEIN2 and GE.
LABEL>1
The main inhibitory action of PROTEIN1, a GE (PROTEIN2), arises from its binding with the GE/GE (GE) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of PROTEIN1, a GE (GE), arises from its binding with the GE/PROTEIN2 (GE) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of GE, a GE (GE), arises from its binding with the GE/PROTEIN1 (PROTEIN2) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of GE, a GE (GE), arises from its binding with the PROTEIN1/PROTEIN2 (GE) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of PROTEIN1, a GE (GE), arises from its binding with the GE/GE (PROTEIN2) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of PROTEIN1, a PROTEIN2 (GE), arises from its binding with the GE/GE (GE) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of PROTEIN1, a GE (GE), arises from its binding with the PROTEIN2/GE (GE) complex that results in G(1)-S arrest.
LABEL>1
The main inhibitory action of GE, a GE (GE), arises from its binding with the PROTEIN1/GE (PROTEIN2) complex that results in G(1)-S arrest.
LABEL>1
The majority of the aromatic residues in PROTEIN1 are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with PROTEIN2.
LABEL>1
The map locates the N-terminal calcium-binding domain and identifies GE-binding site residues on the two PROTEIN1-homology domains of PROTEIN2.
LABEL>1
The map locates the N-terminal calcium-binding domain and identifies PROTEIN1-binding site residues on the two GE-homology domains of PROTEIN2.
LABEL>1
The mechanism of PROTEIN1-promoted PROTEIN2 polymerization has been systematically reinvestigated.
LABEL>1
When measured in the absence of GE, GE assembly curves over a 0.7-4 microM GE concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1.PROTEIN2).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), GE (68,000 daltons), GE (43,000 daltons), and PROTEIN2 (17,000 daltons).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), PROTEIN2 (68,000 daltons), GE (43,000 daltons), and GE (17,000 daltons).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), GE (68,000 daltons), PROTEIN2 (43,000 daltons), and GE (17,000 daltons).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, GE (95,000 daltons), PROTEIN1 (68,000 daltons), GE (43,000 daltons), and PROTEIN2 (17,000 daltons).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, GE (95,000 daltons), GE (68,000 daltons), PROTEIN1 (43,000 daltons), and PROTEIN2 (17,000 daltons).
LABEL>1
The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, GE (95,000 daltons), PROTEIN1 (68,000 daltons), PROTEIN2 (43,000 daltons), and GE (17,000 daltons).
LABEL>1
The monomeric PROTEIN1, PROTEIN2, is a key regulator of GE-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.
LABEL>1
The monomeric GE, PROTEIN1, is a key regulator of PROTEIN2-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.
LABEL>1
The most striking difference was in the relative preference for acetylation of PROTEIN1 PROTEIN2 versus acetylation of GE GE: with the purified GE, GE GE in nucleosomes was acetylated to a much greater extent than was GE GE, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified GE, PROTEIN1 PROTEIN2 in nucleosomes was acetylated to a much greater extent than was GE GE, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified PROTEIN1, GE GE in nucleosomes was acetylated to a much greater extent than was GE PROTEIN2, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified GE, GE GE in nucleosomes was acetylated to a much greater extent than was GE PROTEIN1, whereas the reverse preference was found with the endogenous PROTEIN2.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified GE, GE GE in nucleosomes was acetylated to a much greater extent than was PROTEIN1 PROTEIN2, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of PROTEIN1 PROTEIN2: with the purified GE, GE GE in nucleosomes was acetylated to a much greater extent than was GE GE, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified PROTEIN1, GE PROTEIN2 in nucleosomes was acetylated to a much greater extent than was GE GE, whereas the reverse preference was found with the endogenous GE.
LABEL>1
The most striking difference was in the relative preference for acetylation of GE GE versus acetylation of GE GE: with the purified GE, GE PROTEIN1 in nucleosomes was acetylated to a much greater extent than was GE GE, whereas the reverse preference was found with the endogenous PROTEIN2.
LABEL>1
The multifunctional protein PROTEIN1 is one of the most abundant proteins in the cytoplasm and is thought to regulate PROTEIN2 assembly and the phosphoinositide signaling pathway.
LABEL>1
The mutants ranged in affinity, from those that only weakly affected polymerization of GE to one that bound PROTEIN1 more strongly than wild-type PROTEIN2.
LABEL>1
The role of PROTEIN1 in PROTEIN2 polymerization and nucleotide exchange.
LABEL>1
The N-terminal PROTEIN1 polypeptide eventually disrupted PROTEIN2 stress fibres whereas the C-terminal polypeptide was without effect.
LABEL>1
The Pro1176 to Thr substitution found in PROTEIN1 from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind PROTEIN2 or GE.
LABEL>1
The Pro1176 to Thr substitution found in PROTEIN1 from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind GE or PROTEIN2.
LABEL>1
The ordered assembly of the PROTEIN1 homologue together with PROTEIN2 and a series of other proteins is considered to play a key role in chemotactic orientation.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing GE and its cytoplasmic cofactors GE, PROTEIN1, and PROTEIN2.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing GE and its cytoplasmic cofactors PROTEIN1, PROTEIN2, and GE.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing PROTEIN1 and its cytoplasmic cofactors GE, PROTEIN2, and GE.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing GE and its cytoplasmic cofactors PROTEIN1, GE, and PROTEIN2.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing PROTEIN1 and its cytoplasmic cofactors GE, GE, and PROTEIN2.
LABEL>1
The GE gene encodes a GE substrate that associates with the cell-cell adhesion protein complex containing PROTEIN1 and its cytoplasmic cofactors PROTEIN2, GE, and GE.
LABEL>1
GE binds to and inhibits complexes formed by PROTEIN1-PROTEIN2, GE-GE, and GE-GE.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by PROTEIN2-GE, GE-GE, and GE-GE.
LABEL>1
GE binds to and inhibits complexes formed by GE-GE, PROTEIN1-PROTEIN2, and GE-GE.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by GE-GE, PROTEIN2-GE, and GE-GE.
LABEL>1
GE binds to and inhibits complexes formed by GE-GE, GE-GE, and PROTEIN1-PROTEIN2.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by GE-GE, GE-GE, and PROTEIN2-GE.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by GE-GE, GE-PROTEIN2, and GE-GE.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by GE-GE, GE-GE, and GE-PROTEIN2.
LABEL>1
PROTEIN1 binds to and inhibits complexes formed by GE-PROTEIN2, GE-GE, and GE-GE.
LABEL>1
The phosphoprotein was identified as PROTEIN1, an PROTEIN2, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).
LABEL>1
The GE gene product mediates PROTEIN1-dependent and GE-dependent activation of the transcription factor PROTEIN2.
LABEL>1
The GE gene product mediates GE-dependent and PROTEIN1-dependent activation of the transcription factor PROTEIN2.
LABEL>1
The PROTEIN1 gene product mediates GE-dependent and GE-dependent activation of the transcription factor PROTEIN2.
LABEL>1
The polypeptide folds and the PROTEIN1-binding surfaces of the amoeba PROTEIN2 are very similar to those of bovine and human GE.
LABEL>1
The polypeptide folds and the GE-binding surfaces of the amoeba PROTEIN1 are very similar to those of bovine and human PROTEIN2.
LABEL>1
The polypeptide folds and the PROTEIN1-binding surfaces of the amoeba GE are very similar to those of bovine and human PROTEIN2.
LABEL>1
The proximity of these sites to the PROTEIN1 binding site provides an explanation for the competition between GE and lipids for binding PROTEIN2.
LABEL>1
The proximity of these sites to the GE binding site provides an explanation for the competition between PROTEIN1 and lipids for binding PROTEIN2.
LABEL>1
X-ray structures of isoforms of the PROTEIN1 PROTEIN2 that differ in their affinity for phosphatidylinositol phosphates.
LABEL>1
The position of the PROTEIN1-binding site at the C terminal suggests that PROTEIN2 may work as a crosslinker between GE and GE.
LABEL>1
The position of the GE-binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between PROTEIN2 and GE.
LABEL>1
The position of the GE-binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between GE and PROTEIN2.
LABEL>1
The position of the GE-binding site at the C terminal suggests that GE may work as a crosslinker between PROTEIN1 and PROTEIN2.
LABEL>1
The potentiating effect of GE appears to involve increases in the expression of GE and decreases in the expression of the PROTEIN1 GE(PROTEIN2).
LABEL>1
The potentiating effect of GE appears to involve increases in the expression of GE and decreases in the expression of the PROTEIN1 PROTEIN2(GE).
LABEL>1
The potentiating effect of PROTEIN1 appears to involve increases in the expression of GE and decreases in the expression of the GE GE(PROTEIN2).
LABEL>1
The potentiating effect of PROTEIN1 appears to involve increases in the expression of PROTEIN2 and decreases in the expression of the GE GE(GE).
LABEL>1
The potentiating effect of PROTEIN1 appears to involve increases in the expression of GE and decreases in the expression of the GE PROTEIN2(GE).
LABEL>1
The predicted sequence of GE shares ca. 40% identity with nonplant GE and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1-binding domain in PROTEIN2 and in a larger family of GE cross-linking proteins.
LABEL>1
The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant GE and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN2-binding domain in GE and in a larger family of GE cross-linking proteins.
LABEL>1
The predicted sequence of PROTEIN1 shares ca. 40% identity with nonplant PROTEIN2 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative GE-binding domain in GE and in a larger family of GE cross-linking proteins.
LABEL>1
The proposed LNYV genomic map is 3'-GE-GE-GE-GE-GE-GE-5', where GE is the GE gene; GE and PROTEIN1 are two genes, one of which codes for the proposed GE PROTEIN2 and the other for a putative protein of unknown function; GE is the proposed GE gene; GE is the proposed GE gene; and GE is the proposed GE gene.
LABEL>1
The proposed LNYV genomic map is 3'-GE-GE-GE-GE-GE-GE-5', where GE is the GE gene; GE and GE are two genes, one of which codes for the proposed PROTEIN1 PROTEIN2 and the other for a putative protein of unknown function; GE is the proposed GE gene; GE is the proposed GE gene; and GE is the proposed GE gene.
LABEL>1
The proposed LNYV genomic map is 3'-GE-GE-GE-GE-GE-GE-5', where GE is the GE gene; PROTEIN1 and GE are two genes, one of which codes for the proposed GE PROTEIN2 and the other for a putative protein of unknown function; GE is the proposed GE gene; GE is the proposed GE gene; and GE is the proposed GE gene.
LABEL>1
The protein PROTEIN1 binds to both PROTEIN2 and the head groups of poly)phosphoinositide)s and may regulate both GE assembly and the phosphoinositide signaling pathway.
LABEL>1
The protein PROTEIN1 binds to both GE and the head groups of poly)phosphoinositide)s and may regulate both PROTEIN2 assembly and the phosphoinositide signaling pathway.
LABEL>1
The protein has the two conserved domains identified as PROTEIN1 and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the PROTEIN2 family.
LABEL>1
The proteins encoded by PROTEIN1 and PROTEIN2, which display 35%, sequence identity are both located in the mitochondrial intermembrane space.
LABEL>1
There are only 14 non-conservative substitutions in the two PROTEIN1, three of which are located in the secondary PROTEIN2-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.
LABEL>1
There are three PROTEIN1 PROTEIN2 genes, two of which are identical; four GE GE genes, two of which are identical, one GE GE gene; and two GE GE genes.
LABEL>1
There are three GE GE genes, two of which are identical; four GE GE genes, two of which are identical, one PROTEIN1 PROTEIN2 gene; and two GE GE genes.
LABEL>1
There are three GE GE genes, two of which are identical; four PROTEIN1 PROTEIN2 genes, two of which are identical, one GE GE gene; and two GE GE genes.
LABEL>1
There are three GE GE genes, two of which are identical; four GE GE genes, two of which are identical, one GE GE gene; and two PROTEIN1 PROTEIN2 genes.
LABEL>1
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and PROTEIN2 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>1
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE PROTEIN1 genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>1
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN1 PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>1
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN1 PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>1
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN1 and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>1
These PROTEIN1 PROTEIN2 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>1
These GE PROTEIN1 and GE genes encode approximately 40% of the total PROTEIN2 and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>1
These PROTEIN1 GE and PROTEIN2 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>1
The recombinant material is similar to authentic PROTEIN1 from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, GE-nucleotide exchange rate and the Kd for rabbit PROTEIN2.
LABEL>1
The recombinant material is similar to authentic human PROTEIN1 based on the measured Kd for rabbit PROTEIN2.
LABEL>1
The relatively conservative sequence of PROTEIN1 from yeast, Physarum, Acanthamoeba, echinoid eggs and mammalian cells was found in the N-terminal region, which was suggested to be a common PROTEIN2-binding region.
LABEL>1
The resulting PROTEIN1 product is unable to bind PROTEIN2 that is responsible for GE filament binding and organization.
LABEL>1
The resulting GE product is unable to bind PROTEIN1 that is responsible for PROTEIN2 filament binding and organization.
LABEL>1
The results clearly showed that the mutated GE possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant PROTEIN1 with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with PROTEIN2.
LABEL>1
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with PROTEIN2 and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with PROTEIN2 and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN1, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN1, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and PROTEIN2; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and PROTEIN2; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The results indicate that (a) PROTEIN1 and PROTEIN2 differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>1
The Saccharomyces cerevisiae GE gene belongs to the GE, PROTEIN1 and PROTEIN2 epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Saccharomyces cerevisiae PROTEIN1 gene belongs to the GE, PROTEIN2 and GE epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Saccharomyces cerevisiae GE gene belongs to the PROTEIN1, PROTEIN2 and GE epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Saccharomyces cerevisiae PROTEIN1 gene belongs to the GE, GE and PROTEIN2 epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Saccharomyces cerevisiae GE gene belongs to the PROTEIN1, GE and PROTEIN2 epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN2, GE and GE epistasis group which, together with GE, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>1
The Schizosaccharomyces pombe GE, GE and PROTEIN1 genes are homologous to GE, GE and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>1
The Schizosaccharomyces pombe PROTEIN1, GE and GE genes are homologous to PROTEIN2, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>1
The Schizosaccharomyces pombe GE, PROTEIN1 and GE genes are homologous to GE, PROTEIN2 and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>1
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of PROTEIN1, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent GE activity of Dictyostelium PROTEIN2 requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>1
These data strongly suggest that the head, neck, and tail domains of all PROTEIN1, and light chains at least of PROTEIN2, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent GE activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>1
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN1-dependent GE activity of Dictyostelium PROTEIN2 requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>1
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent PROTEIN1 activity of Dictyostelium PROTEIN2 requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>1
These data strongly suggest that the head, neck, and tail domains of all PROTEIN1, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent GE activity of Dictyostelium PROTEIN2 requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>1
These data suggest that nuclear PROTEIN1 can mediate a stimulus-response action on the PROTEIN2 cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.
LABEL>1
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN2 and GE.
LABEL>1
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>1
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN2, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>1
These findings suggest that this novel PROTEIN1 is involved in the PROTEIN2 signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>1
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>1
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as GE and PROTEIN2.
LABEL>1
These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the GE gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the PROTEIN1 and PROTEIN2 families are independently regulated in human heart.
LABEL>1
These phenotypes are similar to those of the mutant of PROTEIN1, which encodes PROTEIN2, an GE.
LABEL>1
These phenotypes are similar to those of the mutant of GE, which encodes PROTEIN1, an PROTEIN2.
LABEL>1
These proteins each have a GE-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN1rGE/3 complex, leading to rapid PROTEIN2 polymerization.
LABEL>1
These proteins each have a GE-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN1rGE/3 complex, leading to rapid GE polymerization.
LABEL>1
These proteins each have a GE-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN1rGE/3 complex, leading to rapid PROTEIN2 polymerization.
LABEL>1
The sequence of the inhibitory region is similar to that of a beta-hairpin region of the PROTEIN1 PROTEIN2.
LABEL>1
The sequences of the predicted GE, GE, and GE proteins are related to the PROTEIN1 GE, PROTEIN2/GE, and GE, respectively.
LABEL>1
The sequences of the predicted GE, PROTEIN1, and GE proteins are related to the GE GE, PROTEIN2/GE, and GE, respectively.
LABEL>1
The sequences of the predicted GE, GE, and GE proteins are related to the PROTEIN1 PROTEIN2, GE/GE, and GE, respectively.
LABEL>1
The sequences of the predicted GE, GE, and GE proteins are related to the PROTEIN1 GE, GE/GE, and PROTEIN2, respectively.
LABEL>1
The sequences of the predicted GE, GE, and GE proteins are related to the PROTEIN1 GE, GE/PROTEIN2, and GE, respectively.
LABEL>1
The sequences of the predicted PROTEIN1, GE, and GE proteins are related to the GE PROTEIN2, GE/GE, and GE, respectively.
LABEL>1
The sequences of the predicted GE, GE, and PROTEIN1 proteins are related to the GE GE, GE/GE, and PROTEIN2, respectively.
LABEL>1
The sequences of the predicted GE, PROTEIN1, and GE proteins are related to the GE GE, GE/PROTEIN2, and GE, respectively.
LABEL>1
These regions also interact with the physiologically relevant ligands of PROTEIN1, PROTEIN2 and proline-rich peptides.
LABEL>1
These results indicate that (i) cotranslational assembly of PROTEIN1 is developmentally regulated, (ii) structures containing PROTEIN2 and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.
LABEL>1
These results indicate that phosphorylation of PROTEIN1 by GE and consequently increased phosphorylation of PROTEIN2 by GE contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>1
These results indicate that phosphorylation of PROTEIN1 by GE and consequently increased phosphorylation of GE by GE contribute to GE-induced reorganization of the PROTEIN2 cytoskeleton.
LABEL>1
These results indicate that phosphorylation of PROTEIN1 by PROTEIN2 and consequently increased phosphorylation of GE by GE contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of PROTEIN1 by PROTEIN2 contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of GE by PROTEIN1 contribute to GE-induced reorganization of the PROTEIN2 cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of PROTEIN1 by GE contribute to GE-induced reorganization of the PROTEIN2 cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by PROTEIN1 and consequently increased phosphorylation of PROTEIN2 by GE contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of GE by GE contribute to PROTEIN1-induced reorganization of the PROTEIN2 cytoskeleton.
LABEL>1
These results indicate that phosphorylation of GE by PROTEIN1 and consequently increased phosphorylation of GE by GE contribute to GE-induced reorganization of the PROTEIN2 cytoskeleton.
LABEL>1
These results show that PROTEIN1/GE is an important regulator of PROTEIN2-based cell motility during Drosophila development.
LABEL>1
These results show that GE/PROTEIN1 is an important regulator of PROTEIN2-based cell motility during Drosophila development.
LABEL>1
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as GE and PROTEIN2.
LABEL>1
These results suggest that activation of GE precedes the activation of PROTEIN1 and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN2 such as GE and GE.
LABEL>1
These results suggest that activation of PROTEIN1 precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN2 such as GE and GE.
LABEL>1
These results suggest that activation of GE precedes the activation of GE and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN2 such as GE and GE.
LABEL>1
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN1 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN2 such as GE and GE.
LABEL>1
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN2 and GE.
LABEL>1
These results suggest that activation of PROTEIN1 precedes the activation of PROTEIN2 and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>1
These results suggest that activation of GE precedes the activation of PROTEIN1 and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>1
These results suggest that activation of PROTEIN1 precedes the activation of GE and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>1
These results suggest that activation of PROTEIN1 precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>1
These results suggest that activation of GE precedes the activation of GE and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>1
These results suggest that PROTEIN1 may be involved in the pathogenesis of glomerulonephritis by reorganizing PROTEIN2 cytoskeleton.
LABEL>1
These results suggest that PROTEIN1 functions downstream of the GE-PROTEIN2 signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating GE proteins.
LABEL>1
These results suggest that PROTEIN1 functions downstream of the GE-GE signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
LABEL>1
These results suggest that PROTEIN1 functions downstream of the GE-GE signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating GE proteins.
LABEL>1
These results suggest that PROTEIN1 functions downstream of the PROTEIN2-GE signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating GE proteins.
LABEL>1
These results suggest that GE functions downstream of the GE-GE signalling pathway and plays a role in reorganization of PROTEIN1 filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
LABEL>1
We report here that GE and PROTEIN1 phosphorylate both GE and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
LABEL>1
We report here that GE and PROTEIN1 phosphorylate both GE and GE (PROTEIN2) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
We report here that GE and PROTEIN1 phosphorylate both PROTEIN2 and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
We report here that GE and PROTEIN1 phosphorylate both GE and PROTEIN2 (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
We report here that PROTEIN1 and GE phosphorylate both GE and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
LABEL>1
We report here that PROTEIN1 and GE phosphorylate both GE and GE (PROTEIN2) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
We report here that PROTEIN1 and GE phosphorylate both PROTEIN2 and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
We report here that PROTEIN1 and GE phosphorylate both GE and PROTEIN2 (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>1
These results suggest that the heptapeptide sequence is specific for the interaction with GE and, therefore, may constitute part of the PROTEIN1-binding domain of PROTEIN2.
LABEL>1
These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, PROTEIN2, GE, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
These results suggest that GE can cause apoptosis in pancreatic beta cells through PROTEIN1-linked apoptotic factors, PROTEIN2, GE, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, GE, and PROTEIN2, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, PROTEIN2, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
These results suggest that GE can cause apoptosis in pancreatic beta cells through PROTEIN1-linked apoptotic factors, GE, GE, and PROTEIN2, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
These results suggest that GE can cause apoptosis in pancreatic beta cells through PROTEIN1-linked apoptotic factors, GE, PROTEIN2, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>1
The GE GE and GE associate with and activate the PROTEIN1 PROTEIN2 in human T lymphocytes.
LABEL>1
The GE PROTEIN1 and GE associate with and activate the GE PROTEIN2 in human T lymphocytes.
LABEL>1
The GE GE and PROTEIN1 associate with and activate the GE PROTEIN2 in human T lymphocytes.
LABEL>1
The PROTEIN1 PROTEIN2 and GE associate with and activate the GE GE in human T lymphocytes.
LABEL>1
The PROTEIN1 GE and PROTEIN2 associate with and activate the GE GE in human T lymphocytes.
LABEL>1
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 PROTEIN2, the GE GE, and the GE GE.
LABEL>1
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the GE GE, and the PROTEIN1 PROTEIN2.
LABEL>1
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the PROTEIN1 PROTEIN2, and the GE GE.
LABEL>1
These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive PROTEIN1-depolymerizing protein, PROTEIN2, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for GE.
LABEL>1
The sites on the PROTEIN1 that interact with PROTEIN2 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the GE head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the GE head (subfragment 1, S1) in this process.
LABEL>1
The GE homology domain 3 (SH3) of a yeast GE, PROTEIN1, binds to PROTEIN2 and is required for targeting to sites of GE polarization.
LABEL>1
The GE homology domain 3 (SH3) of a yeast PROTEIN1, PROTEIN2, binds to GE and is required for targeting to sites of GE polarization.
LABEL>1
The PROTEIN1 homology domain 3 (SH3) of a yeast GE, PROTEIN2, binds to GE and is required for targeting to sites of GE polarization.
LABEL>1
The structural homology between GE and PROTEIN1 segment-1 binding to PROTEIN2 was confirmed experimentally by two types of competitive binding assays.
LABEL>1
The structural homology between PROTEIN1 and GE segment-1 binding to PROTEIN2 was confirmed experimentally by two types of competitive binding assays.
LABEL>1
The structural homology between PROTEIN1 and PROTEIN2 segment-1 binding to GE was confirmed experimentally by two types of competitive binding assays.
LABEL>1
The structure of an PROTEIN1-crosslinking domain from human PROTEIN2.
LABEL>1
The structure of PROTEIN1 differed entirely from that of PROTEIN2 and resembled the overall fold of the GE regulatory protein, GE.
LABEL>1
The structure of GE differed entirely from that of GE and resembled the overall fold of the PROTEIN1 regulatory protein, PROTEIN2.
LABEL>1
The structure of PROTEIN1 differed entirely from that of GE and resembled the overall fold of the GE regulatory protein, PROTEIN2.
LABEL>1
The Tetrahymena GE has two GE-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN1 probably cross-links PROTEIN2 filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>1
The Tetrahymena PROTEIN1 has two PROTEIN2-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena GE probably cross-links GE filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between GE, PROTEIN1, GE and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (PROTEIN1) and the GE receptor recruit complexes formed by the interactions between GE, PROTEIN2, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the PROTEIN1 receptor recruit complexes formed by the interactions between GE, PROTEIN2, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The PROTEIN1 (GE) and the GE receptor recruit complexes formed by the interactions between GE, PROTEIN2, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between PROTEIN1, PROTEIN2, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between GE, PROTEIN1, PROTEIN2 and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (PROTEIN1) and the GE receptor recruit complexes formed by the interactions between GE, GE, GE and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the PROTEIN1 receptor recruit complexes formed by the interactions between GE, GE, GE and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The PROTEIN1 (GE) and the GE receptor recruit complexes formed by the interactions between GE, GE, GE and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between PROTEIN1, GE, GE and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between GE, GE, PROTEIN1 and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (PROTEIN1) and the GE receptor recruit complexes formed by the interactions between PROTEIN2, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (PROTEIN1) and the GE receptor recruit complexes formed by the interactions between GE, GE, PROTEIN2 and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the PROTEIN1 receptor recruit complexes formed by the interactions between PROTEIN2, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the PROTEIN1 receptor recruit complexes formed by the interactions between GE, GE, PROTEIN2 and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The PROTEIN1 (GE) and the GE receptor recruit complexes formed by the interactions between PROTEIN2, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The PROTEIN1 (GE) and the GE receptor recruit complexes formed by the interactions between GE, GE, PROTEIN2 and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The GE (GE) and the GE receptor recruit complexes formed by the interactions between PROTEIN1, GE, PROTEIN2 and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>1
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated PROTEIN1 than does PROTEIN2, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>1
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher GE-activated PROTEIN2 than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>1
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN1-activated PROTEIN2 than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>1
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>1
The two proteins were found to differ in their interaction with GE, like PROTEIN1 and PROTEIN2 isolated from porcine brain.
LABEL>1
The two proteins were found to differ in their interaction with PROTEIN1, like GE and PROTEIN2 isolated from porcine brain.
LABEL>1
The two proteins were found to differ in their interaction with PROTEIN1, like PROTEIN2 and GE isolated from porcine brain.
LABEL>1
The vaccinia virus PROTEIN1 gene product, GE, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated GE, PROTEIN2.
LABEL>1
The vaccinia virus GE gene product, GE, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated PROTEIN1, PROTEIN2.
LABEL>1
The vaccinia virus GE gene product, PROTEIN1, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated GE, PROTEIN2.
LABEL>1
The vaccinia virus GE gene product, GE, is a dsRNA binding protein that prevents activation of the PROTEIN1-induced, dsRNA-activated GE, PROTEIN2.
LABEL>1
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN1 (GE) and PROTEIN2 (GE).
LABEL>1
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) GE (PROTEIN1) and PROTEIN2 (GE).
LABEL>1
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN1 (GE) and GE (PROTEIN2).
LABEL>1
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) GE (PROTEIN1) and GE (PROTEIN2).
LABEL>1
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a PROTEIN1 alters the assembly of PROTEIN2 receptors, GE and cytoskeletal proteins such as GE and GE.
LABEL>1
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a PROTEIN1 alters the assembly of GE receptors, GE and cytoskeletal proteins such as GE and PROTEIN2.
LABEL>1
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a PROTEIN1 alters the assembly of GE receptors, GE and cytoskeletal proteins such as PROTEIN2 and GE.
LABEL>1
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a PROTEIN1 alters the assembly of GE receptors, PROTEIN2 and cytoskeletal proteins such as GE and GE.
LABEL>1
This activity is independent of GE's ability to bind to three known interacting proteins, PROTEIN1, GE or PROTEIN2 suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This activity is independent of PROTEIN1's ability to bind to three known interacting proteins, GE, GE or PROTEIN2 suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This activity is independent of GE's ability to bind to three known interacting proteins, GE, PROTEIN1 or PROTEIN2 suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This activity is independent of GE's ability to bind to three known interacting proteins, GE, GE or GE suggesting that it is distinct from PROTEIN1's functions at activated PROTEIN2.
LABEL>1
This activity is independent of PROTEIN1's ability to bind to three known interacting proteins, PROTEIN2, GE or GE suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This activity is independent of GE's ability to bind to three known interacting proteins, PROTEIN1, PROTEIN2 or GE suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This activity is independent of PROTEIN1's ability to bind to three known interacting proteins, GE, PROTEIN2 or GE suggesting that it is distinct from GE's functions at activated GE.
LABEL>1
This approach is based on the assumption that an PROTEIN1 mutation that specifically impairs the interaction with an PROTEIN2 will cause a phenotype similar to a null mutation in the gene that encodes the GE.
LABEL>1
21 GE mutations were analyzed in budding yeast, and specific regions of PROTEIN1 subdomain 1 were implicated in the interaction with PROTEIN2, an GE filament-bundling protein.
LABEL>1
21 GE mutations were analyzed in budding yeast, and specific regions of GE subdomain 1 were implicated in the interaction with PROTEIN1, an PROTEIN2 filament-bundling protein.
LABEL>1
This PROTEIN1-PROTEIN2 complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.
LABEL>1
GE and PROTEIN1 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN2 activities.
LABEL>1
PROTEIN1 and GE possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN2 activities.
LABEL>1
This filament growth is driven by a large storage pool of PROTEIN1 bound to the sequestering protein, PROTEIN2.
LABEL>1
This is consistent with PROTEIN1 activation being required for PROTEIN2 reorganization during exocytosis.
LABEL>1
This is the first report describing the coexistence of PROTEIN1 with PROTEIN2 filaments in the division furrow, implying the possible involvement of GE in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
LABEL>1
This novel mutation was predicted to disrupt the binding of PROTEIN1 to PROTEIN2 and may be related to the diffuse type morphology.
LABEL>1
This paper describes the structural and biochemical characterization of PROTEIN1, a protein localized to various cellular sites where bundles of PROTEIN2 filaments attach to the plasma membrane.
LABEL>1
This process involves other PROTEIN1, such as GE and PROTEIN2.
LABEL>1
This process involves other PROTEIN1, such as PROTEIN2 and GE.
LABEL>1
This result was supported by a high protein expression of the PROTEIN1 PROTEIN2 in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>1
This shows that structural changes in the poly(L-proline)-binding region of PROTEIN1 can affect the distantly located PROTEIN2-binding site.
LABEL>1
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN1ortexilliGE or II, two isoforms of the GE-bundling protein PROTEIN2.
LABEL>1
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN1ortexilliGE or II, two isoforms of the GE-bundling protein PROTEIN2.
LABEL>1
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the PROTEIN1-bundling protein PROTEIN2.
LABEL>1
This technique was employed to quantify changes caused by the lack of PROTEIN1, a protein that couples the PROTEIN2 network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>1
Three PROTEIN1-associated proteins, GE, PROTEIN2, and GE, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>1
Three PROTEIN1-associated proteins, PROTEIN2, GE, and GE, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>1
Three PROTEIN1-associated proteins, GE, GE, and PROTEIN2, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>1
Three GE-associated proteins, GE, GE, and PROTEIN1, influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
LABEL>1
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of PROTEIN2), Drosophila GE (GE), and GE.
LABEL>1
Thus, PROTEIN1 was found in association with PROTEIN2 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in GE, did not reveal GE.
LABEL>1
Thus, PROTEIN1 and PROTEIN2 expression are not co-regulated in all cells.
LABEL>1
Thus, it is likely that the both PROTEIN1 isoforms are involved in the regulation of PROTEIN2 assembly during myofibrillogenesis.
LABEL>1
Thus, PROTEIN1 contains an NH(2)-terminal domain homologous to that implicated in GE's endocytic function, three predicted coiled-coils, a leucine zipper, and a GE-like PROTEIN2-binding domain at the COOH terminus.
LABEL>1
Thus, PROTEIN1 contains an NH(2)-terminal domain homologous to that implicated in PROTEIN2's endocytic function, three predicted coiled-coils, a leucine zipper, and a GE-like GE-binding domain at the COOH terminus.
LABEL>1
Thus, PROTEIN1 contains an NH(2)-terminal domain homologous to that implicated in GE's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN2-like GE-binding domain at the COOH terminus.
LABEL>1
Thus, poly-L-proline binding, PROTEIN1 binding, and GE nucleotide exchange are each independent requirements for PROTEIN2 function in fission yeast.
LABEL>1
Thus, poly-L-proline binding, GE binding, and PROTEIN1 nucleotide exchange are each independent requirements for PROTEIN2 function in fission yeast.
LABEL>1
Thus, the PROTEIN1-binding dodecapeptide sequence of PROTEIN2 may constitute a multifunctional domain in GE.
LABEL>1
We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of PROTEIN1 is a potent inhibitor of PROTEIN2 polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).
LABEL>1
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiPROTEIN1 antibodies, PROTEIN2 and GE, and two anti-GE markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>1
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiPROTEIN1 antibodies, GE and PROTEIN2, and two anti-GE markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>1
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the GE (PROTEIN1) PROTEIN2 and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>1
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the PROTEIN1 (GE) PROTEIN2 and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>1
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the GE (PROTEIN1) GE and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>1
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the PROTEIN1 (GE) GE and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>1
Together these results indicate that PROTEIN1 regulates PROTEIN2 gene expression through an GE site and its cognate transcription factor GE, and requires the involvement of GE.
LABEL>1
Together these results indicate that PROTEIN1 regulates GE gene expression through an GE site and its cognate transcription factor PROTEIN2, and requires the involvement of GE.
LABEL>1
Together these results indicate that PROTEIN1 regulates GE gene expression through an PROTEIN2 site and its cognate transcription factor GE, and requires the involvement of GE.
LABEL>1
Together these results indicate that PROTEIN1 regulates GE gene expression through an GE site and its cognate transcription factor GE, and requires the involvement of PROTEIN2.
LABEL>1
Together these results indicate that GE regulates PROTEIN1 gene expression through an GE site and its cognate transcription factor PROTEIN2, and requires the involvement of GE.
LABEL>1
Together these results indicate that GE regulates PROTEIN1 gene expression through an PROTEIN2 site and its cognate transcription factor GE, and requires the involvement of GE.
LABEL>1
Together these results indicate that GE regulates GE gene expression through an PROTEIN1 site and its cognate transcription factor PROTEIN2, and requires the involvement of GE.
LABEL>1
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, GE, PROTEIN1, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, GE, PROTEIN1, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, PROTEIN1, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, PROTEIN1, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, GE, GE, and PROTEIN1 was similar in these cell lines, indicating that the susceptibility to PROTEIN2-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>1
Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, PROTEIN1, and a negative regulatory protein, PROTEIN2.
LABEL>1
Treatment with HNE resulted in activation of PROTEIN1 PROTEIN2 and GE, induction of GE and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>1
Treatment with HNE resulted in activation of PROTEIN1 GE and PROTEIN2, induction of GE and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>1
Two GE, PROTEIN1 and PROTEIN2, are associated with Hirano bodies.
LABEL>1
Two PROTEIN1, PROTEIN2 and GE, are associated with Hirano bodies.
LABEL>1
Two PROTEIN1, GE and PROTEIN2, are associated with Hirano bodies.
LABEL>1
Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick PROTEIN1 and 66% identical to chick PROTEIN2 (GE), two structurally and functionally related proteins.
LABEL>1
Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick PROTEIN1 and 66% identical to chick GE (PROTEIN2), two structurally and functionally related proteins.
LABEL>1
Two isoforms of GE (GE) are generated by alternative splicing; PROTEIN1 differs from PROTEIN2 by the insertion of B2 exon cassette near the GE binding region.
LABEL>1
Two isoforms of GE (GE) are generated by alternative splicing; PROTEIN1 differs from GE by the insertion of B2 exon cassette near the PROTEIN2 binding region.
LABEL>1
Two isoforms of GE (GE) are generated by alternative splicing; GE differs from PROTEIN1 by the insertion of B2 exon cassette near the PROTEIN2 binding region.
LABEL>1
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN1 GE and PROTEIN2 also did not exhibit medial GE-GE staining.
LABEL>1
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN1 PROTEIN2 and GE also did not exhibit medial GE-GE staining.
LABEL>1
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and GE also did not exhibit medial PROTEIN1-PROTEIN2 staining.
LABEL>1
Unlike GE, PROTEIN1's PROTEIN2-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
LABEL>1
Unlike PROTEIN1, GE's PROTEIN2-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
LABEL>1
Unmasking of this site serves as a molecular switch that initiates assembly of an PROTEIN1-based motility complex containing PROTEIN2 and GE.
LABEL>1
Unmasking of this site serves as a molecular switch that initiates assembly of an GE-based motility complex containing PROTEIN1 and PROTEIN2.
LABEL>1
Unmasking of this site serves as a molecular switch that initiates assembly of an PROTEIN1-based motility complex containing GE and PROTEIN2.
LABEL>1
Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN1, a 14 kd protein that regulates PROTEIN2; GE, the 18 kd birch pollen allergen; and a 60-69 kd allergen.
LABEL>1
Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of PROTEIN1, we recently demonstrated that this segment is an PROTEIN2 binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].
LABEL>1
Using ITP (a substrate for PROTEIN1 PROTEIN2) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>1
Using the known three-dimensional structure of the homologous GE-binding domain of PROTEIN1, these results have enabled us to determine the likely orientation of the PROTEIN2 GE-binding domain with respect to the GE filament.
LABEL>1
Using the known three-dimensional structure of the homologous GE-binding domain of GE, these results have enabled us to determine the likely orientation of the PROTEIN1 GE-binding domain with respect to the PROTEIN2 filament.
LABEL>1
Using the known three-dimensional structure of the homologous GE-binding domain of GE, these results have enabled us to determine the likely orientation of the PROTEIN1 PROTEIN2-binding domain with respect to the GE filament.
LABEL>1
Using the known three-dimensional structure of the homologous PROTEIN1-binding domain of PROTEIN2, these results have enabled us to determine the likely orientation of the GE GE-binding domain with respect to the GE filament.
LABEL>1
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that GE protects PROTEIN1 filaments in these cells from Z. mays PROTEIN2 (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>1
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN1 protects PROTEIN2 filaments in these cells from Z. mays GE (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>1
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that GE protects PROTEIN1 filaments in these cells from Z. mays GE (PROTEIN2)-induced depolymerization, in a dose-dependent manner.
LABEL>1
Using these methods, we confirm previous reports that intact PROTEIN1 induces cross-linking as well as filament shortening on PROTEIN2 networks.
LABEL>1
GE (PROTEIN1) clusters were co-localized with GE, an important signal transduction ligand, and with PROTEIN2, which is thought to link the complex to the peri-junctional GE.
LABEL>1
GE (PROTEIN1) clusters were co-localized with PROTEIN2, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional GE.
LABEL>1
GE (GE) clusters were co-localized with GE, an important signal transduction ligand, and with PROTEIN1, which is thought to link the complex to the peri-junctional PROTEIN2.
LABEL>1
PROTEIN1 (GE) clusters were co-localized with GE, an important signal transduction ligand, and with PROTEIN2, which is thought to link the complex to the peri-junctional GE.
LABEL>1
PROTEIN1 (GE) clusters were co-localized with PROTEIN2, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional GE.
LABEL>1
PROTEIN1, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN2, an GE-regulatory protein that stimulates GE filament assembly.
LABEL>1
GE, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN1, an PROTEIN2-regulatory protein that stimulates GE filament assembly.
LABEL>1
GE, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN1, an GE-regulatory protein that stimulates PROTEIN2 filament assembly.
LABEL>1
GE and PROTEIN1 are two GE that bundle PROTEIN2 filaments in the intestine and kidney brush border epithelium.
LABEL>1
PROTEIN1 and GE are two GE that bundle PROTEIN2 filaments in the intestine and kidney brush border epithelium.
LABEL>1
GE and PROTEIN1 are two PROTEIN2 that bundle GE filaments in the intestine and kidney brush border epithelium.
LABEL>1
PROTEIN1 and GE are two PROTEIN2 that bundle GE filaments in the intestine and kidney brush border epithelium.
LABEL>1
PROTEIN1 contains a binding motif for the GE GE as well as PROTEIN2/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>1
PROTEIN1 contains a binding motif for the GE GE as well as GE/PROTEIN2-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>1
PROTEIN1 contains a binding motif for the GE PROTEIN2 as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>1
GE contains a binding motif for the PROTEIN1 PROTEIN2 as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>1
PROTEIN1 contains a binding motif for the GE GE as well as GE/GE-like PROTEIN2-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>1
GE contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN1-PROTEIN2 has been identified.
LABEL>1
GE contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific PROTEIN1 structure regulated by PROTEIN2-GE has been identified.
LABEL>1
GE contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific PROTEIN1 structure regulated by GE-PROTEIN2 has been identified.
LABEL>1
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in PROTEIN1 and GE (homologues of S.cerevisiae PROTEIN2 and GE, respectively) are not affected.
LABEL>1
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in GE and PROTEIN1 (homologues of S.cerevisiae GE and PROTEIN2, respectively) are not affected.
LABEL>1
We believe that this complex may mediate the cortical functions of PROTEIN1 at PROTEIN2 patches in S. pombe.
LABEL>1
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN1" with GE, GE, PROTEIN2, and GE, and the association of these complexes with the GE microfilaments.
LABEL>1
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN1" with PROTEIN2, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>1
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN1" with GE, GE, GE, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>1
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN1" with GE, PROTEIN2, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>1
We examined whether levels of GE or PROTEIN1 correlated with PROTEIN2 levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
LABEL>1
We examined whether levels of PROTEIN1 or GE correlated with PROTEIN2 levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
LABEL>1
We find that GE and PROTEIN1 regulate PROTEIN2-filament formation throughout the cell cortex.
LABEL>1
We find that PROTEIN1 and GE regulate PROTEIN2-filament formation throughout the cell cortex.
LABEL>1
We find that PROTEIN1 contributes in several ways to GE-induced nucleation of PROTEIN2 filaments in high speed supernatant of lysed neutrophils.
LABEL>1
We find that GE contributes in several ways to PROTEIN1-induced nucleation of PROTEIN2 filaments in high speed supernatant of lysed neutrophils.
LABEL>1
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>1
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>1
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>1
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN1 PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>1
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN1 PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>1
We have characterized the interaction and nuclear localization of the GE (PROTEIN1) protein and PROTEIN2 (GE) of sonchus yellow net nucleorhabdovirus.
LABEL>1
We have characterized the interaction and nuclear localization of the PROTEIN1 (GE) protein and PROTEIN2 (GE) of sonchus yellow net nucleorhabdovirus.
LABEL>1
We have characterized the interaction and nuclear localization of the GE (PROTEIN1) protein and GE (PROTEIN2) of sonchus yellow net nucleorhabdovirus.
LABEL>1
We have characterized the interaction and nuclear localization of the PROTEIN1 (GE) protein and GE (PROTEIN2) of sonchus yellow net nucleorhabdovirus.
LABEL>1
We have characterized this PROTEIN1 with respect to its ability to interact with yeast PROTEIN2 and GE, the only yeast GE so far purified and characterized.
LABEL>1
We have characterized this PROTEIN1 with respect to its ability to interact with yeast GE and PROTEIN2, the only yeast GE so far purified and characterized.
LABEL>1
We have characterized this GE with respect to its ability to interact with yeast PROTEIN1 and GE, the only yeast PROTEIN2 so far purified and characterized.
LABEL>1
We have characterized this GE with respect to its ability to interact with yeast GE and PROTEIN1, the only yeast PROTEIN2 so far purified and characterized.
LABEL>1
Yeast PROTEIN1 can sequester yeast PROTEIN2 monomers and thereby reduce the ability of yeast GE to polymerize, whereas it has little effect on the degree of polymerization of rabbit GE.
LABEL>1
Yeast PROTEIN1 can sequester yeast GE monomers and thereby reduce the ability of yeast PROTEIN2 to polymerize, whereas it has little effect on the degree of polymerization of rabbit GE.
LABEL>1
Yeast PROTEIN1 can sequester yeast GE monomers and thereby reduce the ability of yeast GE to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (PROTEIN1) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast PROTEIN2; GE); its aa sequence is 35% identical to porcine GE.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) PROTEIN1 of 143 amino acid (aa) residues (yeast PROTEIN2; GE); its aa sequence is 35% identical to porcine GE.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast PROTEIN1; GE); its aa sequence is 35% identical to porcine PROTEIN2.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (PROTEIN1) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast GE; PROTEIN2); its aa sequence is 35% identical to porcine GE.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) PROTEIN1 of 143 amino acid (aa) residues (yeast GE; PROTEIN2); its aa sequence is 35% identical to porcine GE.
LABEL>1
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast GE; PROTEIN1); its aa sequence is 35% identical to porcine PROTEIN2.
LABEL>1
We have examined the level of GE, a GE, and PROTEIN1, a PROTEIN2, in BALB/c 3T3 cells.
LABEL>1
We have examined the level of PROTEIN1, a PROTEIN2, and GE, a GE, in BALB/c 3T3 cells.
LABEL>1
We have found that PROTEIN1, a 21-kDa PROTEIN2, is a component of these rods.
LABEL>1
We have shown that the GE GE and PROTEIN1 are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE PROTEIN1 and GE are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and GE are potential targets of the GE family GE and bind to an GE, PROTEIN1, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and PROTEIN1 are potential targets of the PROTEIN2 family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and GE are potential targets of the PROTEIN1 family PROTEIN2 and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE PROTEIN1 and GE are potential targets of the PROTEIN2 family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and PROTEIN1 are potential targets of the GE family PROTEIN2 and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and PROTEIN1 are potential targets of the GE family GE and bind to an GE, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the PROTEIN1 GE and PROTEIN2 are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE PROTEIN1 and GE are potential targets of the GE family PROTEIN2 and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE PROTEIN1 and GE are potential targets of the GE family GE and bind to an GE, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the PROTEIN1 PROTEIN2 and GE are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that the GE GE and GE are potential targets of the GE family GE and bind to an PROTEIN1, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>1
We have shown that these proteins are indeed PROTEIN1: the 14 kd is the GE PROTEIN2, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein GE.
LABEL>1
We have shown that these proteins are indeed PROTEIN1: the 14 kd is the GE GE, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein PROTEIN2.
LABEL>1
We have shown that these proteins are indeed PROTEIN1: the 14 kd is the GE GE, the 19 kd is the GE PROTEIN2, and the 25 kd is the sperm-specific protein GE.
LABEL>1
We have shown that these proteins are indeed GE: the 14 kd is the GE GE, the 19 kd is the PROTEIN1 PROTEIN2, and the 25 kd is the sperm-specific protein GE.
LABEL>1
We have shown that these proteins are indeed GE: the 14 kd is the PROTEIN1 PROTEIN2, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein GE.
LABEL>1
We investigated PROTEIN1 filament turnover rates, length, number, barbed end exposure, and binding of PROTEIN2 in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.
LABEL>1
We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins GE, PROTEIN2, and GE.
LABEL>1
We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins GE, GE, and PROTEIN2.
LABEL>1
We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins PROTEIN2, GE, and GE.
LABEL>1
We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN2 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous GE is highly concentrated.
LABEL>1
We report here that PROTEIN1, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN2 and GE from the cores but does not affect GE binding by 110-kD GE.
LABEL>1
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect PROTEIN1 binding by 110-kD PROTEIN2.
LABEL>1
We report here that PROTEIN1, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect GE binding by 110-kD PROTEIN2.
LABEL>1
We report here that PROTEIN1, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and PROTEIN2 from the cores but does not affect GE binding by 110-kD GE.
LABEL>1
We report here that PROTEIN1, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect PROTEIN2 binding by 110-kD GE.
LABEL>1
We report here that PROTEIN1, which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect GE binding by 110-kD GE.
LABEL>1
We show here that the phenotype of ts GE is highly similar to that of GE and that the functions of the gene products of PROTEIN1 and PROTEIN2 are closely interrelated.
LABEL>1
We speculate that PROTEIN1 may help maintain the parallel growth of PROTEIN2 filaments within the stereocilia.
LABEL>1
Western analysis of gel-purified GE-GE and GE-GE-PROTEIN1 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN1 PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-PROTEIN1 and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-GE and GE-PROTEIN1-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified PROTEIN1-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-GE and PROTEIN1-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN1 relative to acetylated GE PROTEIN2.
LABEL>1
Western analysis of gel-purified GE-GE and GE-PROTEIN1-PROTEIN2 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and PROTEIN1-GE-PROTEIN2 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and GE-GE-PROTEIN1 complexes demonstrated the predominant presence of acetylated GE PROTEIN2 relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified PROTEIN1-PROTEIN2 and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-PROTEIN1 and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN2 relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and PROTEIN1-PROTEIN2-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and GE-PROTEIN1-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN2 relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN1 PROTEIN2 relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified PROTEIN1-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN2 relative to acetylated GE GE.
LABEL>1
Western analysis of gel-purified GE-GE and PROTEIN1-GE-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN2 relative to acetylated GE GE.
LABEL>1
We studied the roles of PROTEIN1, an PROTEIN2-binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).
LABEL>1
We suggest that the PROTEIN1 in the nodes functions, via a cross-linking activity, in the convergence of PROTEIN2 filaments at the membrane during development of the ribs.
LABEL>1
While levels of most of these proteins decrease, accumulation of GE and the PROTEIN1 GE GE/PROTEIN2 is observed.
LABEL>1
While levels of most of these proteins decrease, accumulation of GE and the PROTEIN1 PROTEIN2 GE/GE is observed.
LABEL>1
While levels of most of these proteins decrease, accumulation of GE and the PROTEIN1 GE PROTEIN2/GE is observed.
LABEL>1
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of PROTEIN1 PROTEIN2 and only inefficiently competed with DNA for binding of GE GE.
LABEL>1
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of PROTEIN1 PROTEIN2.
LABEL>1
While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1 PROTEIN2, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of GE GE.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, PROTEIN2, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, PROTEIN1, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, PROTEIN1, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, PROTEIN1, PROTEIN2, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, PROTEIN1, GE, GE and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, PROTEIN1, GE, PROTEIN2 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, PROTEIN2, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, PROTEIN2, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, GE, PROTEIN2, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, GE, GE, GE and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, PROTEIN1, GE, GE, PROTEIN2 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, PROTEIN2, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, PROTEIN2, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, PROTEIN1, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, GE and PROTEIN1 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, PROTEIN1 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, PROTEIN1, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, GE and PROTEIN1 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, PROTEIN1 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and PROTEIN2, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, PROTEIN1, GE and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, PROTEIN1, PROTEIN2 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, GE, PROTEIN2, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, GE, PROTEIN2, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, GE, GE, GE, GE, PROTEIN1 and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, GE, GE, GE and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, GE, GE, GE and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, GE, PROTEIN1, GE, GE, GE, PROTEIN2 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, GE, GE, GE, GE, PROTEIN2 and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>1
Within 1 hour of raising the concentration of calcium ions, PROTEIN1, PROTEIN2, GE, GE, GE, GE and GE appeared to accumulate at cell-cell borders, whereas the focal contact proteins, GE and GE, did not.
LABEL>0
There are three GE GE genes, two of which are identical; four GE PROTEIN1 genes, two of which are identical, one GE GE gene; and two PROTEIN2 GE genes.
LABEL>0
There are three GE GE genes, two of which are identical; four GE PROTEIN1 genes, two of which are identical, one GE PROTEIN2 gene; and two GE GE genes.
LABEL>0
There are three GE GE genes, two of which are identical; four GE GE genes, two of which are identical, one GE PROTEIN1 gene; and two GE PROTEIN2 genes.
LABEL>0
There are three GE GE genes, two of which are identical; four GE PROTEIN1 genes, two of which are identical, one GE GE gene; and two GE PROTEIN2 genes.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the GE GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the PROTEIN2 GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the GE PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and PROTEIN2 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and PROTEIN2 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and PROTEIN2 mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and PROTEIN1 mRNA, whereas the GE GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN1 GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN1 and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN1 and PROTEIN2 mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN1 GE genes encode < 10% of the total GE and PROTEIN2 mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN1 GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN1 and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE PROTEIN1 genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the GE GE and GE PROTEIN2 genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN2 GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN2 GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN1 GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN2 GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the PROTEIN2 GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the PROTEIN1 GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the GE PROTEIN2 and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE PROTEIN1 and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and PROTEIN2 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These GE PROTEIN1 and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total PROTEIN2 and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and PROTEIN1 genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN1 GE genes encode < 10% of the total PROTEIN2 and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total PROTEIN2 and GE mRNA, whereas the GE GE and GE GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These PROTEIN1 GE and GE genes encode approximately 40% of the total GE and GE mRNA, whereas the GE GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
These GE GE and GE genes encode approximately 40% of the total PROTEIN1 and GE mRNA, whereas the GE GE and PROTEIN2 GE genes encode < 10% of the total GE and GE mRNA.
LABEL>0
The recombinant material is similar to authentic GE from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, PROTEIN1-nucleotide exchange rate and the Kd for rabbit PROTEIN2.
LABEL>0
The recombinant material is similar to authentic PROTEIN1 from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, PROTEIN2-nucleotide exchange rate and the Kd for rabbit GE.
LABEL>0
The resulting PROTEIN1 product is unable to bind GE that is responsible for PROTEIN2 filament binding and organization.
LABEL>0
The results clearly showed that the mutated PROTEIN1 possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant PROTEIN2 with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with GE.
LABEL>0
The results clearly showed that the mutated PROTEIN1 possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant GE with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with PROTEIN2.
LABEL>0
The results indicate increased fractional synthesis and degradation of PROTEIN1yosiGE and light chains, but not GE, in the left compared to the right ventricular free wall.
LABEL>0
The results indicate increased fractional synthesis and degradation of PROTEIN1yosiGE and light chains, but not PROTEIN2, in the left compared to the right ventricular free wall.
LABEL>0
The results indicate increased fractional synthesis and degradation of PROTEIN1yosiGE and light chains, but not PROTEIN2, in the left compared to the right ventricular free wall.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, GE, PROTEIN1, GE, and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1, PROTEIN2, GE, and GE in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, GE, PROTEIN1, PROTEIN2, and GE in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1, GE, GE, and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, GE, GE, PROTEIN1, and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1, GE, PROTEIN2, and GE in the right and left ventricular free walls of growing, New Zealand White rabbits.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and GE; (b) PROTEIN2-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN1-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN1-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and PROTEIN1; (b) PROTEIN2-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN2-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN1-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN1-dependent transactivation is preferentially driven by PROTEIN2; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and GE; (b) PROTEIN2-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN2; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with PROTEIN1 and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN2; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and PROTEIN1; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN1 and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN1; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, GE and PROTEIN2, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and PROTEIN1; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN1; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of PROTEIN2, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and PROTEIN1; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and PROTEIN1; (b) GE-dependent transactivation is preferentially driven by PROTEIN2; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) PROTEIN1 and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN2; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and GE differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN1; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by GE; and (c) the cytoplasmic partners of GE, PROTEIN2 and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The results indicate that (a) GE and PROTEIN1 differ in their nuclear translocation and complexing with GE and GE; (b) GE-dependent transactivation is preferentially driven by PROTEIN2; and (c) the cytoplasmic partners of GE, GE and GE, can sequester it to the cytoplasm and inhibit its transcriptional activity.
LABEL>0
The Saccharomyces cerevisiae PROTEIN1 and PROTEIN2 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.
LABEL>0
The Saccharomyces cerevisiae GE gene belongs to the GE, PROTEIN1 and GE epistasis group which, together with PROTEIN2, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>0
The Saccharomyces cerevisiae GE gene belongs to the GE, GE and PROTEIN1 epistasis group which, together with PROTEIN2, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>0
The Saccharomyces cerevisiae PROTEIN1 gene belongs to the GE, GE and GE epistasis group which, together with PROTEIN2, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>0
The Saccharomyces cerevisiae GE gene belongs to the PROTEIN1, GE and GE epistasis group which, together with PROTEIN2, is proposed to act at the beginning of the DNA damage checkpoint pathway.
LABEL>0
The same steady state concentrations of polymerized and nonpolymerized PROTEIN1 are reached whether PROTEIN2 is added before initiation of polymerization or after polymerization is complete.
LABEL>0
The Schizosaccharomyces pombe GE, GE and PROTEIN1 genes are homologous to PROTEIN2, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, PROTEIN1 and PROTEIN2 genes are homologous to GE, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe PROTEIN1, GE and PROTEIN2 genes are homologous to GE, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, GE and PROTEIN1 genes are homologous to GE, PROTEIN2 and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, GE and GE genes are homologous to PROTEIN1, GE and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, PROTEIN1 and GE genes are homologous to GE, GE and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe PROTEIN1, GE and GE genes are homologous to GE, GE and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, GE and GE genes are homologous to GE, PROTEIN1 and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, PROTEIN1 and GE genes are homologous to PROTEIN2, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe GE, GE and GE genes are homologous to PROTEIN1, PROTEIN2 and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe PROTEIN1, PROTEIN2 and GE genes are homologous to GE, GE and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
The Schizosaccharomyces pombe PROTEIN1, GE and GE genes are homologous to GE, PROTEIN2 and GE respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
LABEL>0
These cells have both PROTEIN1 and PROTEIN2, display unusual expression of GE, and have the typical fibroblastic phenotype of transformed cells.
LABEL>0
These cells have both GE and PROTEIN1, display unusual expression of PROTEIN2, and have the typical fibroblastic phenotype of transformed cells.
LABEL>0
These cells have both PROTEIN1 and GE, display unusual expression of PROTEIN2, and have the typical fibroblastic phenotype of transformed cells.
LABEL>0
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of PROTEIN1, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN2-dependent GE activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>0
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of PROTEIN1, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent PROTEIN2 activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>0
These data strongly suggest that the head, neck, and tail domains of all GE, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN1-dependent PROTEIN2 activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>0
These data strongly suggest that the head, neck, and tail domains of all PROTEIN1, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN2-dependent GE activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>0
These data strongly suggest that the head, neck, and tail domains of all PROTEIN1, and light chains at least of GE, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated GE-dependent PROTEIN2 activity of Dictyostelium GE requires isoform specific interactions between the heavy chain head and tail and light chains.
LABEL>0
These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of PROTEIN1, GE and PROTEIN2.
LABEL>0
These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of GE, PROTEIN1 and PROTEIN2.
LABEL>0
These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of PROTEIN1, PROTEIN2 and GE.
LABEL>0
These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of PROTEIN1 and PROTEIN2.
LABEL>0
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN2 and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN2 and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to PROTEIN1-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN2 and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN1, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN2 and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN1 and PROTEIN2.
LABEL>0
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as PROTEIN2 and GE.
LABEL>0
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to PROTEIN2-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as GE and GE.
LABEL>0
These findings suggest that this novel PROTEIN1 is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and PROTEIN2.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of GE, which leads to PROTEIN2-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN2, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and PROTEIN2.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to PROTEIN1-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN1, which leads to PROTEIN2-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to PROTEIN1-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and PROTEIN2.
LABEL>0
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to PROTEIN2-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN1, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the GE signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN1, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and PROTEIN2.
LABEL>0
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of GE activation, and mediates the stimulation of PROTEIN2, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and GE.
LABEL>0
These findings suggest that this novel GE is involved in the PROTEIN1 signalling pathway, probably downstream of GE activation, and mediates the stimulation of GE, which leads to GE-related cytoskeletal changes through the hydrolysis of PIP2, which binds to GE such as GE and PROTEIN2.
LABEL>0
These genes were designated PROTEIN1, GE, PROTEIN2, GE, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated PROTEIN1, PROTEIN2, GE, GE, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated PROTEIN1, GE, GE, GE, and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated PROTEIN1, GE, GE, PROTEIN2, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, PROTEIN1, PROTEIN2, GE, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, GE, PROTEIN1, GE, and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, GE, PROTEIN1, PROTEIN2, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, PROTEIN1, GE, GE, and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, PROTEIN1, GE, PROTEIN2, and GE and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These genes were designated GE, GE, GE, PROTEIN1, and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
LABEL>0
These increases were specific; DNA, total protein, GE, PROTEIN1, and PROTEIN2 levels were unchanged in the overexpressing cells.
LABEL>0
These increases were specific; DNA, total protein, PROTEIN1, PROTEIN2, and GE levels were unchanged in the overexpressing cells.
LABEL>0
These increases were specific; DNA, total protein, PROTEIN1, GE, and PROTEIN2 levels were unchanged in the overexpressing cells.
LABEL>0
These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the PROTEIN1 gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the PROTEIN2 and GE families are independently regulated in human heart.
LABEL>0
These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the PROTEIN1 gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the GE and PROTEIN2 families are independently regulated in human heart.
LABEL>0
These phenotypes are similar to those of the mutant of PROTEIN1, which encodes GE, an PROTEIN2.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor GE, and products of yeast pre-mRNA processing genes PROTEIN1, GE, and PROTEIN2 are their likely yeast counterparts.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor GE, and products of yeast pre-mRNA processing genes GE, PROTEIN1, and PROTEIN2 are their likely yeast counterparts.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor PROTEIN1, and products of yeast pre-mRNA processing genes GE, GE, and PROTEIN2 are their likely yeast counterparts.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor GE, and products of yeast pre-mRNA processing genes PROTEIN1, PROTEIN2, and GE are their likely yeast counterparts.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor PROTEIN1, and products of yeast pre-mRNA processing genes PROTEIN2, GE, and GE are their likely yeast counterparts.
LABEL>0
These proteins also compose the essential heterotrimeric splicing factor PROTEIN1, and products of yeast pre-mRNA processing genes GE, PROTEIN2, and GE are their likely yeast counterparts.
LABEL>0
These proteins each have a PROTEIN1-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN2rGE/3 complex, leading to rapid GE polymerization.
LABEL>0
These proteins each have a PROTEIN1-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the GErGE/3 complex, leading to rapid PROTEIN2 polymerization.
LABEL>0
These proteins each have a PROTEIN1-homology (V) domain, PROTEIN2-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the GErGE/3 complex, leading to rapid GE polymerization.
LABEL>0
These proteins each have a PROTEIN1-homology (V) domain, GE-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN2rGE/3 complex, leading to rapid GE polymerization.
LABEL>0
These proteins each have a GE-homology (V) domain, PROTEIN1-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN2rGE/3 complex, leading to rapid GE polymerization.
LABEL>0
These proteins each have a GE-homology (V) domain, PROTEIN1-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the GErGE/3 complex, leading to rapid PROTEIN2 polymerization.
LABEL>0
These proteins each have a GE-homology (V) domain, PROTEIN1-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN2rGE/3 complex, leading to rapid GE polymerization.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE PROTEIN1, PROTEIN2/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE GE, PROTEIN1/GE, and PROTEIN2, respectively.
LABEL>0
The sequences of the predicted GE, GE, and PROTEIN1 proteins are related to the GE GE, PROTEIN2/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE GE, PROTEIN1/PROTEIN2, and GE, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, GE, and GE proteins are related to the GE GE, PROTEIN2/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, PROTEIN1, and GE proteins are related to the PROTEIN2 GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and PROTEIN1 proteins are related to the PROTEIN2 GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, GE, and GE proteins are related to the PROTEIN2 GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE PROTEIN1, GE/GE, and PROTEIN2, respectively.
LABEL>0
The sequences of the predicted GE, PROTEIN1, and GE proteins are related to the GE PROTEIN2, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and PROTEIN1 proteins are related to the GE PROTEIN2, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE PROTEIN1, GE/PROTEIN2, and GE, respectively.
LABEL>0
The sequences of the predicted GE, PROTEIN1, and GE proteins are related to the GE GE, GE/GE, and PROTEIN2, respectively.
LABEL>0
The sequences of the predicted GE, GE, and GE proteins are related to the GE GE, GE/PROTEIN1, and PROTEIN2, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, GE, and GE proteins are related to the GE GE, GE/GE, and PROTEIN2, respectively.
LABEL>0
The sequences of the predicted GE, PROTEIN1, and PROTEIN2 proteins are related to the GE GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, PROTEIN2, and GE proteins are related to the GE GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted GE, GE, and PROTEIN1 proteins are related to the GE GE, GE/PROTEIN2, and GE, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, GE, and PROTEIN2 proteins are related to the GE GE, GE/GE, and GE, respectively.
LABEL>0
The sequences of the predicted PROTEIN1, GE, and GE proteins are related to the GE GE, GE/PROTEIN2, and GE, respectively.
LABEL>0
These results indicate that phosphorylation of PROTEIN1 by GE and consequently increased phosphorylation of GE by PROTEIN2 contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>0
These results indicate that phosphorylation of PROTEIN1 by GE and consequently increased phosphorylation of GE by GE contribute to PROTEIN2-induced reorganization of the GE cytoskeleton.
LABEL>0
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of GE by PROTEIN1 contribute to PROTEIN2-induced reorganization of the GE cytoskeleton.
LABEL>0
These results indicate that phosphorylation of GE by PROTEIN1 and consequently increased phosphorylation of GE by PROTEIN2 contribute to GE-induced reorganization of the GE cytoskeleton.
LABEL>0
These results indicate that phosphorylation of GE by GE and consequently increased phosphorylation of PROTEIN1 by GE contribute to PROTEIN2-induced reorganization of the GE cytoskeleton.
LABEL>0
These results indicate that phosphorylation of GE by PROTEIN1 and consequently increased phosphorylation of GE by GE contribute to PROTEIN2-induced reorganization of the GE cytoskeleton.
LABEL>0
These results show that PROTEIN1/PROTEIN2 is an important regulator of GE-based cell motility during Drosophila development.
LABEL>0
These results suggest that activation of GE precedes the activation of PROTEIN1 and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and PROTEIN2.
LABEL>0
These results suggest that activation of PROTEIN1 precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and PROTEIN2.
LABEL>0
These results suggest that activation of GE precedes the activation of GE and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and PROTEIN2.
LABEL>0
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN1 in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and PROTEIN2.
LABEL>0
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as PROTEIN1 and PROTEIN2.
LABEL>0
These results suggest that activation of GE precedes the activation of PROTEIN1 and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as GE and GE.
LABEL>0
These results suggest that activation of GE precedes the activation of PROTEIN1 and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as PROTEIN2 and GE.
LABEL>0
These results suggest that activation of PROTEIN1 precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as PROTEIN2 and GE.
LABEL>0
These results suggest that activation of GE precedes the activation of GE and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of GE in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as PROTEIN2 and GE.
LABEL>0
These results suggest that activation of GE precedes the activation of GE and GE and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN1 in RBL cells, possibly through the interaction of the polyphosphoinositides with GE such as PROTEIN2 and GE.
LABEL>0
These results suggest that GE functions downstream of the GE-PROTEIN1 signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
LABEL>0
These results suggest that GE functions downstream of the GE-PROTEIN1 signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating GE proteins.
LABEL>0
These results suggest that GE functions downstream of the PROTEIN1-PROTEIN2 signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating GE proteins.
LABEL>0
These results suggest that GE functions downstream of the PROTEIN1-GE signalling pathway and plays a role in reorganization of GE filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
LABEL>0
These results suggest that GE functions downstream of the PROTEIN1-GE signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating GE proteins.
LABEL>0
We report here that PROTEIN1 and PROTEIN2 phosphorylate both GE and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both GE and GE (PROTEIN1) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both PROTEIN1 and GE (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both GE and PROTEIN1 (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both PROTEIN1 and GE (PROTEIN2) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both GE and PROTEIN1 (PROTEIN2) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>0
We report here that GE and GE phosphorylate both PROTEIN1 and PROTEIN2 (GE) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed GE mutants as substrates.
LABEL>0
These results suggest that the heptapeptide sequence is specific for the interaction with PROTEIN1 and, therefore, may constitute part of the GE-binding domain of PROTEIN2.
LABEL>0
These results suggest that the heptapeptide sequence is specific for the interaction with PROTEIN1 and, therefore, may constitute part of the PROTEIN2-binding domain of GE.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, PROTEIN1, GE, and PROTEIN2, and GE-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, PROTEIN1, PROTEIN2, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, PROTEIN1, GE, and GE, and PROTEIN2-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, GE, and GE, and PROTEIN2-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through PROTEIN2-linked apoptotic factors, GE, GE, and GE, and GE-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, PROTEIN1, and PROTEIN2, and GE-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, GE, and PROTEIN1, and PROTEIN2-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through GE-linked apoptotic factors, GE, PROTEIN1, and GE, and PROTEIN2-induced ceramide production may be involved in the pathways.
LABEL>0
These results suggest that GE can cause apoptosis in pancreatic beta cells through PROTEIN1-linked apoptotic factors, GE, GE, and GE, and PROTEIN2-induced ceramide production may be involved in the pathways.
LABEL>0
The GE PROTEIN1 and GE associate with and activate the PROTEIN2 GE in human T lymphocytes.
LABEL>0
The GE GE and PROTEIN1 associate with and activate the PROTEIN2 GE in human T lymphocytes.
LABEL>0
The PROTEIN1 GE and GE associate with and activate the PROTEIN2 GE in human T lymphocytes.
LABEL>0
The PROTEIN1 GE and GE associate with and activate the GE PROTEIN2 in human T lymphocytes.
LABEL>0
The GE PROTEIN1 and PROTEIN2 associate with and activate the GE GE in human T lymphocytes.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE PROTEIN1, the GE GE, and the GE PROTEIN2.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE PROTEIN1, the GE GE, and the PROTEIN2 GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE PROTEIN1, the PROTEIN2 GE, and the GE GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE PROTEIN1, the GE PROTEIN2, and the GE GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 GE, the GE GE, and the GE PROTEIN2.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the PROTEIN1 GE, and the GE PROTEIN2.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the GE PROTEIN1, and the GE PROTEIN2.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 GE, the GE GE, and the PROTEIN2 GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 GE, the PROTEIN2 GE, and the GE GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1 GE, the GE PROTEIN2, and the GE GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the PROTEIN1 GE, and the PROTEIN2 GE.
LABEL>0
These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 GE GE, the GE PROTEIN1, and the PROTEIN2 GE.
LABEL>0
These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive GE-depolymerizing protein, PROTEIN1, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for PROTEIN2.
LABEL>0
These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive PROTEIN1-depolymerizing protein, GE, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for PROTEIN2.
LABEL>0
These were identified as GE, PROTEIN1, GE, GE (GE)-60, an unidentified protein and PROTEIN2, respectively.
LABEL>0
These were identified as PROTEIN1, PROTEIN2, GE, GE (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, PROTEIN1, PROTEIN2, GE (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, PROTEIN1, GE, PROTEIN2 (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, PROTEIN1, GE, GE (PROTEIN2)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as PROTEIN1, GE, GE, GE (GE)-60, an unidentified protein and PROTEIN2, respectively.
LABEL>0
These were identified as GE, GE, PROTEIN1, GE (GE)-60, an unidentified protein and PROTEIN2, respectively.
LABEL>0
These were identified as GE, GE, GE, PROTEIN1 (GE)-60, an unidentified protein and PROTEIN2, respectively.
LABEL>0
These were identified as GE, GE, GE, GE (PROTEIN1)-60, an unidentified protein and PROTEIN2, respectively.
LABEL>0
These were identified as PROTEIN1, GE, PROTEIN2, GE (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as PROTEIN1, GE, GE, PROTEIN2 (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as PROTEIN1, GE, GE, GE (PROTEIN2)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, GE, PROTEIN1, PROTEIN2 (GE)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, GE, PROTEIN1, GE (PROTEIN2)-60, an unidentified protein and GE, respectively.
LABEL>0
These were identified as GE, GE, GE, PROTEIN1 (PROTEIN2)-60, an unidentified protein and GE, respectively.
LABEL>0
The sites on the GE that interact with GE and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN1 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.
LABEL>0
The sites on the GE that interact with PROTEIN1 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN2 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the GE head (subfragment 1, S1) in this process.
LABEL>0
The sites on the PROTEIN1 that interact with GE and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN2 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the GE head (subfragment 1, S1) in this process.
LABEL>0
The sites on the GE that interact with PROTEIN1 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the GE head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.
LABEL>0
The sites on the PROTEIN1 that interact with GE and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the GE head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (PROTEIN2; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (PROTEIN2; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), PROTEIN2 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), PROTEIN2 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN2; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (PROTEIN1; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (PROTEIN2; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (PROTEIN1; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), PROTEIN2 (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), PROTEIN1 (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN1 (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN1 (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN1; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN1 (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN1; 43 kDa) and PROTEIN2 (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN1 (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN1; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN1 (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN2 (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), PROTEIN1 (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (PROTEIN2; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), PROTEIN2 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (PROTEIN2; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (PROTEIN2; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (PROTEIN1; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN2 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), PROTEIN2 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN2; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), PROTEIN2 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (PROTEIN2; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), PROTEIN1 (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (PROTEIN2; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), PROTEIN1 (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN1 (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN1 (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), PROTEIN2 (GE; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), PROTEIN1 (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN1; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN2; 49 kDa), GE (GE; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (PROTEIN1; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (GE; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (GE; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN1; 43 kDa) and GE (PROTEIN2; 35 kDa) proteins.
LABEL>0
The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the GE (GE; 190 kDa), GE (GE; 74 kDa), GE (PROTEIN1; 66 kDa), GE (GE; 63 kDa), GE (GE; 49 kDa), GE (PROTEIN2; 43 kDa) and GE (GE; 35 kDa) proteins.
LABEL>0
The GE homology domain 3 (SH3) of a yeast PROTEIN1, GE, binds to PROTEIN2 and is required for targeting to sites of GE polarization.
LABEL>0
The GE homology domain 3 (SH3) of a yeast GE, GE, binds to PROTEIN1 and is required for targeting to sites of PROTEIN2 polarization.
LABEL>0
The PROTEIN1 homology domain 3 (SH3) of a yeast GE, GE, binds to PROTEIN2 and is required for targeting to sites of GE polarization.
LABEL>0
The GE homology domain 3 (SH3) of a yeast GE, PROTEIN1, binds to GE and is required for targeting to sites of PROTEIN2 polarization.
LABEL>0
The GE homology domain 3 (SH3) of a yeast PROTEIN1, GE, binds to GE and is required for targeting to sites of PROTEIN2 polarization.
LABEL>0
The PROTEIN1 homology domain 3 (SH3) of a yeast PROTEIN2, GE, binds to GE and is required for targeting to sites of GE polarization.
LABEL>0
The PROTEIN1 homology domain 3 (SH3) of a yeast GE, GE, binds to GE and is required for targeting to sites of PROTEIN2 polarization.
LABEL>0
The structure of GE differed entirely from that of PROTEIN1 and resembled the overall fold of the PROTEIN2 regulatory protein, GE.
LABEL>0
The structure of GE differed entirely from that of PROTEIN1 and resembled the overall fold of the GE regulatory protein, PROTEIN2.
LABEL>0
The structure of PROTEIN1 differed entirely from that of GE and resembled the overall fold of the PROTEIN2 regulatory protein, GE.
LABEL>0
The Tetrahymena PROTEIN1 has two GE-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena GE probably cross-links PROTEIN2 filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>0
The Tetrahymena GE has two PROTEIN1-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena GE probably cross-links PROTEIN2 filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>0
The Tetrahymena PROTEIN1 has two GE-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN2 probably cross-links GE filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>0
The Tetrahymena GE has two PROTEIN1-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN2 probably cross-links GE filaments in a Ca(2+)- insensitive manner during cytokinesis.
LABEL>0
The GE (PROTEIN1) and the PROTEIN2 receptor recruit complexes formed by the interactions between GE, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>0
The PROTEIN1 (PROTEIN2) and the GE receptor recruit complexes formed by the interactions between GE, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>0
The PROTEIN1 (GE) and the PROTEIN2 receptor recruit complexes formed by the interactions between GE, GE, GE and GE - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated PROTEIN1 than does GE, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated PROTEIN1 than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated PROTEIN2 than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated PROTEIN2 than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher GE-activated GE than does PROTEIN2, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does PROTEIN1, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does PROTEIN1, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does PROTEIN2, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN1-activated GE than does PROTEIN2, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does PROTEIN2, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher GE-activated GE than does GE, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN2 exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher PROTEIN2-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, PROTEIN2 exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing PROTEIN1 exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN1-activated GE than does GE, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two GEardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN1-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher GE-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing PROTEIN2.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN2-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The two PROTEIN1ardiac myosin heavy chaiGE isoforms, alpha and beta, differ functionally, GE exhibits higher PROTEIN2-activated GE than does GE, and hearts expressing GE exhibit increased contractility relative to hearts expressing GE.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN1 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN1 stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN1 stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN1-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or PROTEIN2 stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN1, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN1-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble PROTEIN2-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN1, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN1-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas PROTEIN2 (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN1-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on PROTEIN2, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN2 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN2 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN2, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN2, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or PROTEIN1 and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN2 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not PROTEIN2 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of PROTEIN2, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not PROTEIN2 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not PROTEIN1 (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN2, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN2, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on PROTEIN1 or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN2, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to PROTEIN2, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of PROTEIN2, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of PROTEIN1, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a GE (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to GE, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN1 (-/-) ES cell mutant (e) were unable to assemble GE or PROTEIN2-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The undifferentiated cells (a) were unable to spread on GE or GE and grew as rounded colonies, although they were able to spread on GE (b) showed reduced adhesion to PROTEIN1, but not GE (c) expressed much reduced levels of GE, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble GE or GE-containing focal adhesions or GE stress fibers on GE, whereas GE (-/-) ES cells were able to assemble GE-containing focal adhesions.
LABEL>0
The vaccinia virus PROTEIN1 gene product, GE, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated PROTEIN2, GE.
LABEL>0
The vaccinia virus PROTEIN1 gene product, PROTEIN2, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated GE, GE.
LABEL>0
The vaccinia virus PROTEIN1 gene product, GE, is a dsRNA binding protein that prevents activation of the PROTEIN2-induced, dsRNA-activated GE, GE.
LABEL>0
The vaccinia virus GE gene product, PROTEIN1, is a dsRNA binding protein that prevents activation of the GE-induced, dsRNA-activated PROTEIN2, GE.
LABEL>0
The vaccinia virus GE gene product, GE, is a dsRNA binding protein that prevents activation of the PROTEIN1-induced, dsRNA-activated PROTEIN2, GE.
LABEL>0
The vaccinia virus GE gene product, PROTEIN1, is a dsRNA binding protein that prevents activation of the PROTEIN2-induced, dsRNA-activated GE, GE.
LABEL>0
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) GE (GE) and PROTEIN1 (PROTEIN2).
LABEL>0
The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN1 (PROTEIN2) and GE (GE).
LABEL>0
They exhibited strong synergistic increases in GE duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN1, GE, and PROTEIN2 for viability.
LABEL>0
They exhibited strong synergistic increases in GE duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes GE, PROTEIN1, and PROTEIN2 for viability.
LABEL>0
They exhibited strong synergistic increases in PROTEIN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes GE, GE, and PROTEIN2 for viability.
LABEL>0
They exhibited strong synergistic increases in GE duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN1, PROTEIN2, and GE for viability.
LABEL>0
They exhibited strong synergistic increases in PROTEIN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN2, GE, and GE for viability.
LABEL>0
They exhibited strong synergistic increases in PROTEIN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes GE, PROTEIN2, and GE for viability.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of PROTEIN1 receptors, GE and cytoskeletal proteins such as GE and PROTEIN2.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of PROTEIN1 receptors, GE and cytoskeletal proteins such as PROTEIN2 and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a PROTEIN1-coated glass surface, suggesting that the expression of a GE alters the assembly of PROTEIN2 receptors, GE and cytoskeletal proteins such as GE and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of PROTEIN1 receptors, PROTEIN2 and cytoskeletal proteins such as GE and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, GE and cytoskeletal proteins such as PROTEIN1 and PROTEIN2.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a PROTEIN1-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, GE and cytoskeletal proteins such as GE and PROTEIN2.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, PROTEIN1 and cytoskeletal proteins such as GE and PROTEIN2.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a PROTEIN1-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, GE and cytoskeletal proteins such as PROTEIN2 and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a GE-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, PROTEIN1 and cytoskeletal proteins such as PROTEIN2 and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a PROTEIN1-coated glass surface, suggesting that the expression of a PROTEIN2 alters the assembly of GE receptors, GE and cytoskeletal proteins such as GE and GE.
LABEL>0
They had altered adhesive properties as measured by their ability to bind to a PROTEIN1-coated glass surface, suggesting that the expression of a GE alters the assembly of GE receptors, PROTEIN2 and cytoskeletal proteins such as GE and GE.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, GE, GE or PROTEIN1 suggesting that it is distinct from PROTEIN2's functions at activated GE.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, GE, GE or PROTEIN1 suggesting that it is distinct from GE's functions at activated PROTEIN2.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, PROTEIN1, GE or GE suggesting that it is distinct from PROTEIN2's functions at activated GE.
LABEL>0
This activity is independent of PROTEIN1's ability to bind to three known interacting proteins, GE, GE or GE suggesting that it is distinct from PROTEIN2's functions at activated GE.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, GE, PROTEIN1 or GE suggesting that it is distinct from PROTEIN2's functions at activated GE.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, PROTEIN1, GE or GE suggesting that it is distinct from GE's functions at activated PROTEIN2.
LABEL>0
This activity is independent of PROTEIN1's ability to bind to three known interacting proteins, GE, GE or GE suggesting that it is distinct from GE's functions at activated PROTEIN2.
LABEL>0
This activity is independent of GE's ability to bind to three known interacting proteins, GE, PROTEIN1 or GE suggesting that it is distinct from GE's functions at activated PROTEIN2.
LABEL>0
This approach is based on the assumption that an PROTEIN1 mutation that specifically impairs the interaction with an GE will cause a phenotype similar to a null mutation in the gene that encodes the PROTEIN2.
LABEL>0
This approach is based on the assumption that an GE mutation that specifically impairs the interaction with an PROTEIN1 will cause a phenotype similar to a null mutation in the gene that encodes the PROTEIN2.
LABEL>0
21 PROTEIN1 mutations were analyzed in budding yeast, and specific regions of PROTEIN2 subdomain 1 were implicated in the interaction with GE, an GE filament-bundling protein.
LABEL>0
21 GE mutations were analyzed in budding yeast, and specific regions of PROTEIN1 subdomain 1 were implicated in the interaction with GE, an PROTEIN2 filament-bundling protein.
LABEL>0
21 PROTEIN1 mutations were analyzed in budding yeast, and specific regions of GE subdomain 1 were implicated in the interaction with GE, an PROTEIN2 filament-bundling protein.
LABEL>0
21 PROTEIN1 mutations were analyzed in budding yeast, and specific regions of GE subdomain 1 were implicated in the interaction with PROTEIN2, an GE filament-bundling protein.
LABEL>0
This arrest can be suppressed by mutations in GE, GE, and GE, suggesting that the cell cycle defect in PROTEIN1 PROTEIN2 mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in GE, PROTEIN1, and GE, suggesting that the cell cycle defect in PROTEIN2 GE mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in GE, GE, and PROTEIN1, suggesting that the cell cycle defect in PROTEIN2 GE mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in PROTEIN1, GE, and GE, suggesting that the cell cycle defect in PROTEIN2 GE mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in GE, PROTEIN1, and GE, suggesting that the cell cycle defect in GE PROTEIN2 mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in GE, GE, and PROTEIN1, suggesting that the cell cycle defect in GE PROTEIN2 mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in PROTEIN1, GE, and GE, suggesting that the cell cycle defect in GE PROTEIN2 mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in GE, PROTEIN1, and PROTEIN2, suggesting that the cell cycle defect in GE GE mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in PROTEIN1, PROTEIN2, and GE, suggesting that the cell cycle defect in GE GE mutants results from inappropriate homologous recombination.
LABEL>0
This arrest can be suppressed by mutations in PROTEIN1, GE, and PROTEIN2, suggesting that the cell cycle defect in GE GE mutants results from inappropriate homologous recombination.
LABEL>0
PROTEIN1 and PROTEIN2 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified GE activities.
LABEL>0
This is the first report describing the coexistence of GE with PROTEIN1 filaments in the division furrow, implying the possible involvement of PROTEIN2 in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
LABEL>0
This is the first report describing the coexistence of PROTEIN1 with GE filaments in the division furrow, implying the possible involvement of PROTEIN2 in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
LABEL>0
This process involves other GE, such as PROTEIN1 and PROTEIN2.
LABEL>0
This result was supported by a high protein expression of the GE PROTEIN1 in 44% of the tumours with high PROTEIN2ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE PROTEIN1 in 44% of the tumours with high PROTEIN2ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE PROTEIN1 in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high PROTEIN2 protein level.
LABEL>0
This result was supported by a high protein expression of the GE PROTEIN1 in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high PROTEIN1ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high PROTEIN1ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high PROTEIN2 protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high PROTEIN1ycliGE and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the PROTEIN1 GE in 44% of the tumours with high PROTEIN2ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high PROTEIN1ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high PROTEIN2 protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high PROTEIN1ycliGE and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the PROTEIN1 GE in 44% of the tumours with high PROTEIN2ycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high GE protein level.
LABEL>0
This result was supported by a high protein expression of the GE GE in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical PROTEIN1 defect tumours showed a high PROTEIN2 protein level.
LABEL>0
This result was supported by a high protein expression of the PROTEIN1 GE in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical GE defect tumours showed a high PROTEIN2 protein level.
LABEL>0
This result was supported by a high protein expression of the PROTEIN1 GE in 44% of the tumours with high GEycliGE and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high GE protein level.
LABEL>0
This technique was employed to quantify changes caused by the lack of PROTEIN1, a protein that couples the GE network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the GE-bundling protein PROTEIN2.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the PROTEIN1 network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the GE-bundling protein PROTEIN2.
LABEL>0
This technique was employed to quantify changes caused by the lack of PROTEIN1, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN2ortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN1ortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN1ortexilliGE or II, two isoforms of the PROTEIN2-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the PROTEIN1 network to the plasma membrane, or by the lack of PROTEIN2ortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of PROTEIN1, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN2ortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of PROTEIN1, a protein that couples the GE network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the PROTEIN2-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the GE network to the plasma membrane, or by the lack of PROTEIN1ortexilliGE or II, two isoforms of the PROTEIN2-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the PROTEIN1 network to the plasma membrane, or by the lack of PROTEIN2ortexilliGE or II, two isoforms of the GE-bundling protein GE.
LABEL>0
This technique was employed to quantify changes caused by the lack of GE, a protein that couples the PROTEIN1 network to the plasma membrane, or by the lack of GEortexilliGE or II, two isoforms of the PROTEIN2-bundling protein GE.
LABEL>0
Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN1 and GE, as well as a more detailed study of PROTEIN2, during segmentation, compaction, and compartmentalization of the somite.
LABEL>0
Those observations were extended to include a spatiotemporal immunohistochemical analyses of GE and PROTEIN1, as well as a more detailed study of PROTEIN2, during segmentation, compaction, and compartmentalization of the somite.
LABEL>0
Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN1 and PROTEIN2, as well as a more detailed study of GE, during segmentation, compaction, and compartmentalization of the somite.
LABEL>0
Three GE-associated proteins, PROTEIN1, PROTEIN2, and GE, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>0
Three GE-associated proteins, GE, PROTEIN1, and GE, influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
LABEL>0
Three GE-associated proteins, GE, PROTEIN1, and PROTEIN2, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>0
Three GE-associated proteins, PROTEIN1, GE, and GE, influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
LABEL>0
Three GE-associated proteins, PROTEIN1, GE, and PROTEIN2, influence gelation, solation, and polymerization, respectively, of GE in vitro.
LABEL>0
Three PROTEIN1-associated proteins, GE, GE, and GE, influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of GE), Drosophila PROTEIN2 (GE), and GE.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of GE), Drosophila PROTEIN1 (GE), and PROTEIN2.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of PROTEIN1), Drosophila PROTEIN2 (GE), and GE.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of GE), Drosophila PROTEIN1 (PROTEIN2), and GE.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of GE), Drosophila GE (GE), and PROTEIN2.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of GE), Drosophila GE (PROTEIN2), and GE.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of PROTEIN1), Drosophila GE (GE), and PROTEIN2.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of GE), Drosophila GE (PROTEIN1), and PROTEIN2.
LABEL>0
Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: GE (homolog of PROTEIN1), Drosophila GE (PROTEIN2), and GE.
LABEL>0
Thus, GE was found in association with PROTEIN1 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN2, did not reveal GE.
LABEL>0
Thus, GE was found in association with PROTEIN1 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in GE, did not reveal PROTEIN2.
LABEL>0
Thus, PROTEIN1 was found in association with GE in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN2, did not reveal GE.
LABEL>0
Thus, GE was found in association with GE in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN1, did not reveal PROTEIN2.
LABEL>0
Thus, PROTEIN1 was found in association with GE in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in GE, did not reveal PROTEIN2.
LABEL>0
Thus, PROTEIN1, GE, and PROTEIN2 have similar prognostic values.
LABEL>0
Thus, GE, PROTEIN1, and PROTEIN2 have similar prognostic values.
LABEL>0
Thus, PROTEIN1, PROTEIN2, and GE have similar prognostic values.
LABEL>0
Thus, GE contains an NH(2)-terminal domain homologous to that implicated in PROTEIN1's endocytic function, three predicted coiled-coils, a leucine zipper, and a GE-like PROTEIN2-binding domain at the COOH terminus.
LABEL>0
Thus, GE contains an NH(2)-terminal domain homologous to that implicated in GE's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN1-like PROTEIN2-binding domain at the COOH terminus.
LABEL>0
Thus, GE contains an NH(2)-terminal domain homologous to that implicated in PROTEIN1's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN2-like GE-binding domain at the COOH terminus.
LABEL>0
Thus, poly-L-proline binding, PROTEIN1 binding, and PROTEIN2 nucleotide exchange are each independent requirements for GE function in fission yeast.
LABEL>0
Thus, the PROTEIN1-binding dodecapeptide sequence of GE may constitute a multifunctional domain in PROTEIN2.
LABEL>0
Thus, the GE-binding dodecapeptide sequence of PROTEIN1 may constitute a multifunctional domain in PROTEIN2.
LABEL>0
PROTEIN1 also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as GE and PROTEIN2.
LABEL>0
PROTEIN1 also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as PROTEIN2 and GE.
LABEL>0
GE also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as PROTEIN1 and PROTEIN2.
LABEL>0
To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different GE (PROTEIN1) isoforms along with a clone containing carp PROTEIN2 sequences.
LABEL>0
To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN1 (GE) isoforms along with a clone containing carp PROTEIN2 sequences.
LABEL>0
To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN1 (PROTEIN2) isoforms along with a clone containing carp GE sequences.
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, PROTEIN1, PROTEIN2, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, PROTEIN1, GE, PROTEIN2, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1, GE, GE, PROTEIN2, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, GE, PROTEIN1, GE, and PROTEIN2) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, GE, PROTEIN1, PROTEIN2, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, PROTEIN1, PROTEIN2, GE, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1, GE, PROTEIN2, GE, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, PROTEIN1, GE, GE, and PROTEIN2) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, PROTEIN1, GE, PROTEIN2, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1, PROTEIN2, GE, GE, GE, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, PROTEIN1, GE, GE, GE, and PROTEIN2) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, PROTEIN1, GE, GE, PROTEIN2, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1, GE, GE, GE, GE, and PROTEIN2) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1, GE, GE, GE, PROTEIN2, and GE) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding GE, GE, GE, GE, PROTEIN1, and PROTEIN2) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, GE, and PROTEIN1 (GE) in PROTEIN2 nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1, GE, and GE (GE) in PROTEIN2 nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, GE, and GE (PROTEIN1) in PROTEIN2 nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, PROTEIN1, and GE (GE) in PROTEIN2 nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1, GE, and PROTEIN2 (GE) in GE nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, GE, and PROTEIN1 (PROTEIN2) in GE nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, PROTEIN1, and PROTEIN2 (GE) in GE nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1, GE, and GE (PROTEIN2) in GE nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1, PROTEIN2, and GE (GE) in GE nephropathy.
LABEL>0
To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of GE, PROTEIN1, and GE (PROTEIN2) in GE nephropathy.
LABEL>0
To check its applicability, well characterized, commercially available antibodies (against GE, PROTEIN1, and PROTEIN2) were used on sections of human small intestine.
LABEL>0
To check its applicability, well characterized, commercially available antibodies (against PROTEIN1, PROTEIN2, and GE) were used on sections of human small intestine.
LABEL>0
To check its applicability, well characterized, commercially available antibodies (against PROTEIN1, GE, and PROTEIN2) were used on sections of human small intestine.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, GE, and PROTEIN1, with additional reverse transcription-PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, PROTEIN1, GE, and PROTEIN2, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, GE, and PROTEIN2, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN1, GE, GE, and PROTEIN2, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, PROTEIN1, and PROTEIN2, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, PROTEIN1, GE, and GE, with additional reverse transcription-PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, GE, and GE, with additional reverse transcription-PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN1, GE, GE, and GE, with additional reverse transcription-PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, PROTEIN1, and GE, with additional reverse transcription-PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, PROTEIN2, GE, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN1, PROTEIN2, GE, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, PROTEIN1, PROTEIN2, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN2, GE, GE, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for GE, GE, PROTEIN2, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To clarify the relation between alteration of expression of GE and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN1, GE, PROTEIN2, and GE, with additional reverse transcription-GE chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, PROTEIN1 and GE, and two anti-GE markers, anti-PROTEIN2 and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, PROTEIN1 and GE, and two anti-PROTEIN2 markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, PROTEIN1 and GE, and two anti-GE markers, anti-GE and anti-PROTEIN2 antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, PROTEIN1 and PROTEIN2, and two anti-GE markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and GE, and two anti-PROTEIN1 markers, anti-PROTEIN2 and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and GE, and two anti-GE markers, anti-PROTEIN1 and anti-PROTEIN2 antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and PROTEIN1, and two anti-GE markers, anti-PROTEIN2 and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiPROTEIN1 antibodies, GE and GE, and two anti-GE markers, anti-PROTEIN2 and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and GE, and two anti-PROTEIN1 markers, anti-GE and anti-PROTEIN2 antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and PROTEIN1, and two anti-PROTEIN2 markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiPROTEIN1 antibodies, GE and GE, and two anti-PROTEIN2 markers, anti-GE and anti-GE antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiGE antibodies, GE and PROTEIN1, and two anti-GE markers, anti-GE and anti-PROTEIN2 antibodies and related antibodies.
LABEL>0
To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antiPROTEIN1 antibodies, GE and GE, and two anti-GE markers, anti-GE and anti-PROTEIN2 antibodies and related antibodies.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, PROTEIN1, the GE (GE) PROTEIN2 and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, GE, GE, the GE (GE) PROTEIN2 and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, PROTEIN1, GE, the GE (GE) PROTEIN2 and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the GE (GE) PROTEIN1 and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, GE, the PROTEIN1 (PROTEIN2) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, PROTEIN1, the GE (PROTEIN2) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, GE, GE, the GE (PROTEIN2) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, PROTEIN1, GE, the GE (PROTEIN2) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, PROTEIN1, the PROTEIN2 (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, GE, GE, the PROTEIN2 (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, PROTEIN1, GE, the PROTEIN2 (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, GE, PROTEIN2, the GE (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, PROTEIN1, PROTEIN2, the GE (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, GE, PROTEIN1, the GE (GE) GE and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, PROTEIN2, GE, the GE (GE) GE and GE, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1, GE, GE, the GE (GE) GE and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of GE, PROTEIN1, GE, the GE (GE) GE and PROTEIN2, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, PROTEIN3, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, GE, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, GE, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, PROTEIN3, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, PROTEIN3, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN1PROTEIN2GE, GE, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
LABEL>0
To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for PROTEIN1 and PROTEIN2.
LABEL>0
Together these results indicate that GE regulates PROTEIN1 gene expression through an GE site and its cognate transcription factor GE, and requires the involvement of PROTEIN2.
LABEL>0
Together these results indicate that GE regulates GE gene expression through an GE site and its cognate transcription factor PROTEIN1, and requires the involvement of PROTEIN2.
LABEL>0
Together these results indicate that GE regulates GE gene expression through an PROTEIN1 site and its cognate transcription factor GE, and requires the involvement of PROTEIN2.
LABEL>0
To improve our ability to study these proteins, we have expressed PROTEIN1, GE, PROTEIN2, and GE in insect cells by using the baculovirus expression system.
LABEL>0
To improve our ability to study these proteins, we have expressed PROTEIN1, PROTEIN2, GE, and GE in insect cells by using the baculovirus expression system.
LABEL>0
To improve our ability to study these proteins, we have expressed PROTEIN1, GE, GE, and PROTEIN2 in insect cells by using the baculovirus expression system.
LABEL>0
To improve our ability to study these proteins, we have expressed GE, PROTEIN1, PROTEIN2, and GE in insect cells by using the baculovirus expression system.
LABEL>0
To improve our ability to study these proteins, we have expressed GE, GE, PROTEIN1, and PROTEIN2 in insect cells by using the baculovirus expression system.
LABEL>0
To improve our ability to study these proteins, we have expressed GE, PROTEIN1, GE, and PROTEIN2 in insect cells by using the baculovirus expression system.
LABEL>0
Various immunological assays suggest that four of these proteins (GE, PROTEIN1, GE, and PROTEIN2) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Various immunological assays suggest that four of these proteins (GE, GE, PROTEIN1, and PROTEIN2) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Various immunological assays suggest that four of these proteins (PROTEIN1, GE, GE, and PROTEIN2) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Various immunological assays suggest that four of these proteins (GE, PROTEIN1, PROTEIN2, and GE) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Various immunological assays suggest that four of these proteins (PROTEIN1, PROTEIN2, GE, and GE) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Various immunological assays suggest that four of these proteins (PROTEIN1, GE, PROTEIN2, and GE) are made in infected cells in very low abundance relative to the other three.
LABEL>0
Total PROTEIN1 and PROTEIN2 mRNAs, and polyadenylated RNA, were determined using slot-blot assays.
LABEL>0
Total protein, GE (PROTEIN1), and PROTEIN2 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
LABEL>0
Total protein, PROTEIN1 (GE), and PROTEIN2 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
LABEL>0
Total protein, PROTEIN1 (PROTEIN2), and GE appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, GE, GE, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, PROTEIN2, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, GE, GE, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of PROTEIN2, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, GE, PROTEIN2, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, PROTEIN2, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of PROTEIN2, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of PROTEIN1, GE, GE, GE, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, PROTEIN1, GE, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, PROTEIN1, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, GE, GE, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, PROTEIN1, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, GE, GE, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, GE, GE, GE, PROTEIN2, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, GE, PROTEIN1, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, PROTEIN1, GE, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, PROTEIN2, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, PROTEIN1, PROTEIN2, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, PROTEIN2, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, PROTEIN2, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, PROTEIN1, GE, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, GE, GE, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, PROTEIN1, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, GE, GE, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, GE, GE, PROTEIN2, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, GE, PROTEIN1, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, GE, PROTEIN2, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, PROTEIN2, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(PROTEIN2), as well as that of GE, GE, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of PROTEIN1(GE), as well as that of GE, GE, GE, GE, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, GE, PROTEIN2, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, GE, PROTEIN2, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, GE, GE, PROTEIN1, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, PROTEIN2, GE, GE, GE, GE, and GE was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(GE), as well as that of GE, PROTEIN1, GE, GE, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transcriptional expression of GE(PROTEIN1), as well as that of GE, GE, GE, GE, GE, GE, and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to GE-induced apoptosis may not be determined by the constitutive expression level of these factors.
LABEL>0
Transfection of PROTEIN1-deficient colon carcinoma cells recruited GE and PROTEIN2 to cell-cell contacts and functional GE-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of GE-deficient colon carcinoma cells recruited GE and PROTEIN1 to cell-cell contacts and functional PROTEIN2-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of GE-deficient colon carcinoma cells recruited PROTEIN1 and PROTEIN2 to cell-cell contacts and functional GE-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of PROTEIN1-deficient colon carcinoma cells recruited GE and GE to cell-cell contacts and functional PROTEIN2-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of PROTEIN1-deficient colon carcinoma cells recruited PROTEIN2 and GE to cell-cell contacts and functional GE-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of GE-deficient colon carcinoma cells recruited PROTEIN1 and GE to cell-cell contacts and functional PROTEIN2-mediated cell-cell adhesion was restored in this way.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (PROTEIN1) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (PROTEIN1), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), PROTEIN1 (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (GE) and PROTEIN1 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (GE), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN2 gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (PROTEIN1) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (PROTEIN1), GE (PROTEIN2) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), PROTEIN1 (PROTEIN2) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (PROTEIN1) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (GE), GE (PROTEIN2) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (PROTEIN1), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), PROTEIN1 (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), GE (GE) and PROTEIN1 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (GE), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to PROTEIN2 activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (PROTEIN1), PROTEIN2 (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (PROTEIN1), GE (GE) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (PROTEIN2), GE (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, GE (GE), PROTEIN1 (GE) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (GE), PROTEIN2 (GE) and GE protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Transfection of plasmids encoding the BRSV minigenome, PROTEIN1 (GE), GE (GE) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 GE gave rise to GE activity and progeny with the minigenome.
LABEL>0
Treatment of cells with gamma linolenic acid (GLA) increased GE expression in most cell lines, while PROTEIN1 levels were reduced, and PROTEIN2 expression was unchanged.
LABEL>0
Treatment of cells with gamma linolenic acid (GLA) increased PROTEIN1 expression in most cell lines, while PROTEIN2 levels were reduced, and GE expression was unchanged.
LABEL>0
Treatment of cells with gamma linolenic acid (GLA) increased PROTEIN1 expression in most cell lines, while GE levels were reduced, and PROTEIN2 expression was unchanged.
LABEL>0
Treatment with HNE resulted in activation of GE PROTEIN1 and PROTEIN2, induction of GE and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE PROTEIN1 and GE, induction of GE and GE protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE PROTEIN1 and GE, induction of GE and PROTEIN2 protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE PROTEIN1 and GE, induction of PROTEIN2 and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and PROTEIN1, induction of GE and GE protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and PROTEIN1, induction of GE and PROTEIN2 protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and PROTEIN1, induction of PROTEIN2 and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and GE, induction of GE and PROTEIN1 protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and GE, induction of PROTEIN1 and GE protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of PROTEIN1 GE and GE, induction of GE and GE protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of GE GE and GE, induction of PROTEIN1 and PROTEIN2 protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of PROTEIN1 GE and GE, induction of GE and PROTEIN2 protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Treatment with HNE resulted in activation of PROTEIN1 GE and GE, induction of PROTEIN2 and GE protein expression, and an increase in transcription factor GE DNA binding activity.
LABEL>0
Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick GE and 66% identical to chick PROTEIN1 (PROTEIN2), two structurally and functionally related proteins.
LABEL>0
Two isoforms of GE (PROTEIN1) are generated by alternative splicing; PROTEIN2 differs from GE by the insertion of B2 exon cassette near the GE binding region.
LABEL>0
Two isoforms of PROTEIN1 (GE) are generated by alternative splicing; PROTEIN2 differs from GE by the insertion of B2 exon cassette near the GE binding region.
LABEL>0
Two isoforms of PROTEIN1 (PROTEIN2) are generated by alternative splicing; GE differs from GE by the insertion of B2 exon cassette near the GE binding region.
LABEL>0
Two isoforms of GE (PROTEIN1) are generated by alternative splicing; GE differs from PROTEIN2 by the insertion of B2 exon cassette near the GE binding region.
LABEL>0
Two isoforms of GE (PROTEIN1) are generated by alternative splicing; GE differs from GE by the insertion of B2 exon cassette near the PROTEIN2 binding region.
LABEL>0
Two isoforms of PROTEIN1 (GE) are generated by alternative splicing; GE differs from PROTEIN2 by the insertion of B2 exon cassette near the GE binding region.
LABEL>0
Two isoforms of PROTEIN1 (GE) are generated by alternative splicing; GE differs from GE by the insertion of B2 exon cassette near the PROTEIN2 binding region.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their GE (PROTEIN1) but lost greater than 80% of GE and PROTEIN2 to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their PROTEIN1 (GE) but lost greater than 80% of GE and PROTEIN2 to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their GE (GE) but lost greater than 80% of PROTEIN1 and PROTEIN2 to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total PROTEIN1 and greater than 70% of their GE (GE) but lost greater than 80% of GE and PROTEIN2 to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their PROTEIN1 (PROTEIN2) but lost greater than 80% of GE and GE to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their GE (PROTEIN1) but lost greater than 80% of PROTEIN2 and GE to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total PROTEIN1 and greater than 70% of their GE (PROTEIN2) but lost greater than 80% of GE and GE to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total GE and greater than 70% of their PROTEIN1 (GE) but lost greater than 80% of PROTEIN2 and GE to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total PROTEIN1 and greater than 70% of their PROTEIN2 (GE) but lost greater than 80% of GE and GE to the supernatant.
LABEL>0
Under all conditions, platelets retained 40-50% of their total PROTEIN1 and greater than 70% of their GE (GE) but lost greater than 80% of PROTEIN2 and GE to the supernatant.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE PROTEIN1 and PROTEIN2 also did not exhibit medial GE-GE staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and PROTEIN1 also did not exhibit medial GE-PROTEIN2 staining.
LABEL>0
Unexpectedly, treatment with the PROTEIN1-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and PROTEIN2 also did not exhibit medial GE-GE staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and PROTEIN1 also did not exhibit medial PROTEIN2-GE staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE PROTEIN1 and GE also did not exhibit medial GE-PROTEIN2 staining.
LABEL>0
Unexpectedly, treatment with the PROTEIN1-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE PROTEIN2 and GE also did not exhibit medial GE-GE staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE PROTEIN1 and GE also did not exhibit medial PROTEIN2-GE staining.
LABEL>0
Unexpectedly, treatment with the PROTEIN1-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and GE also did not exhibit medial GE-PROTEIN2 staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN1 GE and GE also did not exhibit medial GE-PROTEIN2 staining.
LABEL>0
Unexpectedly, treatment with the PROTEIN1-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the GE GE and GE also did not exhibit medial PROTEIN2-GE staining.
LABEL>0
Unexpectedly, treatment with the PROTEIN1-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2 GE and GE also did not exhibit medial GE-GE staining.
LABEL>0
Unexpectedly, treatment with the GE-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN1 GE and GE also did not exhibit medial PROTEIN2-GE staining.
LABEL>0
Unlike PROTEIN1, PROTEIN2's GE-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
LABEL>0
Up to now three allergens have been identified as responsible for cross-reactivity in these associations: GE, a 14 kd protein that regulates PROTEIN1; PROTEIN2, the 18 kd birch pollen allergen; and a 60-69 kd allergen.
LABEL>0
Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN1, a 14 kd protein that regulates GE; PROTEIN2, the 18 kd birch pollen allergen; and a 60-69 kd allergen.
LABEL>0
Using ITP (a substrate for GE PROTEIN1) and/or ATP gamma S (a substrate for GE [PROTEIN2]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for PROTEIN1 GE) and/or ATP gamma S (a substrate for GE [PROTEIN2]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [PROTEIN1]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for PROTEIN1 [PROTEIN2]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [PROTEIN1]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [PROTEIN1]), we demonstrated that phosphorylation of GE occurred at the foci within the PROTEIN2 network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE PROTEIN1) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for GE PROTEIN1) and/or ATP gamma S (a substrate for PROTEIN2 [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE PROTEIN1) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE PROTEIN1) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the PROTEIN2 network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for PROTEIN1 GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for PROTEIN1 GE) and/or ATP gamma S (a substrate for PROTEIN2 [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for PROTEIN1 GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for PROTEIN1 GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the PROTEIN2 network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for PROTEIN1 [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the GE network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of PROTEIN1 occurred at the foci within the GE network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the PROTEIN1 network, a result that suggests that PROTEIN2 was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for PROTEIN1 [GE]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the GE network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for PROTEIN1 [GE]), we demonstrated that phosphorylation of GE occurred at the foci within the PROTEIN2 network, a result that suggests that GE was localized at the foci.
LABEL>0
Using ITP (a substrate for GE GE) and/or ATP gamma S (a substrate for GE [GE]), we demonstrated that phosphorylation of PROTEIN1 occurred at the foci within the PROTEIN2 network, a result that suggests that GE was localized at the foci.
LABEL>0
Using the known three-dimensional structure of the homologous PROTEIN1-binding domain of GE, these results have enabled us to determine the likely orientation of the PROTEIN2 GE-binding domain with respect to the GE filament.
LABEL>0
Using the known three-dimensional structure of the homologous GE-binding domain of PROTEIN1, these results have enabled us to determine the likely orientation of the GE GE-binding domain with respect to the PROTEIN2 filament.
LABEL>0
Using the known three-dimensional structure of the homologous GE-binding domain of PROTEIN1, these results have enabled us to determine the likely orientation of the GE PROTEIN2-binding domain with respect to the GE filament.
LABEL>0
Using the known three-dimensional structure of the homologous GE-binding domain of GE, these results have enabled us to determine the likely orientation of the GE PROTEIN1-binding domain with respect to the PROTEIN2 filament.
LABEL>0
Using the known three-dimensional structure of the homologous PROTEIN1-binding domain of GE, these results have enabled us to determine the likely orientation of the GE GE-binding domain with respect to the PROTEIN2 filament.
LABEL>0
Using the known three-dimensional structure of the homologous PROTEIN1-binding domain of GE, these results have enabled us to determine the likely orientation of the GE PROTEIN2-binding domain with respect to the GE filament.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN1 protects GE filaments in these cells from Z. mays PROTEIN2 (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that GE protects GE filaments in these cells from Z. mays PROTEIN1 (PROTEIN2)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN1 cytoskeleton in living stamen hair cells, we demonstrated that GE protects GE filaments in these cells from Z. mays PROTEIN2 (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN1 cytoskeleton in living stamen hair cells, we demonstrated that GE protects PROTEIN2 filaments in these cells from Z. mays GE (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the GE cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN1 protects GE filaments in these cells from Z. mays GE (PROTEIN2)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN1 cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN2 protects GE filaments in these cells from Z. mays GE (GE)-induced depolymerization, in a dose-dependent manner.
LABEL>0
Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN1 cytoskeleton in living stamen hair cells, we demonstrated that GE protects GE filaments in these cells from Z. mays GE (PROTEIN2)-induced depolymerization, in a dose-dependent manner.
LABEL>0
GE (PROTEIN1) clusters were co-localized with GE, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional PROTEIN2.
LABEL>0
PROTEIN1 (PROTEIN2) clusters were co-localized with GE, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional GE.
LABEL>0
PROTEIN1 (GE) clusters were co-localized with GE, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional PROTEIN2.
LABEL>0
GE (GE) clusters were co-localized with PROTEIN1, an important signal transduction ligand, and with GE, which is thought to link the complex to the peri-junctional PROTEIN2.
LABEL>0
GE (GE) clusters were co-localized with PROTEIN1, an important signal transduction ligand, and with PROTEIN2, which is thought to link the complex to the peri-junctional GE.
LABEL>0
PROTEIN1, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding GE, an PROTEIN2-regulatory protein that stimulates GE filament assembly.
LABEL>0
PROTEIN1, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding GE, an GE-regulatory protein that stimulates PROTEIN2 filament assembly.
LABEL>0
GE, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding GE, an PROTEIN1-regulatory protein that stimulates PROTEIN2 filament assembly.
LABEL>0
GE and GE are two PROTEIN1 that bundle PROTEIN2 filaments in the intestine and kidney brush border epithelium.
LABEL>0
PROTEIN1 and PROTEIN2 are two GE that bundle GE filaments in the intestine and kidney brush border epithelium.
LABEL>0
PROTEIN1 and GE were also up-regulated, whereas an isoform of PROTEIN2 was down-regulated.
LABEL>0
GE and PROTEIN1 were also up-regulated, whereas an isoform of PROTEIN2 was down-regulated.
LABEL>0
PROTEIN1 and PROTEIN2 were also up-regulated, whereas an isoform of GE was down-regulated.
LABEL>0
GE contains a binding motif for the GE GE as well as PROTEIN1/PROTEIN2-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as PROTEIN2/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as PROTEIN1/GE-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as PROTEIN1/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as PROTEIN1/GE-like PROTEIN2-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as PROTEIN1/GE-like GE-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as PROTEIN2/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as GE/PROTEIN2-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/PROTEIN1-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/PROTEIN1-like GE-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/PROTEIN1-like PROTEIN2-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/PROTEIN1-like GE-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as GE/PROTEIN2-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as GE/GE-like PROTEIN2-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE PROTEIN1 as well as GE/GE-like GE-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
PROTEIN1 contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
PROTEIN1 contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
PROTEIN1 contains a binding motif for the GE GE as well as GE/GE-like GE-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
PROTEIN1 contains a binding motif for the PROTEIN2 GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/GE-like PROTEIN1-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by PROTEIN2-GE has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/GE-like PROTEIN1-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as GE/GE-like GE-regulatory domains, but no specific GE structure regulated by GE-PROTEIN2 has been identified.
LABEL>0
GE contains a binding motif for the GE GE as well as GE/GE-like PROTEIN1-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as GE/GE-like PROTEIN2-regulatory domains, but no specific GE structure regulated by GE-GE has been identified.
LABEL>0
GE contains a binding motif for the PROTEIN1 GE as well as GE/GE-like GE-regulatory domains, but no specific PROTEIN2 structure regulated by GE-GE has been identified.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in GE and GE (homologues of S.cerevisiae PROTEIN1 and PROTEIN2, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in GE and PROTEIN1 (homologues of S.cerevisiae PROTEIN2 and GE, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN1-d and two recombination mutants defective in GE and GE (homologues of S.cerevisiae PROTEIN2 and GE, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in PROTEIN1 and GE (homologues of S.cerevisiae GE and PROTEIN2, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN1-d and two recombination mutants defective in GE and GE (homologues of S.cerevisiae GE and PROTEIN2, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant GE-d and two recombination mutants defective in PROTEIN1 and PROTEIN2 (homologues of S.cerevisiae GE and GE, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN1-d and two recombination mutants defective in PROTEIN2 and GE (homologues of S.cerevisiae GE and GE, respectively) are not affected.
LABEL>0
We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN1-d and two recombination mutants defective in GE and PROTEIN2 (homologues of S.cerevisiae GE and GE, respectively) are not affected.
LABEL>0
We conclude that germ-line involvement of PROTEIN1 and GE is rare and that other genes are likely to account for a majority of PROTEIN2-, GE-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We conclude that germ-line involvement of GE and GE is rare and that other genes are likely to account for a majority of PROTEIN1-, PROTEIN2-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We conclude that germ-line involvement of GE and PROTEIN1 is rare and that other genes are likely to account for a majority of PROTEIN2-, GE-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We conclude that germ-line involvement of PROTEIN1 and GE is rare and that other genes are likely to account for a majority of GE-, PROTEIN2-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We conclude that germ-line involvement of PROTEIN1 and PROTEIN2 is rare and that other genes are likely to account for a majority of GE-, GE-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We conclude that germ-line involvement of GE and PROTEIN1 is rare and that other genes are likely to account for a majority of GE-, PROTEIN2-mutation negative families with nonpolypotic colon cancer.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (PROTEIN1, GE, PROTEIN2 and GE) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (PROTEIN1, PROTEIN2, GE and GE) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (PROTEIN1, GE, GE and PROTEIN2) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (GE, PROTEIN1, PROTEIN2 and GE) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (GE, GE, PROTEIN1 and PROTEIN2) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (GE, PROTEIN1, GE and PROTEIN2) in the absence of any of the other proteins required for viral DNA synthesis.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN1" with GE, GE, GE, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, PROTEIN1, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN1, GE, GE, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and PROTEIN1, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, PROTEIN1, GE, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and GE, and the association of these complexes with the PROTEIN2 microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN2" with GE, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "PROTEIN2" with GE, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN1, GE, PROTEIN2, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, PROTEIN1, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, PROTEIN2, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, PROTEIN1, PROTEIN2, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, PROTEIN2, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN1, GE, GE, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN2, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN1, PROTEIN2, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with PROTEIN2, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, PROTEIN1, GE, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and PROTEIN2, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of GE and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, PROTEIN2, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, GE, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We describe the localization of PROTEIN1 and GE along the cell margins of mouse osteoblast-like cells, the colocalization of "GE" with GE, PROTEIN2, GE, and GE, and the association of these complexes with the GE microfilaments.
LABEL>0
We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, PROTEIN1 (GE), PROTEIN2, and mixed muscle proteins in nonfrail elders and younger women and men.
LABEL>0
We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, GE (PROTEIN1), PROTEIN2, and mixed muscle proteins in nonfrail elders and younger women and men.
LABEL>0
We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, PROTEIN1 (PROTEIN2), GE, and mixed muscle proteins in nonfrail elders and younger women and men.
LABEL>0
We examined whether levels of PROTEIN1 or PROTEIN2 correlated with GE levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
LABEL>0
We find that PROTEIN1 and PROTEIN2 regulate GE-filament formation throughout the cell cortex.
LABEL>0
We find that PROTEIN1 contributes in several ways to PROTEIN2-induced nucleation of GE filaments in high speed supernatant of lysed neutrophils.
LABEL>0
We found normal levels of PROTEIN1 and PROTEIN2 in BT549 and HS578t cells; however, low levels of GE were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
LABEL>0
We found normal levels of GE and PROTEIN1 in BT549 and HS578t cells; however, low levels of PROTEIN2 were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
LABEL>0
We found normal levels of PROTEIN1 and GE in BT549 and HS578t cells; however, low levels of PROTEIN2 were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (PROTEIN2), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (PROTEIN2), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (PROTEIN2), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (PROTEIN2), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), PROTEIN2 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (PROTEIN1), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (PROTEIN2), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (PROTEIN2), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), PROTEIN2 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), PROTEIN2 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (PROTEIN1), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (PROTEIN2), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (PROTEIN1), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, PROTEIN2 GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, PROTEIN1 GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), PROTEIN2 GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), PROTEIN1 GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN1 GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE GE, and PROTEIN3 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE GE, and PROTEIN3 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE GEGE + 2B, GE GE, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN1, and PROTEIN2 GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, PROTEIN3 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN1 GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, PROTEIN3 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE GEGE + 2B, PROTEIN2 GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE GE, and GE PROTEIN3, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE PROTEIN3, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE GE, and GE PROTEIN3, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE GEGE + 2B, GE GE, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN1, and GE PROTEIN2, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (PROTEIN2), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (PROTEIN2), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (PROTEIN2), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (PROTEIN1), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), PROTEIN2 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), PROTEIN2 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including PROTEIN1 (GE), GE (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), PROTEIN2 (GE), GE (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), PROTEIN1 (GE), GE (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), PROTEIN2 (GE), GE GE, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), PROTEIN1 (GE), GE (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE PROTEIN2PROTEIN3 + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE GE, GE PROTEIN1PROTEIN2 + 2B, GE PROTEIN3, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE PROTEIN2, GE GEGE + 2B, GE GE, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), GE (GE), GE PROTEIN1, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We found that the expression of all these genes, including GE (GE), GE (GE), GE (GE), PROTEIN1 (GE), GE GE, GE GEGE + 2B, GE PROTEIN2, and GE GE, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
LABEL>0
We have analyzed the expression levels of the genes encoding PROTEIN1, GE and PROTEIN2 in correlation to the GE expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have analyzed the expression levels of the genes encoding PROTEIN1, PROTEIN2 and GE in correlation to the GE expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have analyzed the expression levels of the genes encoding PROTEIN1, GE and GE in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have analyzed the expression levels of the genes encoding GE, PROTEIN1 and PROTEIN2 in correlation to the GE expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have analyzed the expression levels of the genes encoding GE, GE and PROTEIN1 in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have analyzed the expression levels of the genes encoding GE, PROTEIN1 and GE in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
LABEL>0
We have characterized the interaction and nuclear localization of the GE (GE) protein and PROTEIN1 (PROTEIN2) of sonchus yellow net nucleorhabdovirus.
LABEL>0
We have characterized the interaction and nuclear localization of the PROTEIN1 (PROTEIN2) protein and GE (GE) of sonchus yellow net nucleorhabdovirus.
LABEL>0
We have characterized this PROTEIN1 with respect to its ability to interact with yeast GE and GE, the only yeast PROTEIN2 so far purified and characterized.
LABEL>0
We have characterized this GE with respect to its ability to interact with yeast PROTEIN1 and PROTEIN2, the only yeast GE so far purified and characterized.
LABEL>0
Yeast GE can sequester yeast PROTEIN1 monomers and thereby reduce the ability of yeast PROTEIN2 to polymerize, whereas it has little effect on the degree of polymerization of rabbit GE.
LABEL>0
Yeast GE can sequester yeast PROTEIN1 monomers and thereby reduce the ability of yeast GE to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2.
LABEL>0
Yeast GE can sequester yeast GE monomers and thereby reduce the ability of yeast PROTEIN1 to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2.
LABEL>0
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast PROTEIN1; PROTEIN2); its aa sequence is 35% identical to porcine GE.
LABEL>0
We have cloned a Saccharomyces cerevisiae gene (PROTEIN1) encoding a low-M(r) PROTEIN2 of 143 amino acid (aa) residues (yeast GE; GE); its aa sequence is 35% identical to porcine GE.
LABEL>0
We have cloned a Saccharomyces cerevisiae gene (PROTEIN1) encoding a low-M(r) GE of 143 amino acid (aa) residues (yeast GE; GE); its aa sequence is 35% identical to porcine PROTEIN2.
LABEL>0
We have cloned a Saccharomyces cerevisiae gene (GE) encoding a low-M(r) PROTEIN1 of 143 amino acid (aa) residues (yeast GE; GE); its aa sequence is 35% identical to porcine PROTEIN2.
LABEL>0
We have established an PROTEIN1-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type GE and PROTEIN2 genes, to HHUA cells.
LABEL>0
We have established an GE-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN1 and PROTEIN2 genes, to HHUA cells.
LABEL>0
We have established an PROTEIN1-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN2 and GE genes, to HHUA cells.
LABEL>0
We have examined the level of PROTEIN1, a GE, and PROTEIN2, a GE, in BALB/c 3T3 cells.
LABEL>0
We have examined the level of GE, a PROTEIN1, and PROTEIN2, a GE, in BALB/c 3T3 cells.
LABEL>0
We have examined the level of PROTEIN1, a GE, and GE, a PROTEIN2, in BALB/c 3T3 cells.
LABEL>0
We have examined the level of GE, a PROTEIN1, and GE, a PROTEIN2, in BALB/c 3T3 cells.
LABEL>0
We have shown that the GE GE and GE are potential targets of the PROTEIN1 family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the GE family PROTEIN1 and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the GE family GE and bind to an PROTEIN1, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the PROTEIN1 GE and GE are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the PROTEIN2 cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the PROTEIN1 family GE and bind to an GE, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the PROTEIN1 family GE and bind to an PROTEIN2, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the PROTEIN1 GE and GE are potential targets of the PROTEIN2 family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE PROTEIN1 and PROTEIN2 are potential targets of the GE family GE and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and PROTEIN1 are potential targets of the GE family GE and bind to an PROTEIN2, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the GE family PROTEIN1 and bind to an GE, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE GE and GE are potential targets of the GE family PROTEIN1 and bind to an PROTEIN2, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the PROTEIN1 GE and GE are potential targets of the GE family PROTEIN2 and bind to an GE, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the GE PROTEIN1 and GE are potential targets of the GE family GE and bind to an PROTEIN2, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the PROTEIN1 GE and GE are potential targets of the GE family GE and bind to an GE, PROTEIN2, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that the PROTEIN1 GE and GE are potential targets of the GE family GE and bind to an PROTEIN2, GE, at their proline-rich FH1 domains to regulate reorganization of the GE cytoskeleton in the yeast Saccharomyces cerevisiae.
LABEL>0
We have shown that these proteins are indeed PROTEIN1: the 14 kd is the GE GE, the 19 kd is the PROTEIN2 GE, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed PROTEIN1: the 14 kd is the PROTEIN2 GE, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the PROTEIN1 GE, the 19 kd is the PROTEIN2 GE, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the GE PROTEIN1, the 19 kd is the PROTEIN2 GE, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the GE GE, the 19 kd is the PROTEIN1 GE, and the 25 kd is the sperm-specific protein PROTEIN2.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the PROTEIN1 GE, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein PROTEIN2.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the PROTEIN1 GE, the 19 kd is the GE PROTEIN2, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the GE PROTEIN1, the 19 kd is the GE GE, and the 25 kd is the sperm-specific protein PROTEIN2.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the GE PROTEIN1, the 19 kd is the GE PROTEIN2, and the 25 kd is the sperm-specific protein GE.
LABEL>0
We have shown that these proteins are indeed GE: the 14 kd is the GE GE, the 19 kd is the GE PROTEIN1, and the 25 kd is the sperm-specific protein PROTEIN2.
LABEL>0
We previously showed that GE is transported in an unassembled form with its associated proteins GE, PROTEIN1, and PROTEIN2.
LABEL>0
We previously showed that GE is transported in an unassembled form with its associated proteins PROTEIN1, PROTEIN2, and GE.
LABEL>0
We previously showed that GE is transported in an unassembled form with its associated proteins PROTEIN1, GE, and PROTEIN2.
LABEL>0
We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric GE that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN2 is highly concentrated.
LABEL>0
We propose that GE may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN1 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN2 is highly concentrated.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and GE from the cores but does not affect GE binding by 110-kD PROTEIN2.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN2 from the cores but does not affect GE binding by 110-kD GE.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and GE from the cores but does not affect PROTEIN2 binding by 110-kD GE.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN1 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN2 and GE from the cores but does not affect GE binding by 110-kD GE.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and PROTEIN1 from the cores but does not affect GE binding by 110-kD PROTEIN2.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN1 of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect GE binding by 110-kD PROTEIN2.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the GE of isolated cores, and can cause the dissociation of up to 30% of the GE and PROTEIN1 from the cores but does not affect PROTEIN2 binding by 110-kD GE.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN1 of isolated cores, and can cause the dissociation of up to 30% of the GE and PROTEIN2 from the cores but does not affect GE binding by 110-kD GE.
LABEL>0
We report here that GE, which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN1 of isolated cores, and can cause the dissociation of up to 30% of the GE and GE from the cores but does not affect PROTEIN2 binding by 110-kD GE.
LABEL>0
We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN2 and that the functions of the gene products of GE and GE are closely interrelated.
LABEL>0
We show here that the phenotype of ts PROTEIN1 is highly similar to that of GE and that the functions of the gene products of PROTEIN2 and GE are closely interrelated.
LABEL>0
We show here that the phenotype of ts PROTEIN1 is highly similar to that of GE and that the functions of the gene products of GE and PROTEIN2 are closely interrelated.
LABEL>0
We show here that the phenotype of ts GE is highly similar to that of PROTEIN1 and that the functions of the gene products of PROTEIN2 and GE are closely interrelated.
LABEL>0
We show here that the phenotype of ts GE is highly similar to that of PROTEIN1 and that the functions of the gene products of GE and PROTEIN2 are closely interrelated.
LABEL>0
We show that the HSV-1 GE, GE, PROTEIN1, PROTEIN2, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, PROTEIN1, GE, PROTEIN2, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, GE, GE, PROTEIN2, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, PROTEIN1, GE, and GE gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, PROTEIN1, GE, and PROTEIN2 gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, PROTEIN1, PROTEIN2, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, PROTEIN1, PROTEIN2, GE, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, GE, PROTEIN2, GE, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, PROTEIN1, GE, GE, and GE gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, PROTEIN1, GE, GE, and PROTEIN2 gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, PROTEIN1, GE, PROTEIN2, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, PROTEIN2, GE, GE, GE, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, PROTEIN1, GE, GE, GE, and GE gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, PROTEIN1, GE, GE, GE, and PROTEIN2 gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, PROTEIN1, GE, GE, PROTEIN2, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, GE, GE, GE, GE, and GE gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, GE, GE, GE, GE, and PROTEIN2 gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 PROTEIN1, GE, GE, GE, PROTEIN2, and GE gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, GE, GE, and PROTEIN1 gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, GE, PROTEIN1, and GE gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
We show that the HSV-1 GE, GE, GE, GE, PROTEIN1, and PROTEIN2 gene products along with the AAV GE protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
LABEL>0
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN1 GE relative to acetylated GE PROTEIN2.
LABEL>0
Western analysis of gel-purified GE-GE and GE-GE-PROTEIN1 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-PROTEIN1 and GE-GE-PROTEIN2 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-GE and GE-GE-PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN2 GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified PROTEIN1-GE and GE-GE-PROTEIN2 complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-PROTEIN1 and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-GE and GE-PROTEIN1-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN1 GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified PROTEIN1-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-GE and PROTEIN1-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated GE PROTEIN1 relative to acetylated PROTEIN2 GE.
LABEL>0
Western analysis of gel-purified GE-PROTEIN1 and GE-PROTEIN2-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-PROTEIN1 and GE-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN2 GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-PROTEIN1 and PROTEIN2-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-GE and GE-PROTEIN1-GE complexes demonstrated the predominant presence of acetylated PROTEIN2 GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified PROTEIN1-GE and GE-PROTEIN2-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified PROTEIN1-GE and GE-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN2 GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified GE-GE and PROTEIN1-GE-GE complexes demonstrated the predominant presence of acetylated PROTEIN2 GE relative to acetylated GE GE.
LABEL>0
Western analysis of gel-purified PROTEIN1-GE and PROTEIN2-GE-GE complexes demonstrated the predominant presence of acetylated GE GE relative to acetylated GE GE.
LABEL>0
We tested for the presence of GE, GE, GE, PROTEIN1 (heavy chain) and cytoskeletal proteins GE and PROTEIN2.
LABEL>0
We tested for the presence of GE, GE, PROTEIN1, GE (heavy chain) and cytoskeletal proteins GE and PROTEIN2.
LABEL>0
We tested for the presence of PROTEIN1, GE, GE, GE (heavy chain) and cytoskeletal proteins GE and PROTEIN2.
LABEL>0
We tested for the presence of GE, GE, GE, GE (heavy chain) and cytoskeletal proteins PROTEIN1 and PROTEIN2.
LABEL>0
We tested for the presence of GE, PROTEIN1, GE, GE (heavy chain) and cytoskeletal proteins GE and PROTEIN2.
LABEL>0
We tested for the presence of GE, GE, PROTEIN1, PROTEIN2 (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of PROTEIN1, GE, GE, PROTEIN2 (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of GE, GE, GE, PROTEIN1 (heavy chain) and cytoskeletal proteins PROTEIN2 and GE.
LABEL>0
We tested for the presence of GE, PROTEIN1, GE, PROTEIN2 (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of PROTEIN1, GE, PROTEIN2, GE (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of GE, GE, PROTEIN1, GE (heavy chain) and cytoskeletal proteins PROTEIN2 and GE.
LABEL>0
We tested for the presence of GE, PROTEIN1, PROTEIN2, GE (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of PROTEIN1, GE, GE, GE (heavy chain) and cytoskeletal proteins PROTEIN2 and GE.
LABEL>0
We tested for the presence of PROTEIN1, PROTEIN2, GE, GE (heavy chain) and cytoskeletal proteins GE and GE.
LABEL>0
We tested for the presence of GE, PROTEIN1, GE, GE (heavy chain) and cytoskeletal proteins PROTEIN2 and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or GE to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN2, GE, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN2 to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, PROTEIN2, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, PROTEIN2, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, GE, and PROTEIN2.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN2, GE, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1, GE, PROTEIN2, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1, PROTEIN2, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1, GE, GE, and PROTEIN2.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, PROTEIN2, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of GE, PROTEIN2, GE, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, GE, and PROTEIN2.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, PROTEIN1, PROTEIN2, and GE.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, GE, PROTEIN1, and PROTEIN2.
LABEL>0
We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in GE or GE to assess the involvement of mononucleotide repeats contained in the coding regions of GE, PROTEIN1, GE, and PROTEIN2.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, GE, and GE, did not rescue PROTEIN1delta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, PROTEIN1, and GE, did not rescue GEdelta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, GE, and PROTEIN1, did not rescue GEdelta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, PROTEIN1, GE, GE, and GE, did not rescue GEdelta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, PROTEIN1, GE, and GE, did not rescue GEdelta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, GE, GE, GE, and GE, did not rescue GEdelta O6 MeG DNA repair PROTEIN2-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, PROTEIN1, and GE, did not rescue PROTEIN2delta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, GE, and PROTEIN1, did not rescue PROTEIN2delta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, PROTEIN1, GE, GE, and GE, did not rescue PROTEIN2delta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, PROTEIN1, GE, and GE, did not rescue PROTEIN2delta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, GE, GE, GE, and GE, did not rescue PROTEIN2delta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, GE, PROTEIN1, and PROTEIN2, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, PROTEIN1, GE, PROTEIN2, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, PROTEIN1, PROTEIN2, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, GE, GE, PROTEIN2, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, PROTEIN1, GE, GE, and PROTEIN2, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, GE, PROTEIN1, GE, and PROTEIN2, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, GE, GE, GE, and PROTEIN2, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including GE, PROTEIN1, PROTEIN2, GE, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, PROTEIN2, GE, GE, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN1, GE, PROTEIN2, GE, and GE, did not rescue GEdelta O6 MeG DNA repair GE-deficient cells from killing by MNNG.
LABEL>0
When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at GE, PROTEIN1, and PROTEIN2.
LABEL>0
When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at PROTEIN1, GE, and PROTEIN2.
LABEL>0
When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at PROTEIN1, PROTEIN2, and GE.
LABEL>0
When the GE monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN1 and GE are down-regulated compared with PROTEIN2 and 19 other proteins selected at random.
LABEL>0
When the PROTEIN1 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN2 and GE are down-regulated compared with GE and 19 other proteins selected at random.
LABEL>0
When the GE monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN1 and PROTEIN2 are down-regulated compared with GE and 19 other proteins selected at random.
LABEL>0
When the PROTEIN1 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of GE and GE are down-regulated compared with PROTEIN2 and 19 other proteins selected at random.
LABEL>0
When the GE monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of GE and PROTEIN1 are down-regulated compared with PROTEIN2 and 19 other proteins selected at random.
LABEL>0
When the PROTEIN1 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of GE and PROTEIN2 are down-regulated compared with GE and 19 other proteins selected at random.
LABEL>0
While levels of most of these proteins decrease, accumulation of GE and the GE PROTEIN1 GE/PROTEIN2 is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of PROTEIN1 and the GE GE GE/PROTEIN2 is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of GE and the GE GE PROTEIN1/PROTEIN2 is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of PROTEIN1 and the GE PROTEIN2 GE/GE is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of GE and the GE PROTEIN1 PROTEIN2/GE is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of PROTEIN1 and the PROTEIN2 GE GE/GE is observed.
LABEL>0
While levels of most of these proteins decrease, accumulation of PROTEIN1 and the GE GE PROTEIN2/GE is observed.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of PROTEIN1 GE and only inefficiently competed with DNA for binding of PROTEIN2 GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1 GE, it equally competed with DNA for binding of PROTEIN2 GE and only inefficiently competed with DNA for binding of GE GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE PROTEIN1, it equally competed with DNA for binding of PROTEIN2 GE and only inefficiently competed with DNA for binding of GE GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of PROTEIN1 GE and only inefficiently competed with DNA for binding of GE PROTEIN2.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of GE PROTEIN1 and only inefficiently competed with DNA for binding of PROTEIN2 GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1 GE, it equally competed with DNA for binding of GE PROTEIN2 and only inefficiently competed with DNA for binding of GE GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE PROTEIN1, it equally competed with DNA for binding of GE PROTEIN2 and only inefficiently competed with DNA for binding of GE GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE GE, it equally competed with DNA for binding of GE PROTEIN1 and only inefficiently competed with DNA for binding of GE PROTEIN2.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1 GE, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of PROTEIN2 GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE PROTEIN1, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of PROTEIN2 GE.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1 GE, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of GE PROTEIN2.
LABEL>0
While poly(ADP-ribose) effectively competed with DNA for binding of GE PROTEIN1, it equally competed with DNA for binding of GE GE and only inefficiently competed with DNA for binding of GE PROTEIN2.
LABEL>0
Within the sieve-tube exudate, PROTEIN1 was present in 15-fold molar excess to PROTEIN2.
LABEL>0
YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, GE, GE, or PROTEIN2 loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, PROTEIN1, GE, or PROTEIN2 loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, GE, PROTEIN1, or PROTEIN2 loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN1, GE, GE, or PROTEIN2 loci.
LABEL>0
YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, PROTEIN2, GE, or GE loci.
LABEL>0
YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, GE, PROTEIN2, or GE loci.
LABEL>0
YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN2, GE, GE, or GE loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the GE, PROTEIN1, PROTEIN2, or GE loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN1, PROTEIN2, GE, or GE loci.
LABEL>0
YACs containing GE gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN1, GE, PROTEIN2, or GE loci.
